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ABSTRACT 
 
Background 
The efficacy of UK National Health Service (NHS) multidisciplinary pain 
management programmes (PMPs) is currently measured using self-report 
questionnaires. Whilst subjective measurements provide important information about 
personal experiences, they cannot reveal underlying changes in cortical activity 
related to pain that may also accompany PMP treatment. There is no objective 
measurement of treatment efficacy currently available. This thesis contains studies of 
two NHS PMPs that differ in their psychological approach. The effect of these 
treatments was assessed using self-report questionnaire measures, and a newly 
developed neurophysiological assessment technique. 
Methods 
Studies examined the effect of a cognitive-behavioural therapy (CBT) based PMP, 
and an acceptance and commitment therapy (ACT) based PMP, upon questionnaire 
measures of psychological, physical, and social health, as well as measures of coping 
and acceptance. Further studies examined pre- to post-treatment changes in patients’ 
cortical pain processing measured using electroencephalography (EEG), as well as in 
healthy and patient (waiting list/treatment as usual) control groups. The effect of 
treatment on contact heat evoked potentials (CHEPs), and on changes in power 
spectral density (PSD) following exposure to medium duration tonic pain (90s cold 
pressor test) was investigated. 
Results 
Small but significant (p<.05) improvements in self-report measures of mental health, 
coping, and acceptance were found in patients following both CBT- and ACT-based 
PMPs. There were differences in the effect of PMPs on measures of anxiety, 
depression and catastrophising, with the ACT-based programme data showing 
slightly larger effect sizes. Neurophysiological testing revealed no pattern of effect 
upon CHEPs, however there were pre- to post-treatment differences in the effect of 
tonic pain upon PSD. Alpha (α) and theta (θ) rhythms were significantly (p<.05) 
reduced pre-treatment in the CBT group (n=12); post-treatment this effect was not 
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observed. There were no pre- to post-treatment differences in the ACT group (n=4) 
and there were also no changes in either healthy (n=14) or waiting list (n=13) control 
groups between test sessions. 
Conclusion 
Both PMPs studied brought about small but significant improvements in patients’ 
perceived mental and physical health. Despite their differences both programmes 
were clinically beneficial to patients in terms of self-report measures. Measurable 
change was observed in the cortical response to pain pre- to post-treatment with a 
CBT-based PMP, most likely due to a change in cognitive appraisal of painful 
signals brought about by taking part in the PMP. Results imply the possible use of 
neurophysiological assessment to identify patients who may benefit most from 
treatment, to match treatments to patients’ individual psychological and 
neurophysiological profile, and to more closely monitor treatment efficacy. 
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CHAPTER 1 
INTRODUCTION 
 
Pain is usually a finite experience that is felt in response to illness or injury, and which 
disappears following recovery. Yet for some, pain may appear without apparent 
physical cause, or does not subside upon recovery from illness or injury, resulting in a 
long-term condition characterised by the symptom of ‘chronic’ pain. The treatment of 
pain begins by addressing the physical cause of pain – tissue damage is allowed to 
heal, whilst pain medication is used to modify nerve signals relating to the damage and 
ease suffering. If pain were a purely physical phenomenon, with its origin in the 
damaged tissues, this treatment would be all that was required. However, pain is a 
‘sensory and emotional’ experience which results from a complex interaction of 
physiological and psychological factors; therefore modern treatments for chronic pain 
consist of a mix of pharmacological, physiological, and psychological approaches, 
which mirror the present theoretical understanding of pain as a biopsychosocial 
phenomenon. One treatment in particular which offers respite from suffering in those 
patients who do not achieve satisfactory relief through medication is the pain 
management programme (PMP). Based upon a psychotherapeutic approach, the PMP 
aims to promote recovery from chronic pain by exploiting the role of psychological 
factors that contribute to the pain experience. 
At present, the success of PMP treatment is measured using questionnaires concerning 
psychosocial health, examining such factors as anxiety, depression, pain 
catastrophising, coping strategies, daily activity, and beliefs about pain. These 
measures have demonstrated that the treatment can be effective (Morley, Eccleston & 
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A. Williams 1999). Such subjective reporting of improvement by patients is arguably 
the most important assessment of treatment efficacy, as it relates directly to the goal 
of treatment, which is to promote better patient health. Two PMPs delivered by 
regional treatment centres in the West Midlands region of the UK are focused on in 
this study. The first is based on the psychological principles of cognitive-behavioural 
therapy (CBT), and the second based on the principles of acceptance and commitment 
therapy (ACT). Since their inception, several hundred patient questionnaires have been 
collected by the staff of both programmes. Two chapters of this thesis (Ch. 3 & 5) are 
dedicated to the analysis and presentation of these questionnaire datasets. 
Questionnaire data can provide a detailed picture of the efficacy of PMPs in terms of 
subjective improvement from pre- to post-treatment. However, the questionnaires 
cannot reveal biological mechanisms and underlying changes in the brain 
accompanying treatment success or failure in these patients (Linden 2006). Advances 
in the field of functional brain imaging over the past decades have made it possible to 
measure brain structure and brain activity with high spatial and temporal resolution 
and it has now become possible to examine the biological consequences of 
psychotherapeutic interventions using the  techniques available (Etkin et al. 2005). 
This thesis therefore also explores the possibility that the neuroimaging technique of 
electroencephalography (EEG) can be used to record measurable changes in electrical 
brain activity as a consequence of PMP treatment for chronic pain, either in CBT-
based (Ch. 4) or ACT-based (Ch. 6) programmes. The relationship between 
questionnaire and EEG data is also explored in a short case series (Ch. 6). 
The studies contained within this work were designed following a thorough 
exploration of pain theory, pain treatment, and the use of questionnaires and 
neuroimaging to assess pain and the effects of pain treatment. Background information 
3 
Literature review 
(Chapter 2) 
‘Audit’ 1 
CBT-PMP 
(Chapter 3) 
‘Audit’ 2 
ACT-PMP 
(Chapter 5) 
 
EEG study 1 
CBT-PMP 
(Chapter 4) 
EEG study 2 
ACT-PMP 
(Chapter 6) 
+ case series 
 
Experimental 
chapters 
Conclusions 
(Chapter 7) 
relevant to the studies is presented in the literature review (Ch. 2), which ends with a 
summary of the theoretical basis for the study and an accompanying rationale. 
The final chapter (Ch. 7) contains discussion of the main findings from this work, the 
implications, and recommendations for future research. Figure 1.1 illustrates the 
structure of the thesis. 
 
 
 
 
  
 
 
 
 
 
 
Figure 1.1 Flow chart illustrating the structure of the thesis. 
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1.1 AIMS AND OBJECTIVES 
The aims of this study are: 
(1) To assess the efficacy of two pain management programmes, which are either 
based on principles of CBT or ACT, in terms of patient self-report in the form 
of questionnaires. 
(2) To identify measurable changes in brain activity related to the processing of 
painful stimuli brought about by treatment using a pain management 
programme (based on CBT or ACT). 
The objectives of this study are: 
(1) To investigate changes in psychophysical health and pain related thinking 
(measured by self-report questionnaires) in the population of patients which 
have attended either the CBT-based Dudley Group of Hospitals NHS trust 
PMP or the ACT-based Royal Wolverhampton NHS trust PMP. 
(2) To perform an assessment of cortical electrical activity following painful 
stimulation (measured using EEG) in samples of chronic pain patients and 
control participants over a time period during which a subset of patients will 
partake in one of the above PMPs. 
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1 HISTORY OF PAIN THEORIES 
“Nature has placed in the front part of man, as he moves, all those parts which 
when struck cause him to feel pain; and this is felt in the joints of the legs, the forehead 
and the nose, and has been so devised for the preservation of man, because if such 
pain were not felt in these limbs they would be destroyed by the many blows they 
receive.”  
Leonardo Da Vinci (n.d.), Thoughts on Art and Life, 82. 
 
The search for a working model, or theory, of how pain works has probably been going 
on as long as the concept of pain has been in existence. According to Gatchel (1999) 
descriptions of pain treatment were recorded as early as 4000 B.C. in ancient Egypt, 
and acupuncture therapy for pain reduction was first used in ancient China nearly 2000 
years ago. Throughout history, several theories of pain have dominated current 
thinking. With advances in our understanding of biology, psychology, and with the 
advent of new medical technologies, older theories have been replaced or updated. 
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2.1.1 Specificity Theory 
Descartes’ (1664) concept of the pain system (Figure 2.1) was of a ‘straight-through’ 
channel running from the skin to the brain, which transmits the sensation of pain from 
one place to another. 
 
 
Figure 2.1 Descartes’ pain system (from Descartes 1664, in Descartes & Hall 2003). 
 
The central premise of specificity theory held the existence of a specific pain system 
which carried messages from pain receptors in the skin to a pain area in the brain. 
Through experiments in anatomy and physiology, it was known that nerve pathways 
existed and that these were responsible for conveying sensory messages to the brain. 
It was clear that nerves were capable of carrying messages from specific sense organs 
which described a variety of sensations – sight, sound, touch, taste, and smell – 
however it was not clear how these qualities were translated into experiences felt by 
the mind. Sensory properties of nerves were thought to be determined by the brain area 
in which the nerve terminated. Areas of the brain responsible for vision and hearing 
had already been located, and it was reasoned that specific brain areas for touch, taste, 
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smell and pain also existed. The evidence for a specific pain centre in the brain was 
lacking, however Head and colleagues (1920) suggested it was located in the thalamus, 
as lesions or removal of the thalamus tended to worsen pain. 
Specificity theory could not explain the ‘phantom limb’ pain felt by amputees, and 
also the failure of complete transsections of the spinal cord to abolish pain. It was also 
known that pain could be elicited by non-noxious stimulation in some patients, and 
that patients would complain of pain in the absence of any stimulus, which was not 
possible under specificity theory. 
Specificity theory was also unable to account for the effect of pain on the mind. In 
order to bring together the physiological and psychological aspects of pain, Hardy, 
Wolff and Goodell (1952) proposed an extension to specificity theory, which stated 
that pain was made up of two components: the perception of pain and the reaction to 
pain. In their theory, there remained a one-to-one relationship between the intensity of 
the stimulus and the pain message arriving at the brain; however it was possible for an 
individual to react to the pain differently depending on psychological factors. This 
theory of pain as a sensory and affective experience was able to account for individual 
differences in reactions to painful stimuli which could not be explained by specificity 
theory; however the body and mind were treated as separate entities and there was no 
notion that the mind could exert influence over the sensory system. 
2.1.2 Sensory Interaction Theory 
Noordenbos (1959) took ideas from Goldsheider’s (1894) pattern theory and combined 
them with recent evidence that showed the existence of two separate fibre systems (fast 
and slow) responsible for transmitting sensory information to the spinal cord. Pattern 
theory took into account the effect of stimulus intensity on the pattern of nerve firing, 
and suggested that pain sensation is felt when the total output of nerve cells exceeds a 
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certain threshold level. Sensory interaction theory held that the rapidly conducting 
sensory fibre system had inhibitory control over the more slowly conducting system 
that carries the signal for pain. When the activity in the slow fibre system overcame 
the inhibition of the fast ‘control’ system, a summation of pain signals at a spinal 
ganglion resulted in the transmission of a pain signal to the brain. This theory displayed 
a marked departure from the idea of a straight through pain system from the periphery 
to the brain. 
2.1.3 Gate Control Theory (GCT) 
During the early 1960s a great deal of research was carried out to examine the 
properties of the sensory nerve fibres which had been identified by Noordenbos and 
others described above. In 1960 Patrick Wall published work in which he described 
recordings from single cells in the spinal cord which responded to input from both fast 
and slow fibres in a characteristic manner. The ‘gate control system’ represents the 
area of the spinal cord containing the afferent synapses of the peripheral sensory 
nerves, the substantia gelatinosa, and the transmission cells (T-cells) which project to 
the ‘action system’ (Figure 2.2). The transmission of afferent impulses to the T-cells 
is controlled by a gating mechanism which acts to facilitate or inhibit the incoming 
signals. This gating mechanism is influenced by the relative activity in the large and 
small-diameter fibres; more small fibre activity tends to facilitate transmission (open 
the gate); more large fibre activity tends to inhibit transmission (close the gate). Large, 
fast-transmitting fibres (the central control trigger) transmit signals direct to the brain, 
activating cognitive processes which in turn return signals which can influence the 
gating mechanism. When output of the T-cells reaches a threshold level, the action 
system is activated, resulting in the response and perception of pain (Melzack & Wall 
1996; Bonica & Loeser 2001). 
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Figure 2.2 Diagram of the gate control theory of pain. The large (L) and small (S) fibres 
project to the substantia gelatinosa (SG) and first central transmission (T) cells. The inhibitory 
effect exerted by the SG on the afferent fibre terminals is increased by activity in the L fibres 
and decreased by activity in the S fibres. The central control trigger is represented by a line 
running from the large fibre system to the central control mechanisms; these mechanisms, in 
turn, project back to the gate control system. The T-cells project to the entry cells of the action 
system. + = excitation, – = inhibition (from Melzack & Wall 1965, p.975). 
 
The GCT was successful in refuting many of the claims made by specificity theory, 
particularly that a specific system was involved in pain transmission and that there was 
a one-to-one relationship between stimulus intensity and pain perception. However, 
large parts of the theory were still theoretical and had not yet been empirically proven, 
thus opening up a number of avenues for research to proceed along in the following 
years – mainly in the areas of the fine detail of the physiology of the sensory system 
and in the role of the brain and cognitive processes in the perception of pain. The next 
section will describe our current understanding of nervous system physiology as it is 
related to pain. 
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2.2 PHYSIOLOGY OF PAIN 
“It is customary to describe the somatosensory system by proceeding from the 
peripheral receptors…to areas in the brain. However, it is essential to remember that 
stimulation of receptors does not mark the beginning of the pain process…Stimulation 
produces neural signals that enter an active nervous system…already the substrate of 
past experience, culture, anticipation, anxiety and so forth.” 
R. Melzack & P.D. Wall (1996). The Challenge of Pain, p.81. 
 
The role of the nociceptive system is to protect the organism from harmful stimulation. 
Nociception is accomplished using a relatively simple process: a stimulus of sufficient 
intensity to cause tissue damage activates a specialised nerve ending, which sets off a 
signal that is transmitted along a chain of nerves until it reaches a group of muscle 
cells which activate to move the organism away from the point of stimulation. This 
nociceptive signal may also pass into more complex systems and networks of nerves 
where it is assessed, encoded and interpreted as something more than mere 
nociception. It may affect the behaviour, cognitions, and emotions of the organism, 
resulting in the organism feeling this nociception as something more than actual or 
potential tissue damage. The feeling of pain is the result of a complex exchange 
between signalling systems, modulation from higher centres and the unique perception 
of the individual (Steeds 2009) (Figure 2.3). 
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Figure 2.3 The path of pain – 1) Transduction: the conversion of a noxious stimulus into 
electrical energy by peripheral nociceptors – 2) Transmission: propagation of the signal 
through the peripheral nervous system via first-order neurons – 3) Modulation: adjustment of 
pain intensity at the point where first-order neurons synapse with second-order neurons in the 
dorsal horn of the spinal cord – 4) Perception: the cerebral cortical response to nociceptive 
signals projected to the brain by third-order neurons. Stimulation of the descending pathway 
from the brain (green arrow) sends modulatory signals back to the spinal cord that may 
facilitate or inhibit further transmission (adapted from Cepeda et al. 2007, p.11). 
 
2.2.1 The Nociceptors and Peripheral Nerves 
The skin, musculo-skeletal system, and viscera are penetrated by widely branching, 
bushy networks of nerve fibres which are sensitive to temperature, pressure, and 
chemical stimulation. Three types of fibres are known to exist: A-beta (Aβ), A-delta 
(Aδ), and C-fibres (Table 2.1). The Aβ-fibres respond only to light mechanical 
pressure and are not involved in nociception; the Aδ- and C-fibres respond to a wide 
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range of temperature, pressure, and chemical influences, and are thus capable of 
detecting potentially damaging stimulation. 
 
Table 2.1 Properties of different types of afferent fibres. 
 Myelinated  Unmyelinated 
Fibre type A-beta (Aβ) A-delta (Aδ) C 
Diameter 5-15 μm 1-5 μm 0.25-1.5 μm 
Conduction 
velocity 
30-100 m/sec 6-30 m/sec 1.0-2.5 m/sec 
Receptor type specialised & free free free 
Respond to * light pressure 1  light pressure 
2  heavy pressure 
3  heat (45°C + ) 
4  chemicals 
5  cooling 
1  light pressure 
2  heavy pressure 
3  heat (45°C + ) 
4  chemicals 
5  warmth 
* Each fibre in the Aδ and C may respond to only one or to more than one of the 
types of stimuli; for example, there are C ‘polymodal fibres’ that respond to heavy 
pressure, heat, and chemicals (adapted from Melzack & Wall 1996, p.86). 
 
Transduction of a noxious stimulus into an electrical signal occurs at the peripheral 
nociceptor through the activation of receptors positioned around the nerve ending. The 
process by which stimuli are converted into a nerve impulse is thought to be mediated 
by cell membrane proteins of the transient receptor potential (TRP) family of ion 
channels (Ramsey et al. 2006).  The details of TRP channels are beyond the scope of 
this thesis, suffice it to say that receptors exist that are specialised to respond to 
mechanical, heat, cold and chemical stimuli. Aδ- and C-fibres do not respond equally 
to all types of stimulation; instead there are fibres that respond preferentially to one or 
other stimulus, or do not respond to some stimuli at all. This may allow for the different 
aspects of nociceptive sensation (e.g. burning, itch, pricking, aching) due to the 
enhanced discrimination made possible by a mixture of response properties. The Aδ-
nociceptors are separated into two categories: Type-I Aδ nociceptors, or high-
threshold mechanoreceptors (HTM), typically respond to mechanical and chemical 
13 
stimuli, but are also activated by high (>50°C) temperatures; Type-II Aδ nociceptors 
respond preferentially to noxious thermal stimuli, and most show no response to 
mechanical stimuli. The C-fibre nociceptors contain populations of neurons 
responding to either mechanical, heat or cold stimuli; there are C-fibre nociceptors that 
are affected by mechanical and heat stimuli; and also so called ‘silent’ nociceptors, 
which develop sensitivity to heat and chemical stimuli in the presence of inflammatory 
chemicals released following tissue damage (Porreca 2010).  
In the event of intense stimulation, the myelinated Aδ-fibres transmit the initial 
sensations: the intense, sharp pain felt immediately following pinprick, pinch or 
noxious heat. The unmyelinated C-fibres transmit the delayed, unpleasant sensations 
which are more dull, diffuse, throbbing and/or burning than the initial pain. This 
‘nociceptive’ pain warns of potential tissue damage. In the event of tissue damage, a 
range of inflammatory chemicals will be released, including bradykinin and 
prostaglandins which sensitise the terminals of Aδ-HTM and C-fibres, meaning that 
pain will persist in and around the injured tissues for minutes, hours, or days. 
2.2.2 The Spinal Cord 
The final destination of the first order sensory neurons is the dorsal horn of the spinal 
cord, which they enter after passing through the dorsal root ganglion (DRG). The DRG 
is a nodule which contains the cell bodies of the primary afferent fibres and lies just 
outside the spinal cord.  
2.2.3 Central Modulation and Descending Pathways 
Transmission of nociceptive signals from the dorsal horn is modulated by descending 
pathways from brainstem structures, the periaqueductal grey and the rostral 
ventromedial medulla (Fields et al. 2006). These structures are part of a descending 
modulatory circuit with inputs from multiple cortical sites including the hypothalamus, 
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amygdala, and anterior cingulate cortex, which acts to facilitate or inhibit nociceptive 
traffic in the spinal cord (Ossipov et al. 2010).  
2.2.4 Cortical Processing 
Axons of both types of second order neurons ascend to regions of the brainstem and 
thalamus in the spinothalamic tract (STT). The fibres of the lateral STT terminate in 
several locations, including the brainstem reticular formation and medial nuclei of the 
thalamus, which project third order neurones to limbic structures and the frontal cortex, 
parts of the brain associated with emotion, memory and decision making. Fibres in the 
anterior STT terminate in the lateral nuclei of the thalamus where they synapse with 
neurones which pass signals to the somatosensory cortex. The somatosensory cortex 
is the initial site of sensory processing, encoding information regarding location and 
intensity of stimulation. Following these initial points of entry into the cortex, further 
processing of information received from the periphery across multiple sites 
(collectively known as the pain matrix) gives rise to the conscious feeling of pain. 
2.2.5 From Nociception to Pain 
A large distributed network of brain areas are activated during the processing of 
nociceptive information. These include the thalamus, basal ganglia, hippocampus, 
amygdala, cerebellum, primary and secondary somatosensory cortices (S1 and S2), 
primary motor cortex (M1), insular cortex, amygdala, anterior cingulate cortex (ACC), 
and prefrontal cortex (PFC). There is no single pain centre where the feeling of pain is 
generated; instead there exists an interconnected matrix of areas which work in concert 
to give rise to the complex experience of pain. The sensory-discriminatory (e.g. 
location, intensity, duration) aspects of pain are thought to be processed by S1, S2, 
thalamus and posterior insula; the affective-cognitive-evaluative (e.g. unpleasantness, 
emotion, motivation) aspects are encoded in the ACC, PFC, and anterior insula. The 
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precise level of involvement of each brain area in the experience of pain varies 
considerably depending not only on the location and severity of injury, but also on less 
tangible factors such as mood, cognition, environment, and past experience, which 
means that the pain matrix is not a strictly defined entity (Tracey 2010). 
 
2.3 CURRENT UNDERSTANDING OF PAIN 
2.3.1 The Biopsychosocial Model 
One of the strengths of the GCT was that sensory mechanisms were not solely 
responsible for the experience of pain. Cognitive, emotional, and situational factors 
such as memory, arousal, and context also played a part. However, medicine at the 
time was ill equipped to deal with such a symptom which spanned the body and the 
mind. The biomedical model that had prevailed since the renaissance assumed that 
symptoms could be traced to a purely biological origin, and that illness was treated by 
correcting the specific body structure or organ system at fault. In the cases of mental 
illness and chronic pain, where no fault could be found, the biomedical model was of 
no use. A paper by George L. Engel published in 1977 called for a new 
‘biopsychosocial’ medical model. Under this model, diagnosis and treatment of illness 
would be made not solely on the basis of laboratory findings, but also by investigating 
the psychological, behavioural, and social circumstances which led to the patient 
arriving in the healthcare system (Figure 2.4a).  
Loeser (1982) applied the biopsychosocial model to the concept of pain, describing 
four interrelated dimensions: nociception, pain, suffering (the emotional responses 
triggered by pain, such as anxiety or depression), and pain behaviour (the visible 
responses to pain, such as avoiding activities and seeking treatment) (Figure 2.4b). 
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Each of the four dimensions becomes a target for treatment, and pain is no longer the 
most important element of the illness.  
 
 
Figure 2.4 Diagram of the biopsychosocial concept of illness (a) general model, (b) applied 
to pain (adapted from Waddell 1987, p.637). 
 
 
2.3.2 Neuromatrix Theory 
 
“We don’t need a body to feel a body.” 
R. Melzack (1989), p.4. 
 
The greatest problem with GCT was that it could not explain the phantom limb pains 
of patients who had a completely severed spinal cord, and therefore no connection 
between the gate control system and the brain. The new theory proposed by Melzack 
(1989) described a network of nerve cells distributed around the entire brain that work 
together to hold a representation of the whole body, termed ‘the body-self 
neuromatrix’. Crucially, the inputs to this neuromatrix are not only limited to sensory 
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afferents from the periphery, but also include inputs from within the brain itself, 
representing cognitive, emotional, and motivational processes. These inputs are 
processed by the neuromatrix in a series of converging and diverging neuronal loops, 
generating a unified output termed the ‘neurosignature’. The neurosignature flows 
continuously into the brain areas which generate a constantly changing stream of 
awareness, in order for the body to experience sensation and emotion; and also to areas 
that initiate muscle activity, generating behavioural responses. Neuromatrix theory 
allowed for the explanation of phantom limb pain, even with a severed spinal cord: the 
neuromatrix contains a representation of the missing limb, and inputs from within the 
brain itself can activate the neuromatrix in such a way that produces a neurosignature 
for pain in the phantom limb. 
Figure 2.5 presents a diagram describing the body-self neuromatrix, including the 
outputs of the neuromatrix: pain perception, action programs, and stress-regulation 
programs.
 
Figure 2.5 Factors that contribute to the patterns of activity generated by the body-self 
neuromatrix, which comprises sensory (S), affective (A), and cognitive (C) neuromodules. 
The output patterns from the neuromatrix produce the multiple dimensions of pain experience 
as well as concurrent homeostatic and behavioural responses (adapted from Melzack 2001, 
p.1382). 
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A key concept in the theory was that the pattern generating mechanism (the body-self 
neuromatrix) was not a fixed system. The initial spatial distribution and synaptic 
architecture of the neuromatrix was determined genetically, but there is plasticity – the 
neuronal connections are constantly being updated and altered by the chemical 
mediators of sensory, cognitive, and emotional experiences. This meant that the theory 
could account for almost any pain phenomenon. Previous experience, be it injury, 
pathology, hormonal stress, or psychology, could shape the neuromatrix in such a way 
that the pain neurosignature could be generated by a combination of angst, context, 
and emotion, in the absence of any physical stimulation. Furthermore, the theory 
suggested that chronic pain could be modulated by treatments targeting cognitive, 
emotional, and behavioural factors. 
 
2.4 CHRONIC PAIN 
Pain is unpleasant, but it is also a useful mechanism that promotes the healing process, 
forcing the sufferer to rest the affected area and seek out medical assistance. When 
pain continues for extended periods of time – either beyond the usual amount of time 
expected for an injury to heal, or in the absence of injury – it is referred to as chronic 
pain (Turk & Melzack 2011). The International Association for the Study of Pain 
(IASP) define chronic pain as pain which lasts for longer than three months (IASP 
1986). Chronic pain syndromes, such as low back pain, fibromyalgia, or sciatica, 
commonly begin following injury or disease, but may be perpetuated by factors other 
than the cause of the pain (Loeser & Melzack 1999). The pain persists long after it can 
serve any useful function and is no longer just a symptom of injury or disease but 
becomes a medical problem in its own right (Melzack & Wall 1996). 
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2.4.1 Epidemiology of Chronic Pain 
It has been estimated that disorders characterised by chronic pain account for 21.3% 
of the worldwide total years lived with disability – more than diabetes and cancer 
combined (Vos et al. 2012). Low back pain and neck pain are the first and fourth 
(respectively) leading causes of disability worldwide (Vos et al. 2012). In a meta-
analysis of 13 studies examining chronic pain conducted in Europe, Israel, Canada, 
and Australia, the prevalence of chronic pain ranged from 10.1‒55.2% (Harstall & 
Ospina 2003). Another study of 46,394 people (aged ≥ 18 years) across 15 European 
countries and Israel (including 3,800 from the UK), screened for chronic pain lasting 
≥ 6 months, with an intensity of ≥ 5 on the 10-point Numerical Rating Scale (NRS, 1 
= no pain, 10 = worst pain imaginable). Using these specific criteria, prevalence ranged 
from 12‒30%, with the UK at 13% (Breivik et al. 2006). Further analysis revealed that 
chronic pain sufferers in the UK had a mean age of 49.2 years, mean pain duration of 
5.9 years, and 49% were female; 37% reported they received inadequate pain control, 
highlighting how difficult it is to achieve successful treatment of chronic pain.  More 
recently, the Health Survey for England (HSE) 2011 interviewed 8,610 adults, finding 
31% of men and 37% of women had suffered pain for more than 3 months (HSCIC 
2012). Finally, analysis of a large scale dataset from UK Biobank, which included 
503,325 people aged 40‒69 years, put the prevalence of pain lasting ≥ 3 months at 
42.9% (Macfarlane et al. 2015). 
2.4.2 Living with Chronic Pain 
Patients with chronic pain frequently present with a number of other psychological and 
social complaints which may have preceded or been brought on by the stress of living 
in near constant pain. Many patients may have to stop working, cancel enjoyable 
physical and social activities, and withdraw from contact with friends and family due 
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to their disability (Kemler & Furnée 2002). The HSE 2011, which included over 4,000 
pain patients, documented that for 22% of men and 24% of women, pain had limited 
daily activities for over 14 days in the past three months (HSCIC 2012).  Chronic pain 
is likely to alter traditional family roles, to cause financial difficulties, result in 
deterioration of marital and sexual relationships, and create distress for other family 
members, as well as for the patient (Turk et al. 1987). Elevated rates of depressive, 
anxiety, substance use, somatoform, and personality disorders have been noted in 
chronic pain patients (Dersh et al. 2002). 
2.4.3 The Development and Maintenance of Chronic Pain 
Biomedical explanations for chronic pain can be categorised into four broad 
syndromes: nociceptive pain; inflammatory pain; dysfunctional pain; and neuropathic 
pain (Costigan et al. 2009). The reasons for the development and maintenance of three 
of the pain syndromes are easily identified: prolonged noxious stimulation 
(nociceptive pain); chronic inflammation (inflammatory pain); nerve lesions or disease 
(neuropathic pain). However in the case of dysfunctional pain there is no obvious 
reason for the occurrence of persistent pain. 
In contrast to biomedical explanations, psychosocial theories of pain do not place 
emphasis on the origin of pain, but instead focus on how pain in general can affect and 
be affected by an individual’s cognitions, behaviours, and environment. Not only is 
the relationship between tissue damage and pain highly variable, but also the 
relationship between the experience of pain and the level of functional disability is far 
from absolute. Patients may experience intense pain without suffering any disability 
(Vlaeyen et al. 2007). Psychological and social theories attempt to explain this variable 
relationship by recognising that the person and their environment play active roles in 
the pain experience. 
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2.4.3.1    Behavioural theory 
Wilbert Fordyce applied the principles of behavioural psychology to explain the 
development, maintenance, and treatment of pain behaviours (Fordyce, Fowler, & 
DeLateur 1968; Fordyce, Fowler, Lehmann, et al. 1968). Behaviourism places 
emphasis on observable actions, which are an objective, visible measure – “for the 
behaviourist, the crying (plus the kicking, facial expression, and other overt activities) 
is itself the pain” (Rachlin 1985, p.48). Fordyce recognised that there was a variable 
relationship between pain reports and pain behaviours, and believed that behaviour 
held the key to the maintenance of or recovery from pain.  
2.4.3.2    Cognitive theory 
In contrast to behaviourism, cognitive theory recognises the contribution of thought 
processes in the development of an illness and the corresponding behaviours. The 
pioneer of cognitive theory, A.T. Beck, believed that an individual’s emotion and 
behaviour were largely determined by the way in which they structure the world and 
the reciprocal influences of thoughts, feelings and behaviours (Figure 2.6) (Beck 1967; 
Beck et al. 1979).  
Figure 2.6 The cognitive-behavioural model (from Simmons & Griffiths 2009, p.21). 
 
Thoughts 
Feelings (emotions) 
Feelings (physical sensations) 
Behaviours 
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A number of cognitive-psychological processes are involved with pain and may 
contribute to the development of a persistent pain problem (Linton & Shaw 2011). 
Cognitions such as beliefs, attributions, expectations, self-efficacy, attention, 
catastrophising, coping, and locus of control can all influence the way in which an 
individual interprets and reacts to feelings of pain: 
Beliefs and attributions about pain can affect the way in which patients engage with 
their problem, and may lead to maladaptive coping, exacerbation of pain, increased 
suffering, and greater disability (Turk & Monarch 2002). Patients who believe that 
their pain is due to ongoing tissue damage report more severe pain than patients with 
an identical condition who believe that the pain is a stable symptom of a condition that 
may improve (Spiegel & Bloom 1983).  
Expectations include anticipation of pain and the fear of pain. When patients believe 
that activities will result in pain, they are likely to engage in avoidance behaviours to 
prevent a potential painful experience (Vlaeyen & Linton 2000).  
Self-efficacy is concerned with a person’s judgement of their capabilities to perform 
activities, and their perceived control over events (Bandura et al. 1987). In samples of 
chronic pain patients, perceived self-efficacy is significantly correlated with actual 
physical performance of exercise tasks (Council et al. 1988), and has been shown to 
be predictive of pain behaviours and avoidance behaviours, even when controlling for 
actual pain severity, chronicity, and disability (Asghari & Nicholas 2001). 
Attention to acute pain is beneficial, interrupting ongoing tasks with a signal to bodily 
threat that urges escape (Vlaeyen et al. 2007). In the case of chronic pain, where the 
signal may be considered unhelpful, pain still demands attention. The individual in 
chronic pain can become fixated on the pain, closely monitoring every fluctuation and 
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constantly searching for causes and treatments – a state known as hypervigilance 
(Crombez et al. 2005). When repeated attempts to relieve or cure the pain end in 
failure, patients experience physical, emotional, and cognitive distress, further 
worsening their overall health (Aldrich et al. 2000). 
Catastrophic thinking about pain, or catastrophising, is characterised by negative self-
statements and exaggerated pessimistic thoughts and ideation (Rosenstiel & Keefe 
1983). Patients and healthy subjects who show a tendency to catastrophic thinking are 
likely to report more intense pain and emotional distress during painful stimulation 
than non-catastrophisers (Keefe et al. 1989; Sullivan et al. 1995).  
Locus of control concerns the degree to which a person believes that outcomes are 
controlled by their own behaviours (internal locus) or by external factors such as 
chance or other people (external locus) (Rotter 1966). One study measuring locus of 
control over pain has shown that patients who score highly on the internality dimension 
report their pain as less intense and frequent than those with lower scores (Toomey et 
al. 1991). Locus of control has been studied in relation to coping strategies used in 
chronic pain patients (Crisson & Keefe 1988). Patients who perceived outcomes as 
controlled by ‘chance’ or ‘luck’ were likely to use maladaptive coping strategies such 
as catastrophising, diverting attention, praying or hoping, and report that they had little 
control over their pain. In both of the above studies, ‘internals’ showed reduced levels 
of physical and psychological symptoms and responded better to treatment than 
‘externals’ (Main & Waddell 1991). 
2.4.3.3    The fear-avoidance model 
Bringing together both behavioural and cognitive factors to explain the development 
of musculoskeletal pain problems, the fear-avoidance model has been highly 
influential (Lethem et al. 1983; Vlaeyen, Kole-Snijders, Boeren et al. 1995; Vlaeyen, 
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Kole-Snijders, Rotteveel et al. 1995; Vlaeyen & Linton 2000). Under the model 
(Figure 2.7), patients suffering from acute pain may either engage in confrontation or 
avoidance behaviours in order to deal with the pain. The avoidance of feared activities 
leads to an overall reduction in activity, which can be the beginning a downward spiral 
of disability and pain. 
 
 
Figure 2.7 The fear-avoidance model. If pain (possibly caused by an injury) is interpreted as 
threatening (pain catastrophising), pain related fear evolves. This leads to avoidance 
behaviours, and hypervigilance to bodily sensations followed by disability, disuse, and 
depression (adapted from Vlaeyen & Linton 2000, p.329). 
 
The strength of the fear-avoidance model is that it brings together a number of 
psychological factors which are related to chronic pain and combines them into a 
unified cognitive-behavioural model with clear targets for psychosocial treatment. 
2.4.3.4    The psychological flexibility model 
This model has evolved as a response to the limitations of behavioural theory (which 
does not deal with cognition) and the complex and mechanistic nature of cognitive 
theory (in which numerous discrete modules of cognition interact). It is a general 
25 
model of psychopathology and not specific for pain, however the treatment which 
emerges from the theory (Acceptance and Commitment Therapy, ACT) has proven 
useful as a therapeutic approach to chronic pain (discussed later, Section 2.5.8). Under 
the psychological flexibility model, behaviour is viewed as a function of the individual 
interacting with and in the context of an experience. The model has six interrelated 
processes which contribute to psychopathology: experiential avoidance, cognitive 
fusion, preoccupation with the past or future, inability to take a perspective separate 
from thoughts and feelings, failures in clarity or pursuit of values, and rigid persistence 
or impulsive avoidance (Hayes 2004a; McCracken & Morley 2014).  
Experiential avoidance can be a particular source of distress to the chronic pain patient, 
as no matter how much the person avoids activities or thoughts that are related to pain, 
the pain itself cannot be avoided. Cognitive fusion describes the manner in which a 
person becomes automatically guided by their elaborate relational networks without 
awareness of the process involved; making the individual less in contact with here-
and-now experiences and more dominated by verbal rules and evaluations (Hayes 
1989). In the pain patient, every environmental stimulus can become linked to pain 
through a relational network, meaning that everyday life becomes more stressful if the 
person unquestioningly believes their automatic thoughts and feelings. 
2.4.4 Summary 
The term chronic pain describes a biopsychosocial syndrome, characterised by 
persistent physical pain, disability, emotional disturbance, and social withdrawal 
symptoms existing together and influencing one another, in what Bandura (1978) has 
termed ‘reciprocal determinism’. Prolonged bodily stress and psychological distress 
lead to a deprived social environment and a dependence on medical and social support. 
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Constant pain leads to a fear of movement and a catastrophic belief that more pain and 
injury will occur, and it is likely that the patient will become depressed. 
Treatment of chronic pain requires a biopsychosocial approach. The next section will 
discuss available treatments including pain relieving drugs, as well as cognitive and 
behavioural strategies to manage pain, increase functional ability, and increase 
wellbeing. 
2.5 TREATMENTS FOR CHRONIC PAIN 
2.5.1 Analgesic Medication for Pain 
Pain reducing medications range from common ‘painkillers’ which can be found in 
any pharmacy or supermarket in the UK, to powerful opioids and antidepressants 
which are prescribed only for severe or chronic pain.  
In treating a case of pain the physician usually follows the steps on the World Health 
Organisation (WHO) analgesic ladder (Ventafridda et al. 1985; Figure 2.8). Initially 
developed for the treatment of cancer pain, but applicable to most pain conditions, the 
ladder suggests that analgesic medications should be given orally with increasing dose 
and potency until pain relief has been achieved. It is a simple and inexpensive approach 
that produces pain relief in 80-90% of patients (WHO 2015). The first step consists of 
non-opioid analgesics, such as paracetamol or Non-Steroidal Anti-Inflammatory drugs 
(NSAIDs), which act to reduce inflammation and provide pain relief by reducing the 
sensitisation and stimulation of nociceptors by chemicals released during 
inflammation. The second step adds weak opioids. Opioid drugs mimic the effects of 
naturally occurring pain reducing chemicals (endorphins) which activate opioid 
receptors in the central nervous system that attenuate transmission of nociceptive 
signals.  The third step calls for strong opioids, which are more potent but also have 
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more severe side effects than weak opioids. At each step, adjuvant medications may 
be given to relieve fear and anxiety caused by the pain (Table 2.2). 
 
 
Figure 2.8 The WHO analgesic ladder (adapted from Ventafridda et al. 1985, p.94). 
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Table 2.2 Common analgesic medications, mechanisms, and side-effects. 
Category Drug Use(s) Mechanism of action Side-effects 
Non-opioids 
Paracetamol 
NSAIDs 
Aspirin 
Ibuprofen 
Diclofenac 
Naproxen 
Celecoxib 
Etoricoxib 
Mild 
to 
moderate 
pain 
 
 
Arthritis 
pain 
COX-3 inhibition? 
 
 
COX-1 and 2 inhibition 
 
 
COX-2 inhibition 
None at normal doses 
 
 
Risk of GI bleed, 
impair renal function 
 
 
Risk of CV event 
Weak 
opioids 
+ 
Paracetamol 
Codeine 
Dihydrocodeine 
Co-codamol 
Co-dydramol 
Mild  
to 
moderate 
pain 
Opioid receptor agonist Constipation 
Other opioid Tramadol Severe pain 
Weak opioid agonist, 
inhibits noradrenaline 
uptake and serotonin 
release 
Dizziness, no 
respiratory 
depression 
Strong 
opioids 
Morphine 
Oxycodone 
Fentanyl 
Buprenorphine 
Severe pain 
Opioid receptor 
agonists 
Sedation, respiratory 
depression, 
constipation, nausea, 
itching, tolerance and 
dependence, euphoria 
Anti-
depressants 
TCAs 
Amitriptyline 
Nortriptyline 
SNRIs 
Venlafaxine 
Duloxetine 
Neuropathic 
pain 
Unknown, may include 
opioid receptor 
activation, sodium 
channel blockade 
Sedation, confusion, 
weight gain, dry 
mouth, constipation 
Nausea, agitation, 
diarrhoea 
Anti-
epileptics 
Gabapentin 
Pregabalin 
 
Carbamazepine 
Neuropathic 
pain 
 
Trigeminal 
neuralgia 
Calcium channel 
blockade, glutamate 
suppression 
Sodium channel 
blockade 
Sedation, ataxia 
NSAID=Non-steroidal anti-inflammatory drug; COX=Cyclo-oxygenase; GI=Gastrointestinal; 
CV=Cardiovascular; TCA=Tricyclic antidepressant; SNRI=Serotonin and noradrenaline reuptake 
inhibitor (Rang et al. 2012; Gilron 2010; Mico et al. 2006; Perucca 2005; Dworkin et al. 2007). 
2.5.2 Invasive Procedures 
The WHO pain treatment guidelines take in most of the available analgesics, however 
it is mainly concerned with oral preparations, and invasive procedures are not included. 
These include nerve block injections, denervation surgery, implantable drug delivery 
systems, and nerve stimulators. Invasive procedures are often risky and expensive, so 
they are usually reserved for cases of severe pain that do not respond to oral and 
systemic analgesics. 
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2.5.3 Pain Relief by Counter-irritation 
A well-known phenomenon in traditional medicine, the ‘pain inhibiting pain effect’ 
(Reinert et al. 2000) or ‘counter-irritation’ (Wand-Tetley 1956) is the relief of pain by 
application of intense stimulation to the painful area or another area of the body. The 
mechanism of action by which pain relief is achieved depends upon the technique used. 
Counter-irritation techniques for pain relief include transcutaneous electrical nerve 
stimulation (TENS), percutaneous electrical nerve stimulation (PENS), acupuncture, 
topical capsaicin, and application of heat or cold. 
Experimental studies, in which brief noxious stimuli are applied to an area, whilst 
another area receives ongoing painful stimulation (known as conditioned pain 
modulation, CPM); shed light on a common mechanism that may subserve counter-
irritation. An endogenous, anti-nociceptive neural process termed ‘diffuse noxious 
inhibitory controls’ (DNIC) is characterised by a reduction in the activity of pain 
signalling neurons in the spinal dorsal horn and trigeminal nuclei in response to 
noxious stimuli applied to a remote area of the body (LeBars et al. 1979; Moont et al. 
2010). Although the phenomenon of DNIC has only been observed under experimental 
conditions, it may explain the beneficial effects of counter-irritation which have been 
observed in patients. 
2.5.4 Biopsychosocial Treatment 
Neuromatrix theory suggests that in the absence of overt physical damage, it is the 
psychological factors of emotion and cognition that can contribute most to the 
experience of pain. In turn, these psychological factors are influenced by the social 
and cultural environment in which the patient is living. Biopsychosocial treatment 
draws on the knowledge of several healthcare disciplines including physicians, 
psychologists, specialist nurses, physiotherapists, and occupational therapists, 
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combined to deliver ‘multidisciplinary pain management’. In the UK, a patient will be 
referred by their general practitioner to the local pain clinic for multidisciplinary 
treatment. In 2010, there were 214 pain clinics in the UK (Price et al. 2012). Upon 
entering the pain clinic system the patient will usually meet individually with each 
member of the team in order to discuss their situation and how treatment should 
proceed. Patients may continue to meet regularly with team members to receive 
ongoing treatment and monitor progress, however it is likely that the patient will 
eventually be recommended to attend a series of group treatment sessions, known as 
the pain management programme (PMP) (of which there were 97 in the UK in 2013; 
S. Williams 2013). This section will look at the separate treatments available in the 
pain clinic before discussing the components of PMPs. 
2.5.4.1    Physiotherapy 
Physiotherapy represents a variety of treatment modalities ranging from passive 
manipulation, stretching, and movements to intensive exercise and activity simulation. 
In the case of treating chronic pain the goal of physiotherapy is to maximise and 
maintain the patients’ functional ability, without contributing to any increase in pain. 
Patients are taught that pain does not necessarily imply that tissue damage is taking 
place, and that avoiding activity can actually worsen pain in the long run through 
deconditioning.  
2.5.4.2    Occupational therapy 
Occupational therapy is concerned with enabling patients to maintain, recover, or 
develop the skills needed for daily living and for work. In the patient with chronic pain, 
interventions focus on increasing physical capacities, mastery of self and the 
environment through activities, and productive and satisfying performance of life tasks 
and roles (Engel 2013). Patients are taught early on that rest is not a good way to deal 
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with chronic pain, and that the performance of a baseline level of daily activity is the 
key to recovery. Activity levels are increased gradually over time, and the patient is 
able to perform more activity without the pain worsening. Activities are planned in 
advance, including regular breaks for rest – a technique known as pacing. 
2.5.4.3    Pain specialist nursing 
The nurse specialising in pain can advise patients on their medications, explaining the 
reasons why they have been prescribed, and suggesting the best time of day to take 
them to minimise the impact of side effects. Patients can be confused and worried 
when they are prescribed an antidepressant for their pain, which may lead to non-
compliance; if patients understand why they are taking particular medications, they are 
more likely to take them (Claxton et al. 2001). 
2.5.4.4    Clinical psychology 
 The clinical psychologist is concerned with the impact that the pain condition has on 
the mental health and wellbeing of the patient. Initial assessment involves a 
psychological screening to ascertain how the pain has affected mood, sleep, appetite, 
motivation, daily activities, relationships, work, and finances. Patients’ may be unsure 
why they are seeing a psychologist for pain treatment; that it somehow implies that 
their pain is a psychological rather than a physical problem. The psychologist must 
take care to explain the role of non-physiological factors in the maintenance of pain 
symptoms and their responses to treatment (Turk & Monarch 2002). Of vital 
importance to recovery are the ways in which the patient reacts to, and copes with 
physical pain and the emotional suffering that accompanies it. There are numerous 
approaches to psychological treatment, including: motivational interviewing, 
psychodynamic psychotherapy, operant therapy, cognitive-behavioural therapy 
(CBT), biofeedback, hypnosis, graded exposure, mindfulness based stress reduction, 
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acceptance and commitment therapy (ACT), and solution-focused brief therapy. In a 
pain clinic setting, patients are often invited to attend a group pain management 
programme which combines elements of psychological treatment from various 
approaches with physiotherapy, occupational therapy, information on medication, pain 
physiology, sleep hygiene, local support groups, and relaxation techniques. 
 
2.5.5 Multidisciplinary Pain Management Programmes 
 
“A PMP aims to improve the physical, psychological, emotional and social 
dimensions of quality of life of people with persistent pain, using a multidisciplinary 
team working according to behavioural and cognitive principles. The problems of 
people with persistent pain are formulated in terms of the effects of persistent pain on 
the individual’s physical and psychological wellbeing, rather than as disease or 
damage in biomedical terms, or as deficits in the individual’s personality or mental 
health.”  
British Pain Society (2007), p.6. 
 
The basic concepts, goals and content are in general quite similar across different types 
of pain management programmes. Typically, patients are treated in groups of 5-15, 
over a course of 8-12 sessions taking place once or twice a week on an outpatient basis. 
PMPs are delivered in a group format because this normalises the experience of pain 
for the patients and maximises opportunities to draw on the experiences of group 
members; it is also cost effective (British Pain Society 2013, p.8). Sessions last 3-4 
hours and consist of physical, psychological, medical, and occupational themes. The 
treatment team usually consists of a specialist nurse, physiotherapist, psychologist, 
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occupational therapist, and pain physician. Each session will generally proceed using 
the same structure of five components, the contents of which change from session to 
session: exercise, education, skills training, relaxation, and homework. 
2.5.5.1    Exercise 
Led by the physiotherapist, stretches and light exercises aim to increase flexibility and 
strength. Patients are encouraged to perform stretches regularly at home between 
sessions. Some examples are shown in Figure 2.9. 
 
 
Figure 2.9 Stretches and light exercises (adapted from New Cross Hospital PMP Exercise 
Diary, unpublished). 
 
2.5.5.2    Education 
All members of the treatment team are involved in leading lecture type teaching 
sections covering topics that deal with a variety of problems faced by chronic pain 
patients (Table 2.3). These may differ slightly according to the needs of the group and 
the psychological basis of the PMP. 
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Table 2.3 Patient education topics. 
Pain mechanisms 
Gate control theory 
Biomechanics 
Medication use 
Disability benefit 
Expert patient visit 
Acute vs. Chronic pain 
Healing and disuse 
Depression 
Effects of exercise and 
inactivity 
Role of surgery 
Dealing with doctors 
Maintenance of gains 
Cognitive-behavioural theory 
ACT theory 
 
Adapted from Loeser & Egan (1989) in Loeser & Turk (2001), 
p.2073. 
 
2.5.5.3    Skills Training 
Patients are taught skills to assist them in living with chronic pain (Table 2.4). These 
include topics such as activity-rest cycling (Gil et al. 1988), also known as pacing, 
which is designed to help patients avoid a pattern of over activity followed by a flare-
up of extreme pain followed by a period of prolonged rest; and replace it with periods 
of planned moderate activity and limited rest. CBT-based programmes will go into 
detail on cognitive strategies for dealing with stress, depression, and anger responses 
to pain, guided by the relationship between thoughts, feelings, and behaviours. ACT 
programmes will address these problems using acceptance and cognitive diffusion 
strategies, including mindfulness practice. 
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Table 2.4 Topics for skills training. 
Stress management 
Relaxation training 
Coping skills 
Anger management 
Pain behaviours 
Sleep hygiene 
Physiology of stress 
Planning/pacing 
Assertiveness training 
Cognitive strategies 
Communication skills 
Dealing with depression 
Crisis management 
Costs/meanings of pain 
Mindfulness meditation 
 
Adapted from Loeser & Egan (1989) in Loeser & Turk (2001), 
p.2073. 
 
2.5.5.4    Relaxation 
Each session will typically include a period of guided relaxation led by the 
psychologist or other member of the team. ACT programmes use guided mindfulness 
exercises for relaxation, acceptance, and cognitive diffusion, whereas CBT 
programmes use a variety of techniques including progressive muscle relaxation 
(Jacobson 1965), visualisation, and breathing exercises. 
2.5.5.6    Homework 
Patients are asked to complete homework assignments in order practice what they have 
learned in class whilst they are in their usual environment (Table 2.5). Patients’ 
feedback to the treatment team and other group members on challenges and successes 
they have encountered. ACT programmes include a daily mindfulness exercise to work 
towards automatic use of this technique in daily life. CBT-based programmes also 
include homework tasks designed to test negative assumptions that patients may have 
about their ability to cope with pain – with the aim of helping patients prove to 
themselves that these assumptions are false and unreliable, fostering cognitive change 
and increased self-efficacy. 
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Table 2.5 Homework topics. 
Goal setting 
Time management 
Setback/flare-up planning 
Rewarding self 
(reinforcement) 
Testing assumptions 
Relaxation practice 
Mindfulness practice 
Activity-rest cycling/pacing 
 
 The present study investigated patient outcomes in two pain management 
programmes. These programmes were based on different psychological theories – 
CBT and ACT, both of which have been demonstrated to be effective in improving 
patient health and wellbeing. 
2.5.6 Cognitive Behavioural Therapy (CBT) 
CBT is intended to recognise, evaluate, and rectify maladaptive conceptualisations and 
dysfunctional beliefs that patients have about themselves and their pain. Patients are 
taught to become aware of the connections between thoughts, feelings, and behaviours 
– to recognise that negative thoughts and feelings about the pain are directly linked to 
maladaptive behaviours and exacerbation of symptoms (Eccleston 2001). Unrealistic 
or unhelpful thoughts about pain and pain catastrophising are identified and replaced 
with thoughts that are oriented towards adaptive behaviour and positive functioning, 
through cognitive restructuring. Pain symptoms themselves are reconceptualised 
during the therapy process, with patients learning that they can control their symptoms 
to an extent by employing the cognitive and behavioural skills acquired during therapy 
(Turk et al. 1983). CBT for pain develops coping skills for pain management and 
improved mental health, including structured relaxation, planned daily activities and 
scheduling of pleasurable events, assertive communication, and pacing of behaviour 
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to avoid exacerbation of pain flares (Sturgeon 2014). The goals of CBT are 
summarised in Box 2.1. 
 
 
 
2.5.7 Evidence for Efficacy of CBT 
A large number of studies have investigated the effectiveness of CBT for chronic pain, 
and since 1994 a number of meta-analyses and reviews have collected together the 
evidence for CBT. Morley, Eccleston, and A. Williams (1999), in a meta-analysis of 
25 randomised controlled trials (RCTs), compared the effectiveness of cognitive-
behavioural treatments with the waiting list control and alternative treatment control 
conditions upon questionnaire-based measures of psychophysical health. Cognitive-
behavioural treatments were associated with significant effect sizes (median effect size 
Box 2.1 Goals of CBT. 
 Reconceptualisation of patients’ views of their problems from overwhelming to 
manageable (combat  demoralization) 
 Convince patients that skills necessary for responding to problems more adaptively will 
be included in treatment (enhance outcome efficiency) 
 Reconceptualisation of patients’ views of themselves from being passive, reactive, and 
hopeless to active, resourceful, and competent (foster self-efficacy) 
 Ensure that patients learn how to monitor their thoughts, feelings, behaviours, and 
physiology and learn interrelationships among these (break up automatic, maladaptive 
patterns) 
 Teach patients how to use and when to use adaptive overt and covert behaviours 
required for adaptive response to problems associated with chronic pain (skills training 
and use) 
 Encourage patients to attribute success to their own efforts (self-attribution) 
 Anticipate problems and discuss these as well as ways to deal with them (facilitate 
maintenance and generalisation) 
Adapted from Turk (2002), p.144. 
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= 0.5) on all domains of measurement, when compared to waiting list (i.e. treatment 
as usual). Pain experience, positive cognitive coping and appraisal, and reduced 
behavioural expression of pain were improved significantly by CBT compared to other 
active treatments (including information, physiotherapy, and relaxation). No 
difference was found between CBT and alternatives on measures of mood (depression 
etc.), negative coping and appraisal (e.g. catastrophising), and social role functioning 
(Morley et al. 1999). Another meta-analysis of 22 controlled studies of psychological 
treatment for low back pain concluded that CBT was efficacious in improving 
measures of pain intensity, pain-related interference, health-related quality of life, and 
depression (Hoffman et al. 2007). Finally, in an update to their 1999 review, A. 
Williams, Eccleston, and Morley (2012) performed a Cochrane review of CBT for 
chronic pain (excluding headache) in 35 RCTs with 4,788 participants. The benefits 
of CBT emerged almost entirely from comparisons with treatment as usual/waiting 
list, not with active controls, and CBT was effective in improving measurements of 
mood and catastrophising. There was some evidence that improvements were 
maintained after 6 months, and they conclude that CBT is a useful approach to the 
management of chronic pain (A. Williams et al. 2012). Taken together, these studies 
present convincing evidence that psychological therapies including CBT are more 
effective in bringing about improvements in coping and mental health than 
pharmaceutical treatment alone. It should also be noted that CBT may not bring about 
a reduction in pain per se; however this is not a goal of the treatment. 
2.5.8 Acceptance and Commitment Therapy (ACT) 
ACT is an approach to treatment designed around processes from the psychological 
flexibility model (Hayes et al. 1999; Hayes 2004a; Hayes 2004b; Hayes et al. 2006; 
McCracken & Morley 2014). Thoughts, feelings and behaviours are not seen as the 
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problem which must be addressed; rather it is the response to these factors which is 
the target for change. For example in chronic pain, the tendency to react in maladaptive 
ways and fight against the pain is what causes suffering, rather than the pain itself. The 
patient is encouraged to question whether their current courses of action are preventing 
them or helping them move towards their life goals and values. The goal of ACT is to 
help the patient develop their ability to follow the six core processes of psychological 
flexibility (Box 2.2). Mindfulness is an important technique which is employed to 
foster acceptance, to help view the self as separate from thoughts and emotions, and to 
aid defusion and letting go of automatic thoughts. The essence of mindfulness is 
paying attention to the present moment without attaching meaning or judgmental 
language to thoughts that arise (Kabat-Zinn 1994). Patients practice mindfulness 
techniques that promote a distancing from, and a non-judgemental awareness of 
thoughts, such as imagining watching ones thoughts as they float by like leaves on a 
stream (Hayes 2004b). Seeing thoughts as transient events separate from the self, 
cultivates psychological flexibility, allowing the patient to deal with difficult thoughts 
and feelings that might otherwise become barriers to pursuing their goals. ACT differs 
from CBT in the regard that it does not attempt to change thoughts and feelings: how 
a person has dealt with their problems in the past is not important. Patients can learn 
to use the skills taught in ACT to begin living a fulfilling life right away, without first 
“winning a war with their own history” (Hayes 2004b, p.652). 
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2.5.9 Evidence for Efficacy of ACT 
The use of ACT as a treatment approach for chronic pain problems has grown steadily 
over the past 15 years. During this time evidence has accumulated that supports the 
use of ACT as a good alternative to CBT, with similar effects on a range of treatment 
outcomes (Veehof et al. 2011). A systematic review and meta-analysis of acceptance 
based interventions for chronic pain management by Veehof and colleagues (2011) 
concluded that the treatments were not superior, but a good alternative to CBT. A 
systematic review of ten RCTs using ACT in 623 adults with chronic pain concluded 
that ACT was effective in increasing physical functioning, and decreasing anxiety, 
depression, and distress, compared to inactive treatments (Hann & McCracken 2014).  
 
 
Box 2.2 Core Processes of Psychological Flexibility 
(1) Acceptance: a broad-based willingness to have pain or discomfort. 
(2) Defusion: a lack of dominance of verbal, often cognitive, content or narrowing of 
perspective such that it is predominately focused on this content. 
(3) Moment-to-Moment Awareness: a purposeful, non-judgmental, and fluid attending to 
present experiences. 
(4) Self-as-Context: a conscious perspective taking on the content of one’s experience 
where a distinction is made between the person having the experience and the 
experiences themselves. 
(5) Values Orientation: freely identified (e.g., noncoerced) directions for activity that 
bring meaning, importance, or vitality to living. 
(6) Committed Action: a pattern of behaviour that encompasses a flexible persistence 
oriented towards valued living. 
Adapted from Vowles et al. (2014), p.391. 
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2.6 TECHNIQUES FOR MEASURING PAIN 
 
Pain is a complex sensation; it has location, intensity, frequency, texture, and 
emotional unpleasantness, all of which may change from one moment to the next. To 
make matters more complicated, it is also not only the consequence of tissue damage 
(‘actual or potential’), but also the product of the environmental circumstances and the 
psychological characteristics of the person experiencing it. To reduce these many 
factors into a manageable and useful report is clearly challenging, and there are 
compromises to be made between the practicality of the measure and the level of detail 
it can achieve. Single measurements are quickly taken, but at the cost of leaving out 
all other information. Highly detailed reports are comprehensive but time consuming. 
A number of different self-report and observational measures have been developed for 
use under a variety of circumstances where pain and associated factors are to be 
assessed. 
A simple method is to ask the patient to rate their pain on a numerical scale from zero 
to ten, where zero is ‘no pain’ and ten is ‘the worst pain imaginable’; known as the 
Numerical Rating Scale (NRS). However, pain is subjective – what constitutes a ‘ten’ 
to one person might conceivably constitute an ‘eight’ in another person, or a ‘five’ in 
another; one has no way of standardising and comparing different scores across a 
population. By contrast, one can observe the impact of pain on a person’s behaviour – 
such as distance walked or amount of pain medication required; or on a person’s 
physiology – such as brain structure or brain activity. These more objective 
observations can be used as indirect measures of pain. The limitation to using objective 
measures is that the observations are of behaviours or reactions related to pain, not of 
the pain itself, therefore the subjective qualities of pain are not recorded. 
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2.6.1 Subjective measures: Self-report questionnaires 
In contrast to the unidimensional NRS, questionnaires have the potential to assess 
multiple dimensions of the pain experience including sensory, emotional, and 
cognitive aspects. Such aspects are experienced subjectively by the individual and 
therefore must be assessed via self-report. Information revealed from self contains 
introspective and motivational data that cannot be accessed through any other method. 
Measurements that rely on self-assessment have the potential for response bias. This 
may be caused by a desire to ‘look good’ (social-desirability bias), by a 
misunderstanding in what is being measured, or by inaccurate evaluation of past events 
(recall bias). Such biases can be minimised by use of questionnaires that have been 
well tested for reliability and validity, and proven to be useful measurement tools. Self-
reports can help to provide a wider range of responses than many other data collection 
instruments, and also have the advantages of being easy to administer and easy to 
interpret. 
As well as assessment of the sensation of pain itself, questionnaires can be used to 
assess the impact of chronic pain on patient quality of life – in terms of psychological 
factors, behavioural changes, and perceived health status, as discussed above. The 
present research made use of a variety of questionnaires to measure the effect of pain 
management programmes upon psychosocial health, coping strategies, and attitudes 
towards pain. The questionnaires were selected on good evidence that they are both 
valid and reliable measures of the constructs under investigation, and this is discussed 
further in the methods sections of subsequent experimental chapters. 
2.6.2 Behavioural Measures 
The experience of pain motivates protection of the painful area and the seeking of 
treatments to reduce pain. These behaviours may be observed and thus provide an 
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indication of the amount of pain being suffered. The frequency of verbal or non-verbal 
complaints, facial grimaces, rubbing, bracing, sitting or lying down, and use of (or 
demand for) medications have all been employed as observational measures of pain 
(Richards et al. 1982; Keefe & Block 1982; Chapman et al. 1985). The utility of these 
measures depends not only on agreement between observers, but also on agreement 
between observer and sufferer. A movement recorder (accelerometer) can be used to 
objectively measure a person’s activity levels throughout the day (Sanders 1983). 
2.6.3 Recording Brain Activity during Pain 
Advances in non-invasive functional brain imaging mean that it is now possible to 
record the brain activity that takes place during the perceptual experience of pain. 
Techniques used include functional magnetic resonance imaging (fMRI), positron 
emission tomography (PET), electroencephalography (EEG), and 
magnetoencephalography (MEG). These techniques differ in terms of the type of 
information they provide. fMRI and PET measure the change in blood flow following 
neuronal activation, which is a surrogate measure of cell activity, and are capable of 
providing an image of the entire brain with a spatial resolution of up to 1mm3. 
However, the data for each image takes a long time to collect, and their temporal 
resolution is limited. In contrast, EEG and MEG directly measure the electric and 
magnetic field disturbances generated by neuronal activity, with millisecond temporal 
accuracy, by the use of multiple sensors placed over the scalp. EEG and MEG record 
data outside the skull, therefore their spatial resolution is limited, as the signal reaching 
the sensor reflects a combination of sources. Over the past 20 years, numerous studies 
have examined the neural correlates of acute painful stimulation in normal subjects, 
revealing a network of cortical and sub-cortical structures that are consistently 
activated. These include S1, S2, the ACC, insula, PFC, and thalamus, collectively 
44 
referred to as the pain matrix (Figure 2.10) (Melzack 1999; Treede et al. 1999; 
Derbyshire 2000; Apkarian et al. 2005; Lee & Tracey 2010).  
 
 
 
Figure 2.10 The Pain Matrix. Anterior cingulate cortex (ACC), anterior insular cortex (aINS), 
amygdala (amyg), primary and secondary somatosensory areas (SI and SII), posterior insular 
cortex (pINS), dorsolateral (dl), venterolateral (vl), venteromedial (vm), orbital (orb), 
prefrontal cortex (PFC),  periaqueductal grey (PAG), rostral venteromedial medulla (RVM) 
(adapted from Lee & Tracey 2010, p.126). 
 
Activations of S1 and S2 reflect nociceptive input underlying the perception of sensory 
features of pain, and a number of studies have noted that activity in these areas is 
correlated with perceived pain intensity (Coghill et al. 1999; Bushnell et al. 1999; 
Bornhovd et al. 2002; J.I. Chen et al. 2002). The ACC and insular cortex are both 
components of the limbic system; activation of these regions has been linked to the 
affective processing of pain, and activity has been shown to correlate with perceived 
stimulus unpleasantness (Rainville et al. 1997; Fulbright et al. 2001). Activation in 
PFC and parietal association areas may reflect cognitive factors, such as evaluation of 
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the stimulus or memory (Coghill et al. 1999; Bornhovd et al. 2002; Strigo et al. 2003). 
Subcortical activation in the thalamus is also regularly observed in studies of pain, 
likely reflecting the transmission of nociceptive inputs from the spinothalamic 
pathway (Coghill et al. 2003). Motor and pre-motor cortex activations are occasionally 
reported, although not reliably, and this may be due to secondary effects of stimulation 
such as pain-evoked movements or suppression of movement (Apkarian et al. 2005). 
These findings are consistent with the concept of the neuromatrix as described by 
Melzack, reflecting the interaction of sensory, affective, cognitive, and motoric 
components to generate the pain experience. 
After more than two decades of functional brain imaging studies, there is still debate 
over whether or not the network of brain areas activated during pain actually represents 
a specific, objective signature for pain. The fact that these areas are integral to the pain 
experience is certain; however some researchers have recently argued that the pain 
matrix represents a non-specific salience network, triggered by any salient stimulus 
occurring in the sensory environment, regardless of its sensory modality (Iannetti et 
al. 2008; Iannetti & Mouraux 2010; Legrain et al. 2011). 
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The following sections: 2.7, 2.8, 2.9 are based on literature discovered in the writing 
of the abstract below, which was published in Regional Anaesthesia and Pain 
Medicine, 36 (7, Suppl.), p.E186. 
 
30th Annual ESRA Congress · Abstract: A-384-0005-00532 
Title: Evaluation of the use of EEG in the assessment of chronic pain syndromes: 
a systematic literature review. 
Background and aims: Clinical pain syndromes are difficult to diagnose, and often 
require trials of different forms of treatment before patients experience reliable pain 
relief. Furthermore, standard objective assessment of treatment efficacy is lacking, 
with clinicians having to rely on subjective report from patients. EEG equipment is 
relatively inexpensive, compact, non-invasive, safe, and found in most hospitals. The 
aim of this review was to investigate the use of EEG in diagnosis and assessment of 
chronic pain. 
Methods: Systematic literature review was undertaken by searching databases 
EBSCOhost (CINAHL, EMBASE, Medline & PsycINFO) using search terms (EEG, 
electroencephalogra*, diagnos*, assess*, chronic pain, pain measurement). This 
yielded 52 papers, 24 of which were considered relevant. A hand search of references 
yielded 5 further papers. 
Results: The evoked response potential to phasic noxious stimulation is a robust 
finding, and reliably comprises 4 components (N1, N2, P2, P3), of which the N2-P2 
amplitude correlates with perceived pain intensity. In continuous EEG data, the peak 
α frequency is related to subjective perception of tonic pain intensity, and relative 
changes in slow wave power (δ, θ, α) are linked to subjective pain control. 
Conclusions: It may be possible to utilise EEG in the objective assessment of pain 
treatment efficacy. The capacity for diffuse noxious inhibitory controls, habituation, 
sensitisation, and temporal summation is differentially affected across conditions, 
opening the possibility for EEG guided diagnosis and treatment in the future: many 
conditions are yet to be investigated in this way. 
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2.7 THE STUDY OF PAIN PERCEPTION USING EEG 
2.7.1 Evoked Response Potentials 
The characteristic pattern of electrical activity in the brain following a stimulus is 
known as the evoked response potential (ERP). Painful heat delivered to the skin by a 
CO2 laser stimulator was first shown to elicit fluctuations in ongoing EEG by Carmon 
and colleagues in 1976. Subsequent studies have used similar brief heat stimuli to 
investigate the electrical activity of the brain in response to painful peripheral 
stimulation. Pain ERPs tend to reflect the dual pain sensation elicited by the two types 
of nociceptive sensory afferent fibres from the skin. Small myelinated Aδ fibres and 
large unmyelinated C fibre afferents both respond to changes in skin temperature and 
pressure, with rapidly conducting Aδ fibres delivering the initial sharp pain sensation 
at around 100-200ms (Treede et al. 1988) followed by the dull aching pain sensation 
being delivered by the slow conducting C fibres around 1000ms later (Iannetti et al. 
2003).  
EEG source analysis of laser evoked potentials (LEPs) (Garcia-Larrea et al. 2003; 
Tarkka & Treede 1993; B. Bromm & A.C.N. Chen 1995) suggests that the earliest 
ERP component (N1 ~160ms) originates from contralateral S1 and S2 cortices, and 
represents the arrival of the nociceptive signal at the cortex. The next observed 
components (the N2-P2 complex ~240ms) originate from bilateral S2 and ACC, 
respectively, and represent the early stages of pain processing by the brain. 
2.7.1.1    Contact heat evoked potentials 
More recently, brief painful stimulation using heat delivered via a thermode placed 
into contact with the skin has been used as an alternative to laser stimulation. The 
Contact Heat Evoked Potential Stimulator (CHEPS: Medoc, Ramat Yishai, Israel) is a 
safe and reliable method for generating ERPs in both healthy (e.g. A.C.N. Chen et al. 
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2001; LePera et al. 2002; Greffrath et al. 2007; Warbrick et al. 2009) and patient 
samples (Atherton et al. 2007; Chi et al. 2008; Truini et al. 2007; Staud et al. 2008). 
CHEP studies have reported a slightly different ERP time course than LEP studies, 
with longer component latencies (N1 ~450ms, N2-P2 ~550ms) and smaller amplitudes 
(A.C.N. Chen et al. 2001, 2006; LePera et al. 2002; Granovsky et al. 2005; Iannetti et 
al. 2006; Greffrath et al. 2007; Roberts et al. 2008; Warbrick et al. 2009). The longer 
latency of the CHEP is due to the fact that the thermode used to deliver stimuli heats 
up at ~70°C/sec, compared to ~10,000°C/sec for laser stimuli (A.C.N. Chen et al. 
2001). The rapid heating achieved with laser stimuli results in a more coherent afferent 
volley of nerve input to the brain, and a larger ERP than contact heat stimuli (Figure 
2.11, upper panels). 
 
 
Figure 2.11 Comparison of average waveforms (upper panels) and stacked plots of single 
trials (lower panels) obtained using laser (left side) and contact heat (right side) stimulation. 
Recorded from the Cz electrode in the same subject, showing the N2 and P2 waves after stimuli 
were applied to dorsum of left hand. To assess trial-to-trial consistency, one stacked plot of 
single-trial responses is shown for each stimulus modality (adapted from Iannetti et al. 2006). 
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The slow temperature increase of the CHEPS thermode also generates greater 
variability in response latencies (known as latency jitter) of CHEP compared to LEP 
signals, which is apparent when viewing a stacked plot of the single trial data (Figure 
2.11, lower panels). Latency jitter has the effect of attenuating the peak amplitudes and 
distorting the waveform when averaging across multiple trials. To avoid such loss of 
information it is preferential to extract peak amplitude from each trial individually, 
and then use these numbers to calculate a more accurate average of peak amplitude 
(Iannetti et al. 2005, 2006). A method of automated single-trial analysis was developed 
by Mayhew and colleagues (2006) using a multiple linear regression approach. Briefly, 
a basis-set is constructed from the subject average ERP waveform; regressors are 
formed that represent the N and the P peak of interest,  then this basis set is regressed 
against each single-trial in the data. The regression coefficients between the data and 
the basis-set are used to reconstruct a fit for each trial and then the amplitudes and 
latencies are measured from this (Mayhew et al. 2006). This method has been shown 
to reliably generate a more consistent ERP average and is considered the desired 
method for analysis of CHEPs (Iannetti et al. 2006; Hu et al. 2010; Mayhew et al. 
2013). 
Stimulus location effects ERP latencies, with trigeminal (facial) stimulation producing 
much shorter latencies than lower limb stimulation, simply because of the shorter 
distance that the nerve signal has to travel to the brain (Truini et al. 2007; Warbrick et 
al. 2009). Also a late P3 (~1000ms) component is occasionally but not reliably reported 
across CHEP studies; it has been suggested that it represents either a processing of 
noxious information carried by slower conducting C-fibres (A.C.N. Chen et al. 2001), 
or that it represents a shift of attention towards a novel stimulus (Lorenz & Garcia-
Larrea 2003; Kakigi et al. 2005). Finally, both amplitude and latency of CHEPs and 
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LEPs have not been shown to differ between male and female participants (Truini et 
al. 2005; I.A. Chen et al. 2006). 
2.7.2 Phenomena of Pain Perception 
2.7.2.1    Correlation of ERPs with pain ratings 
A large number of studies have demonstrated a significant positive correlation between 
the amplitude of pain ERPs and the subjective perception of pain intensity using 
electrical (Harkins & Chapman 1978; A.C.N. Chen et al. 1979; de Lima et al. 1982), 
laser (Carmon et al. 1978; Kakigi et al. 1989; Beydoun et al. 1993; Arendt-Nielsen 
1994; Garcia-Larrea et al. 1997; Iannetti et al. 2005), and contact heat stimuli (A.C.N. 
Chen et al. 2001; A.C.N. Chen et al. 2002; LePera et al. 2002; Granovsky et al. 2005, 
2006, 2008; Greffrath et al. 2007; Roberts et al. 2008). Only two studies reported no 
significant correlation between ERPs and pain ratings (I.A. Chen et al. 2006; Warbrick 
et al. 2009; both CHEP studies). The majority of the studies above compared the mean 
pain rating with the mean ERP amplitude when calculating the correlation. In the case 
of the Iannetti and colleagues (2005) study, the authors extracted ERP amplitude data 
at the single-trial level, and found that ERP amplitude correlated with participant’s 
trial-by-trial ratings of pain intensity, thus reinforcing the finding that there is a 
correlation between evoked brain activity and perceived pain intensity. 
2.7.2.2    Habituation 
The phenomenon of habituation describes a reduction in response with repeated 
stimulation. In healthy subjects, perceptual habituation (of subjectively reported pain 
intensity ratings) has been observed with interstimulus intervals (ISI) of anywhere 
between 3 and 80 seconds and has been attributed to nociceptor suppression or fatigue 
(Price et al. 1977; Kleinböhl et al. 2006). Similar studies in chronic pain patients reveal 
that habituation is reduced in conditions characterised by increased pain sensitivity – 
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such as fibromyalgia (Smith et al. 2008), chronic low back pain (Flor et al. 2004), and 
migraine (Valeriani et al. 2003), and it has been suggested that deficits in habituation 
may play a role in the development of some chronic pain conditions (Smith et al. 2008). 
Habituation can also be observed in the pain ERP, as a reduction in N2-P2 peak-to-
peak amplitudes with repeated stimulation. Two types of habituation of evoked 
potentials have been documented, peripheral and central. Peripheral habituation occurs 
rapidly when the stimuli are applied to a fixed location, and reflects nociceptor fatigue 
(Greffrath et al. 2006, 2007). Single trial ERPs are seen to gradually decrease over the 
first three or four stimuli of a block and then plateau at around 50% of the size of the 
initial ERP (Greffrath et al. 2007), with the result that the N2-P2 complex is greatly 
reduced in the average waveform (Warbrick et al. 2009). Central habituation occurs at 
a much longer timescale when stimuli are applied to non-overlapping locations, with 
amplitude reduction becoming visible after 20-30 trials (Valeriani et al. 2005; 
Warbrick et al. 2009). Central habituation is not due to peripheral nociceptor fatigue, 
as stimuli applied to other areas of the body once habituation has been induced also 
result in attenuated ERPs (Arendt-Nielsen 1990; Hüllemann et al. 2013). Reduced 
habituation of LEPs has been reported in patients with migraine compared to control 
subjects (Valeriani et al. 2003). 
2.7.2.3    Sensitisation 
The application of repeated identical nociceptive stimuli, at a greater frequency than 
0.33 Hz, results in a progressive increase in perceived pain intensity in healthy subjects 
known as sensitisation (sometimes called ‘temporal-summation’, or ‘wind-up’) (Price 
et al. 1977; Herrero et al. 2000; Kleinbohl et al. 2006; Meeus & Nijs 2007). This is 
thought to be due to a central mechanism, as the firing of peripheral C-nociceptors has 
been observed to remain the same or decline with stimulus repetition (Price et al. 
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1977). Perceptual sensitisation has also been shown to be correlated with levels of 
anxiety and catastrophising in healthy individuals (Granot et al. 2006), and with fear-
avoidance beliefs and catastrophising in LBP patients (George et al. 2007), indicating 
the influence of psychological factors on pain sensitivity. In patients suffering with 
fibromyalgia, sensitisation is induced at lower frequencies and lower temperatures of 
stimulation, and can be maintained with less frequent stimulation than in healthy 
control subjects (Staud et al. 2001, 2009; Price et al. 2002). Enhanced perceptual 
sensitisation is also found in other chronic pain conditions such as osteoarthritis 
(Arendt-Nielsen et al. 2010), whiplash (Curatolo et al. 2001), migraine (Weissman-
Fogel et al. 2003), and temporomandibular disorder (Sarlani et al. 2004). 
2.7.2.4    Attention/distraction 
A review of the effects of attending to painful stimuli, or attending to other sensory 
modalities or tasks (i.e. distraction from painful stimuli) by Lorenz and Garcia-Larrea 
(2003) reported that the N2-P2 complex was strongly enhanced by purposeful attention 
towards painful stimuli. The habituation to stimuli over a session may be due to a 
decrease in attention towards the stimuli (vigilance) as participants become 
accustomed to the sensations. 
2.7.2.5    Conditioned pain modulation (pain inhibiting pain) 
The phenomenon of conditioned pain modulation (CPM) refers to a reduction in 
ongoing pain brought about by a painful stimulus applied to another area of the body. 
It is mediated by a mechanism of endogenous analgesia acting via descending 
modulatory systems, known as diffuse noxious inhibitory control (DNIC) (LeBars et 
al. 1979). When exploring this effect in an experimental setting the most commonly 
used paradigm is to compare the response to a brief (phasic) stimulus presented alone, 
known as the test stimulus, to the response to the same stimulus in the presence of a 
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long-lasting (tonic) stimulus, known as the conditioning stimulus (Pud et al. 2009). 
The observed effect of the conditioning stimulus on the response to the test stimulus 
is known as CPM (Yarnitsky et al. 2010) (the term ‘heterotopic noxious conditioning 
stimulation’ has also been used; Sprenger et al. 2011), and this effect is mediated by 
DNIC.  A systematic review and meta-analysis of 30 controlled studies of CPM in 
clinical populations revealed that some chronic pain conditions (including 
fibromyalgia, osteoarthritis, migraine, and irritable bowel syndrome) are associated 
with impaired DNIC (overall effect size 0.78) (Lewis et al. 2012). 
The effect of dual (tonic and phasic) painful stimulation on the nociceptive ERP has 
rarely been studied. Two studies have investigated the effect of ischaemic muscle pain 
(the conditioning stimulus) on somatosensory evoked potentials (SSEPs) elicited by 
painful electrical stimulation (the test stimulus) (A.C.N. Chen et al. 1985; Reinert et 
al. 2000). The earlier study reported that SSEPs were depressed during and after 
concurrent tonic pain (A.C.N. Chen et al. 1985). In the later study, after tonic pain was 
induced, SSEPs were attenuated and remained so for up to 20 minutes afterwards, 
indicating a long lasting effect of tonic pain stimulation. Subjective pain ratings also 
remained reduced for 10 minutes after ischaemic muscle work, and there was an 
increase in beta power which also persisted for 10 minutes after tonic stimulation. 
DNICs are believed to be the cause of the reduced SSEP amplitudes, as auditory 
evoked potentials recorded before and after tonic pain were unaffected (Reinert et al. 
2000). 
2.7.3 Power Spectral Density 
EEG data can be converted into a set of simple sine waves representing the power of 
the signal at discrete frequencies (known as the power spectral density or ‘PSD’) using 
a mathematical process called Fourier analysis. Recordings of different brain states are 
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dominated by certain frequency bands which are thought to be connected to different 
states of arousal (Niedermeyer 2005; M.P. Jensen et al. 2008; Table 2.6). 
 
Table 2.6 Examples of filtered bandwidths and the states usually associated with 
them (adapted from M.P. Jensen et al. 2008, p.195; Sherlin 2009, p.87). 
Frequency 
Band 
Frequency 
Bandwidth 
State 
Associated 
with 
Bandwidth 
Example of Filtered Bandwidth 
Delta (δ) 0.5-4 Hz Deep Sleep 
 
Theta (θ) 4-7 Hz Drowsy 
 
Alpha (α) 8-12Hz Relaxed 
 
Beta (β) 13-30 Hz Engaged 
 
 
The effect of pain upon PSD in healthy subjects has been investigated in several 
studies, using a variety of tonic pain stimuli (Table 2.7). There is a definite trend of an 
overall increase in power in the presence of tonic pain. β- (and occasionally δ-) 
frequencies appear to increase relatively more than other bands, accompanied by a 
relative decrease in α-power. θ-power changes are occasionally observed. Two of the 
studies observed that pain was accompanied by an initial decrease in α-power which 
then increased towards the end of stimulation (Backonja et al. 1991; Chang et al. 
2001b). Three of the studies noted that during stimulation, the EEG was subject to 
contamination by muscle activity artefacts in the high β-range (18-30 Hz), particularly 
at temporal recording sites (Backonja et al. 1991; Veerasarn & Stohler 1992; Dowman 
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et al. 2008). Furthermore, one study recorded EEG during a period of imagined pain, 
finding that the results were similar to those obtained with experimental pain, 
suggesting that the effects on β-frequency are non-specific to pain (Veerasarn & 
Stohler 1992). Two studies reported that power spectrum changes remained 
measurable from one minute (Stevens et al. 2000) to ten minutes (Reinert et al. 2000) 
after the tonic pain stimulus was removed. 
 
Table 2.7 overleaf. 
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Table 2.7 Effects of tonic experimental pain on EEG power spectra in healthy 
subjects (grouped by stimulus type). 
Study Stimulus Delta (δ) 
Theta 
(θ) 
Alpha (α) Beta (β) 
ACN Chen et al. 
(1989) 
Cold 
pressor 
↑ (P)     ‒ ‒ ↑ (P)(β2) 
Backonja et al. 
(1991) 
‒ ↑ (i.F) ↓,↑ (FP) 
↑ 
(FP)(β1) 
ACN Chen & 
Rappelsberger 
(1994) 
‒ 
 
‒ 
 
↓ (C) 
 
↑ (C) 
 
Ferracuti et al. 
(1994) 
↑ (F) ‒ ↓ (c.P)(α2) ‒ 
Stevens et al. (2000) ↑ ↑ ↓ (α2) ↑ (β1,2) 
Chang et al. (2002a) ↑ (F) ↑ (F) ↓ (O)(α1,2) ↑ (T)(β2) 
Dowman et al. 
(2008) 
‒ ↓ (FCT) 
↓(c.T), 
↑(P) 
↑ (β2) 
Shao et al. (2012)  ↓ ↓ ↑ (β2) 
Huber et al. (2006) 
Contact heat 
↑ ↓ (i.FT) ↓ (FT)(α1) 
↑ 
(i.T)(β1) 
Giehl et al. (2013) ↑ (PO) ‒ ↓ (C)(α1,2) ‒ 
Zhang et al. (2013) ‒ ‒ ↓ (c.CT) ‒ 
Veerasarn & Stohler 
(1992) 
Hypertonic 
saline i.m. 
‒ 
 
‒ 
 
‒ 
 
↑ (T) 
 
Le Pera et al. (2000) ↑ ‒ ↑ (c.P)(α1) ‒ 
Chang et al. (2002b) ‒ ‒ ↓ (PO)(α1) ‒ 
Chang et al. (2003) ‒ ‒ ↓,↑ (α1,2) ↑ (β2) 
Reinert et al. (2000) 
 
Ischemic 
muscle 
work 
‒ 
 
‒ 
 
‒ 
 
↑ 
 
Chang et al. (2001a) 
 
Capsaicin 
injection i.d. 
‒ 
 
↓ (CP) 
 
↓ 
(CP)(α1,2) 
 
‒ 
 
Chang et al. (2001b) 
 
Capsaicin 
injection 
i.m. 
‒ 
 
‒ 
 
↓ (O)(α1,2) 
 
↑ (β2) 
 
Key: i.m. = intramuscular injection, i.d. = intradermal injection, i. = area ipsilateral to 
stimulation, c. = area contralateral to stimulation, ↑ = general relative increase in power 
following stimulation, ↓ = general relative decrease in power following stimulation, F = frontal 
area, C = central area, T = temporal area, P = parietal area, O = occipital area, α1, α2, β1, β2 = 
sub-divided alpha- and beta-power bands (if reported). 
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The changes in relative power spectral density of these frequency bands have been 
attributed to quite general shifts in brain activity not specific to painful stimulation: 
2.7.3.1    Delta band (δ) 
Increased δ-oscillatory activity has been recorded in response to pain, reward, and 
fatigue; also patients with schizophrenia, depression, and anxiety have raised baseline 
δ-power; and it has been speculated that δ-rhythms are associated with more primitive 
motivational urges triggered by motivational rewards and dangers (Knyazev 2012). A 
review of experimental studies reporting δ-activity changes reported that power 
increases were observed in states of ‘internal concentration’ such as working memory 
tasks, and also during the inhibition of movement in a Go/No-Go task (Harmony 
2013). Studies have also shown that experienced meditators have increased resting δ-
power in prefrontal areas compared to controls (Faber et al. 2008, Tei et al. 2009). 
fMRI has also revealed evidence of reduced prefrontal cortex activity in experienced 
meditators, suggesting that the δ-rhythm is involved in inhibition of brain activity 
(Holzel et al. 2007). 
2.7.3.2    Theta band (θ) 
Theta frequency power changes have previously been associated with meditative 
states, focused attention, and hypnotic susceptibility (Schacter 1977; Doppelmayr et 
al. 2008; Baijal & Srinivasan 2010; Finnigan & Robertson 2011). Also, evidence from 
two case studies has shown that enhanced θ-activity is related to a conscious effort to 
lower the perception of pain. Larbig and colleagues (1982) measured cerebral 
responses in anticipation of a painful stimulus and during pain in a fakir (person with 
incredible self-discipline) and 12 male controls; both before and during pain the fakir 
showed more θ-power relative to controls. In a second study the same author found 
enhanced θ-wave activity during pain control demonstrations by the fakir (Larbig 
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1994, cited by B. Bromm & Lorenz 1998). θ-activity has also been associated with 
task performance in trained subjects under the extreme environmental conditions of 
deep sea diving (Lorenz et al. 1992) and prolonged confinement (Lorenz et al. 1996). 
Finally, a study investigated pain report and PSD following CPT in four groups: 
women with borderline personality disorder who do, and do not report pain during 
self-harm, women with major depression, and healthy women (Russ et al. 1999). 
Results showed that θ-power after CPT was significantly higher in the group who do 
not report pain compared to depressed and healthy groups; θ-power was also correlated 
with scores on the Dissociative Experiences Scale (Bernstein & Putnam 1986) 
suggesting a link between raised θ-power and dissociation from pain. 
2.7.3.3    Alpha (α) and beta (β) bands 
A desynchronisation of α-activity upon stimulation of any type is commonly observed 
(B. Bromm & Lorenz 1998) and is termed event related desynchronisation (ERD; 
Pfurtscheller & Aranibar 1977). The opposite, event related synchronisation (ERS; 
Pfurtscheller 1992) also occurs in response to a stimulus, and may be observed in the 
same frequency band at a different location to the ERD, or in the same location in a 
different band (Pfurtscheller & Lopes da Silva 1999). The α-reduction and β-
enhancement following painful stimulation which dominates the findings in Table 2.8 
are therefore unlikely to be pain specific. B. Bromm and Lorenz (1998) suggest that 
α-frequency changes may indicate selectivity of salient features of stimulation in 
preparation for a motor response to the painful interruption and the increase in β-
activity may indicate the replacement of α-activity by faster rhythms. 
2.7.3.4    Correlation of PSD with pain ratings 
A relationship between aspects of PSD and subjective pain ratings has also been 
reported, but not to the same extent as the ERP based correlation. The peak frequency 
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in the α-band during noxious stimulation (cold pressor), and the same measured at rest, 
has been shown to correlate positively with pain intensity ratings in healthy subjects, 
indicating that peak α-frequency may provide a measure of pain experience during 
stimulation, and may also predict sensitivity to tonic painful stimuli (Nir et al. 2010). 
A recent study using techniques to measure the PSD of different brain structures 
(frequency-domain EEG source analysis) reported negative correlations between (cold 
pressor) pain ratings and left medial frontal, left superior frontal θ-activity; anterior 
cingulate α activity; and posterior cingulate β activity (Shao et al. 2012). 
 
2.8 THE USE OF EEG TO STUDY CHRONIC PAIN 
2.8.1 ERP Studies 
In pain conditions characterised by nerve damage and dysfunction of nociceptive 
pathways, ERPs from noxious stimuli applied to the affected area are attenuated or 
absent – syringomelia (Treede et al. 1991), peripheral neuropathy (Kakigi et al. 1992), 
central neuropathic pain (Garcia-Larrea et al. 2002), post-herpetic neuralgia (Truini et 
al. 2003). In fibromyalgia, a condition characterised by heightened pain sensitivity, 
LEPs are enhanced compared to controls (Brown & Jones 2009; de Tommaso et al. 
2010). Some chronic pain conditions exhibit normal ERPs from noxious stimuli – 
migraine/chronic tension type headache (Valeriani et al. 2003), CBP (Flor et al. 2004), 
and cardiac syndrome X (Valeriani et al. 2005). Several studies have also reported that 
the normal reduction in ERP amplitude seen with repeated stimulation (i.e. 
habituation) does not occur. Conditions in which ERP habituation is absent include: 
migraine (Valeriani et al. 2003; de Tommaso et al. 2005; Coppola et al. 2010), CBP 
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(Flor et al. 2004, Vossen et al. 2015), cardiac syndrome X (Valeriani et al. 2005; 
Sestito et al. 2008), and fibromyalgia (de Tommaso et al. 2010).  
ERPs have also been used to investigate DNIC. One study investigated this using 
electrical stimulation as a phasic stimulus and intramuscular injection of glutamate as 
the tonic stimulus, in groups of chronic tension type headache patients and healthy 
controls (Buchgreitz et al. 2008). Compared to phasic stimulation presented alone, 
ERPs during tonic stimulation were attenuated in the healthy group, but remained 
unaffected in the patient group, which the authors posit to be due to a deficiency in 
DNIC related to their condition (Buchgreitz et al. 2008, p.3237). Self-reported pain 
intensity was not recorded in the study, so it is not possible to know if the reduced 
ERPs reflected a reduction in pain intensity. In contrast, another study investigated 
DNIC in osteoarthritis patients using electrical stimulation as a phasic stimulus, and 
provoked osteoarthritis pain to cause the tonic painful stimulus (by holding a slightly 
hyperextended joint position), measuring perceived pain intensity by self-report and 
brain activity using EEG and MEG (Quante et al. 2008). Despite not rating the phasic 
stimulus as any less painful during the tonic pain condition, N2-P2 complex 
amplitudes evoked by phasic stimulation were reduced by over 50% during tonic pain 
compared to the phasic pain alone condition. The lack of a reduction in reported pain 
intensity agrees with the finding that DNIC is impaired in chronic pain conditions 
including osteoarthritis (Lewis et al. 2012). However, the lack of a reduction in 
subjectively reported pain when ERPs were so clearly reduced is interesting, as pain 
intensity and ERP amplitude have been shown to be correlated in many studies using 
healthy samples. Quante and colleagues (2008) suggest that as the N2-P2 complex 
originates in the cingulate cortex, it is related to the cognitive and emotional dimension 
of pain rather than the sensory dimension (which is localised to the somatosensory 
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cortex; Lorenz & Garcia-Larrea 2003). Some authors have suggested that ERP 
magnitude is determined by stimulus saliency in general rather than by absolute pain 
intensity (Iannetti et al. 2008), which may explain the difference between perceived 
intensity and N2-P2 complex amplitude observed by Quante and colleagues (2008). 
The study did not include a control group, meaning it is hard to know if the 
observations were specific to the patient group or not. Also, patients were given local 
anaesthetic injection into the painful joint to reverse the provoked osteoarthritis pain, 
which could have introduced further effects on nociceptive transmission alongside 
DNIC, leaving uncertainty over the effect that was actually being measured. 
2.8.2 PSD Studies 
PSD of EEG frequency bands recorded at rest appear to be similar in chronic pain 
patients and healthy controls: one study found no difference in frequency composition 
between CBP patients and healthy controls (Schmidt et al. 2012); another study 
compared resting PSD between a mixed group of patients (CBP, IBS, and 
fibromyalgia) and controls and also found no difference in relative δ-, θ-, α-, and β-
power (Vossen et al. 2014).  A notable study has investigated PSD in a sample of spinal 
cord injury patients, half of which experienced pain as a result of injury and half who 
did not (Braden et al. 2011). The PSD of the ‘in pain’ group displayed relative 
decreases in α-power and increases in β-power compared to the ‘no pain’ group. This 
result is similar to observations made of healthy subjects stimulated with tonic pain 
(i.e. decreased α-power and increased β-power compared to rest; Table 2.8). Another 
study compared EEG PSD changes in response to tonic pain induced by the CPT 
between fibromyalgia patients and healthy controls (Stevens et al. 2000). During 
immersion in the cold pressor, both groups displayed significant increases in δ-, θ-, 
and β-power compared to rest; however, α-power decreased in the healthy group but 
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increased slightly in the patient group. The reason for this is unclear; Stevens and 
colleagues (2000) speculate that it reflects an increased thalamic processing of painful 
stimuli in fibromyalgia patients. 
An interesting set of studies has investigated the relationship between θ- and β- 
oscillations and their origin within the brain in a set of patients with 
neuropathic/neurogenic pain. Using MEG to measure spontaneous brain activity and 
perform source analysis, two studies have demonstrated a coherent increase in θ- and 
β-rhythms in neurogenic pain patients compared to healthy controls, which results 
from a resonant interaction between thalamus and cortex – known as thalamocortical 
dysrhythmia (TCD; Llinás et al. 1999; Schulman et al. 2005). These observations are 
supported by EEG findings of increased coherent θ- and β-activation in similar patient 
groups (Sarnthein et al. 2006; Stern et al. 2006; Sarnthein & Jeanmonod 2008). It has 
been suggested that the loss of afferent input to the thalamus following nerve damage 
gives rise to spontaneous discharges in thalamic neurones that sustain the observed 
TCD, causing neurogenic pain (Sarnthein & Jeanmonod 2008). 
Finally a number of studies have reported that the dominant frequency peak in the PSD 
of some groups of pain patients is lower than that of healthy controls. For example in 
neuropathic pain (Llinás et al. 1999; Sarnthein et al. 2006; Boord et al. 2008; 
Wydenkeller et al. 2009); chronic regional pain syndrome (Walton et al. 2010); and 
chronic pancreatitis (Olesen et al. 2011; deVries et al. 2013). This slowing of the 
dominant frequency is thought to be a result of TCD (Llinás et al. 1999; Sarnthein et 
al. 2006). 
2.8.3 Psychological Correlates of EEG Activity in Chronic Pain 
A small number of studies have investigated relationships between psychological 
measures (e.g. depression, catastrophising) and abnormalities in brain structure and 
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function in chronic pain patients. In a study examining habituation of LEPs in 
fibromyalgia patients, as well as finding that both ERPs and pain ratings showed 
significantly reduced habituation to repeat stimuli in patients compared to controls, it 
was observed that self-reported depression scores were negatively correlated with the 
extent of habituation in the patient group (de Tommaso et al. 2010). Operant reward 
conditioning increased N2-peak ERP amplitudes in response to identical stimulation 
in CBP patients and controls, which displayed a slower rate of extinction in the CBP 
patient group (Flor et al. 2002). Finally, a very recent study by M.P. Jensen and 
colleagues (2015) investigated the predictive value of frontal α-power asymmetry on 
catastrophising scores measured two years later in a sample of spinal cord injury 
patients. Based on the theories that right frontal activity is related to ‘negative’ feelings 
and left frontal activity ‘positive’ (Davidson 2004), and that increases in α-power are 
associated with inhibitory activity (Klimesch et al. 2007), the authors hypothesised 
that asymmetry in frontal α-power (left > right) would be related to catastrophising 
scores measured in the future. In a sample of spinal cord injury patients, this hypothesis 
was supported (M.P. Jensen et al. 2015). These findings not only demonstrate that 
physiological brain activity is related to psycho-behavioural phenomena, but also that 
it may be possible to detect the emergence of such phenomena using physiological 
measures. 
 
2.9 THE USE OF EEG TO ASSESS PAIN TREATMENT 
2.9.1 Surgical Treatments 
Studies have investigated the effect of a surgical lesion to the thalamus (central lateral 
thalamotomy, CLT) in neurogenic pain patients exhibiting the increased coherent θ- 
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and β-activations of TCD (Sarnthein et al. 2006; Stern et al. 2006). In both studies, θ- 
and β-activations were significantly reduced 12 months after successful surgery, which 
paralleled a reduction in reported pain intensity. These studies point to TCD as the 
underlying mechanism for chronic neurogenic pain, and also demonstrate that EEG 
can be used as a tool both for diagnosis of this condition, and for monitoring the effects 
of CLT treatment. 
2.9.2 Pharmacological Treatments 
The effects on brain activity of medications used to treat chronic pain have rarely been 
studied in patient groups, however a number of studies have been carried out in healthy 
samples. The majority of these have been placebo controlled investigations of the 
effect of drugs on the ERP in response to painful stimulation. The almost universal 
finding has been that ERP amplitudes are reduced in the presence of the medication 
compared to placebo, paralleled by reductions in perceived pain intensity. Studies 
which have computed PSD tended to find increases in δ-, β-, and most commonly θ-
power, occasionally reduced α-power is reported. The present study recruited pain 
patients into groups which varied in their medication use. Patients could not be 
expected to change their medication regimen for the purpose of controlling the 
confounding effects of drugs on the EEG. However, as individual patients did not 
change their medication throughout the study it can be assumed that these effects 
remained constant over time. By comparing data within each participant it is expected 
that any effects due to medication would remain constant and cancel out, and that 
observed changes (if any) are due to the experimental intervention. 
2.9.3 Psychological Treatments 
Research into the effect of psychological treatment upon brain physiology explores the 
boundary between cognitive and biological processes. It attempts to quantify the 
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outcomes of therapy intended to change the mind by measuring changes in the brain. 
This type of research is not only important from a neuroscience point of view, but also 
provides the most objective method by which to measure the outcome of psychological 
therapy. There is evidence for efficacy of these therapies when applied to chronic pain 
in terms of improvements in pain intensity, physical activity, wellbeing, anxiety, 
depression, catastrophising, and other questionnaire based, subjective report outcome 
measures. What makes the use of EEG and other measures of brain activity to assess 
therapy outcomes interesting is that they are almost entirely free of subjective 
influence (with the exception of the subjective confirmation of painful stimulus 
intensity) and therefore permit investigation of physiological changes associated with 
therapy, and their relationship with subjective measures.  
2.9.3.1    Cognitive-behavioural therapy 
To date only two studies have investigated the effect of CBT on brain activity in 
chronic pain patients. Lackner and colleagues (2006) scanned a group of eight female 
irritable bowel syndrome (IBS) patients using PET to record activity at rest and in 
response to painful bowel stimulation, before and after a ten-week group CBT 
programme. Post-treatment, patients displayed significantly reduced resting state 
activity in the cingulate cortex and parahippocampal gyrus compared to pre-treatment. 
This reduction in activity was correlated with reductions in measures of vigilance and 
attention to pain and may reflect these psychological changes (Lackner et al. 2006). 
K.B. Jensen and colleagues (2012) recorded fMRI in response to painful stimulation 
in a randomised, waiting-list controlled trial of a 12-week group CBT programme in 
43 female fibromyalgia patients. As well as significant improvements on anxiety and 
depression measures, the CBT group also displayed increased post-treatment 
activations in the venterolateral PFC, which correlated with the change in anxiety. The 
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authors note that this brain region is associated with executive cognitive control and 
the appraisal of pain, and suggest that CBT led to the increased involvement of this 
brain area in pain processing (K.B. Jensen et al. 2012).  
2.9.3.2    Mindfulness 
The effect of mindfulness based therapies upon brain activity, measured using EEG, 
has been investigated in two studies. The first was a controlled study of the effects of 
an 8-week mindfulness based PMP on laser-evoked potentials, as well as measures of 
physical and mental health, physical pain, ability to control pain, and mindfulness, in 
a mixed group of 28 patients with chronic musculoskeletal pain (Brown & Jones 2013). 
The therapy, similar to the ACT-based PMP discussed earlier, was delivered in group 
sessions by a private company and has previously been shown to have positive effects 
on measures of physical and mental health (Cusens et al. 2010). Brown and Jones 
(2013) found those patients who participated in the PMP reported improvements in 
mental health and control over pain, and the P2 component amplitude (measured at the 
C2 electrode) decreased in the intervention group, and increased in the control group 
from baseline to follow-up. The authors did not comment on the meaning of the 
attenuated P2 component; however source-analysis revealed that deactivation of the 
dorsolateral PFC in anticipation of pain was reduced after treatment in the intervention 
group, which the authors speculate to be due to increased cognitive processing in the 
emotional regulation of pain (Brown & Jones 2013). The second study investigated 
the effects of an 8-week mindfulness based stress reduction (MBSR; Kabat-Zinn 1982) 
programme upon EEG spectral density and measures of mental and physical health in 
a single group of 22 CBP patients (Schmidt et al. 2015). The therapy was not tailored 
to pain management, did not contain any education on pain, and was focused on 
mindfulness practice, mindfulness during stressful situations, and dynamic yoga. 
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Patients made improvements in quality of life, health satisfaction, and depression, 
however there was no significant difference in PSD between pre- and post- 
intervention (Schmidt et al. 2015). 
2.9.3.3    Other non-pharmacological pain treatments 
Finally, two studies by M.P. Jensen and colleagues (2013a, 2014) have demonstrated 
that measurable change occurs in the PSD of continuous EEG from pre- to post-
treatment with a number of different psychologically mediated therapies. In the first 
study, the PSD of 31 spinal cord injury patients with chronic pain was measured before 
and after they had each partaken in a single 20 minute session of four non-
pharmacological pain treatments: hypnosis, meditation, biofeedback, transcranial 
direct current stimulation (tDCS), and a control condition of sham tDCS. Treatment 
sessions were counterbalanced across participants and took place weekly to reduce 
carry over effects. Each treatment yielded a different pattern of pre- to post-session 
changes in PSD. Hypnosis was associated with general increases in θ- and α-power, 
and was accompanied by a significant reduction in reported pain intensity, as was 
meditation, which produced central electrode increases in α- and β-power. 
Biofeedback produced an increase in occipital β-power, tDCS increased θ-power 
generally, and sham tDCS was associated with an increase in general α-power (M.P. 
Jensen et al. 2013a). The active treatments yielded different results compared to the 
placebo condition, meaning that observed changes were not merely a placebo effect. 
Reductions in pain intensity were not significantly correlated with PSD changes 
meaning the authors could not associate a particular pattern of activity with the 
experience of pain; however it is possible that the observed PSD changes reflected 
some other psychological variable that was not measured. The second study used a 
similar group of patients and employed the same non-pharmacological treatments 
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given in a single 20 minute session; however this time the authors investigated the 
relationship between pre-treatment PSD and the pre- to post-session change in 
subjects’ pain intensity. Baseline θ-power was correlated with response to hypnosis, 
with higher θ-power predicting pain reduction; α-power was also correlated with 
response to meditation, with lower α-power predicting pain reduction (M.P. Jensen et 
al. 2014). Although correlation does not imply causation, these results suggest that 
hypnosis and meditation achieve pain relief via different mechanisms, and that 
treatment efficacy might be improved by matching patients to treatments based on 
their baseline brain activity. 
 
2.10 RESEARCH CARRIED OUT IN THIS THESIS 
2.10.1 Theoretical Basis and Rationale 
The following list summarises the reasoning behind pursuing the research which 
follows, based on information presented in the literature review: 
1. Questionnaire measures are the current ‘gold’ standard to assess the efficacy of 
psychological pain management. Improvements in patient quality of life, mental 
and physical health, daily activity, and a shift from maladaptive to adaptive pain 
coping strategies have regularly been observed. A problem inherent with using self-
report questionnaires to assess treatment outcomes is that they are a measure of subjective 
experience and cannot reveal underlying physiological mechanisms that may accompany 
successful treatment. 
2. Studies have shown that successful pain treatments (surgical, pharmacological, and 
psychological) are associated with measurable changes in brain activity, however 
to date no such study has investigated these measures pre-/post-PMP. 
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3. EEG is a sensitive tool by which to measure brain activity related to pain 
processing. Literature reviewed above has illustrated that both ERP and PSD 
information is not only altered in patients with chronic pain compared to healthy 
controls, but also that it is sensitive to the effects of certain pain treatments in certain 
groups of patients. From a practical viewpoint, EEG is a relatively cheap, portable, 
and uncomplicated measurement tool which can be used at multiple sites by a single 
investigator. 
4. The development of an objective measure of PMP efficacy which can confirm the 
subjective measures currently used has the potential to not only reveal mechanisms 
by which this treatment affects the brain, but also to indicate which patients might 
benefit most from treatment based on baseline brain activity. 
 
2.10.2 Overview of the Studies 
This research investigated psychosocial health and brain activity in patients attending 
two different NHS pain management programmes, one based on CBT, the other based 
on ACT. In order to determine efficacy of each PMP using the current standard of 
assessment, studies were undertaken in which questionnaire data collected since the 
inception of each programme was analysed (henceforth referred to as ‘audits’). These 
audits looked retrospectively at the whole population of patients that had attended the 
PMP. Next, in order to investigate the effect of the PMP on brain activity related to 
pain processing, prospective studies (henceforth, ‘EEG studies’) were conducted. The 
studies of the CBT-based PMP (both audit and EEG) were carried out first, and the 
results of these studies prompted the investigation of a second, ACT-based PMP, in a 
similar manner. The thesis has been structured so that studies are presented in 
chronological order, with Chapters 3 and 4 containing the audit and EEG study of the 
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CBT-PMP, and Chapters 5 and 6 containing the audit and EEG study of the ACT-
PMP. The case series, which examined the relationship between self-report measures 
and EEG data in two patients, is included in Chapter 6 (Figure 2.12). 
 
 
 
 
 
 
 
 
 
Figure 2.12 An overview of the studies contained within this research. 
 
2.10.3 Experimental design 
The following observational studies looked at groups of participants before and after 
they underwent treatment in a pain management programme. Some groups did not 
partake in treatment and acted as control groups. The inclusion of patients in either 
treatment or control groups was not randomised. Such experimental design is known 
as a quasi-experimental, or pre-post intervention, design. Quasi-experiments aim to 
evaluate interventions but that do not use randomisation. Similar to randomised trials, 
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71 
quasi-experiments aim to demonstrate causality between an intervention and an 
outcome. Although the randomised controlled trial is generally considered to have the 
highest level of credibility with regard to assessing causality, randomisation may not 
be possible or viable for a number of reasons. For example, if the intervention under 
study incorporates an accepted, well-established therapeutic intervention, it would not 
be ethically sound to withhold such treatment from patients who stand to benefit from 
it. In the studies presented here, observations were made during routine clinical 
practice, therefore patients could not be randomised to groups. 
Hypothesis testing 
The following studies investigate the effect of pain management therapy upon several 
psychological and physiological parameters. Hypotheses are not explicitly stated. In 
the cases of the audits, past research has already demonstrated the hypothesis that there 
is an effect of treatment upon self-report measures. These studies were conducted to 
make observations about the treatments and discuss them in context of past research.  
In the EEG studies, outcomes could not be hypothesised from prior research. The 
findings were exploratory and intended to reveal patterns that could inform future 
work. It should be noted however, that statistical testing (i.e. null-hypothesis 
significance testing) was used to demonstrate that differences in parameters from pre- 
to post-intervention were unlikely to have arisen by chance and were in fact a 
consequence of the intervention. 
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CHAPTER 3 
PSYCHOPHYSICAL HEALTH AND PAIN COPING 
STRATEGIES IN PATIENTS ATTENDING A COGNITIVE-
BEHAVIOURAL THERAPY (CBT) PAIN MANAGEMENT 
PROGRAMME 
 
3.1 ABSTRACT 
(This abstract has been published in British Journal of Pain, 6(2), 75. It has been 
reformatted to fit with the overall PhD thesis). 
Background: Cognitive-behavioural therapy (CBT) for pain management seeks to 
identify and correct problematic behaviour patterns that can contribute to increased 
pain and reduced quality of life in chronic pain patients. A typical pain management 
programme contains sessions which focus on increasing patients’ understanding of 
pain; training in behavioural and cognitive coping skills; and training in relaxation 
techniques. The goals of CBT are to change the way in which the patient thinks 
about their pain, and to equip patients with the tools to manage living with chronic 
pain. This study aimed to investigate changes in pain coping strategies and 
psychophysical health in a cohort of patients throughout CBT for pain management. 
Methods: 360 patients attended the pain management programme at a West Midlands 
NHS trust regional hospital between Oct 1997 and May 2010. All patients were 
asked to complete the Pain Coping Strategies Questionnaire, the Hospital Anxiety 
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Depression Scale, the Frenchay activity questionnaire, and the Short-Form-36 
general health questionnaire at baseline (pre-course), at outcome (end-course), and at 
follow-up (three months). In order to be included in the analysis patients were 
required to have completed questionnaires at a minimum of two time points (n = 195, 
mean age 46.2 ±10.21, range 22-68). 
Results: There was a significant improvement in use of the coping strategy ‘cognitive 
coping/suppression’ between baseline and outcome (p < .05). There was also a 
significant decrease in the maladaptive coping strategy ‘helplessness’ between 
baseline and outcome (p < .01), which was also significant between baseline and 
follow-up (p < .05). There were also significant decreases in anxiety (p < .01) and 
depression (p < .01); and improvements in activity (p < .01), physical function (p < 
.05), social function (p < .05) and mental health (p < .05) between baseline and 
follow-up. Correlations of the changes in scores over time revealed that ‘cognitive 
coping/suppression’ was positively related to improvement in psychophysical health 
(p < .05) while ‘helplessness’ was negatively related to psychophysical health 
changes (p < .05). 
Conclusion: The pain management programme has been instrumental in bringing 
about significant improvements in psychophysical health and daily activity of 
patients. It has also contributed to a significant change in coping strategies used by 
chronic pain patients, with an increase in ‘cognitive coping/suppression’ and a 
decrease in ‘helplessness’. 
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3.2 BACKGROUND 
 
The West Midlands NHS trust regional hospital (henceforth: Centre A) PMP is 
conceptually based on the behavioural (Fordyce et al. 1968, 1973, 1984) and 
cognitive-behavioural models of pain (Turk et al. 1983; Flor & Turk 1984; Turk & 
Flor 1984). The programme has three basic elements: education; behavioural and 
cognitive coping strategies; and progressive relaxation training. The programme is 
delivered by the Centre A multidisciplinary pain clinic team, consisting of 
psychologist, specialist nurse, physiotherapist, and occupational therapist. The 
psychologist and specialist nurse are trained in CBT and experienced in applying 
CBT to patients who have persistent pain. This PMP has previously been shown to 
be effective in reducing patient anxiety and depression, improving general wellbeing, 
daily activity, and use of adaptive coping strategies as measured by subjective report 
in 95 patients (LeMarchand & Raphael 2008). Due to the small number of patients 
this research was underpowered and the present study will update these findings by 
including data from an additional 265 patients who have since attended the 
programme. 
Upon being enrolled into the programme, patients are asked by the clinical staff to 
fill in several questionnaires: the Short Form 36-item general health questionnaire 
(SF-36); the Hospital Anxiety and Depression Scale (HADS); the Pain Coping 
Strategies Questionnaire (PCSQ); and the Frenchay Activities Index (FAI). Patients 
are asked to fill in the same questionnaires at the end of the programme, and at a 
follow-up session approximately three months later. 
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Since the inception of the CBT-based PMP at Centre A in October 1997, up until the 
time that this study was conducted (May 2010), the programme has been run 40 
times, and 360 patients have attended.  
3.2.1 Aim 
The aim of this study was to assess the efficacy of the CBT-based PMP at Centre A. 
3.2.2 Objectives 
The objectives of this study were to gather the entire available patient generated 
questionnaire data together into a single dataset, and to analyse this dataset to reveal 
overall changes in psychosocial health and pain coping strategies from baseline to 
outcome and baseline to follow-up. 
 
3.3 METHODS 
3.3.1 Study Design 
The study used a longitudinal retrospective design to assess the impact of a CBT-
based PMP treatment upon questionnaire measures collected from patients at three 
time points (baseline, outcome, follow-up). In order to be included in the analysis 
patients were required to have completed questionnaires at a minimum of two time 
points.  
3.3.1.1    Power calculation 
To determine the required sample size, an a priori power calculation was carried out 
using G*Power software (version 3.1.9; Faul et al. 2007). Population effect size was 
estimated using the results of two large scale meta-analyses which examined the 
effects of CBT for pain upon behavioural measures. Morley, Eccleston, and Williams 
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(1999) reported significant effect sizes (median = 0.5) on all measurement domains 
(including pain, mood, cognitive coping, activity, and social functioning). However, 
a later study by the same group (Williams et al. 2012) included a larger number of 
studies and reported smaller effect sizes on pain (0.21), mood (0.38), disability 
(0.26), and catastrophising (0.53), effect on coping was not measured. The present 
study included a measure of pain, so estimated effect size was set conservatively at 
0.21 for the power calculation. Probability of type 1 error (α) was set at 0.05 and 
power was set at 0.8, as is the convention suggested by Cohen (1969, 1992) that is 
typically used in behavioural sciences research (Sullivan & Feinn 2012). 
The calculation using the above parameters reported that a sample size of 142 
participants would be required for power to be above the 0.8 level. 
 
3.3.2 Pain Management Programme Design 
Outpatient programmes ran approximately three times per year, depending upon 
patient demand and staff availability. Patients were required to attend 12 sessions of 
approximately 150 minutes each, given over an 11 week period. The programme 
followed the same timetable (Table 3.1) and consisted of two sessions per week in 
the first three weeks, a two week break, and then one session per week for the 
remaining six weeks. 
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Table 3.1 Timetable of the Centre A Pain Management Programme. 
Session 1 
Introduction to the Programme 
Relatives Session 
Exercise Circuit 
Pain Journey 
Session 2 
Exercise 
Exercise & Posture talk 
Relaxation Theory (breathing) 
Session 3 
Exercise 
Theories of Pain 
Pacing 
Relaxation 
Session 4 
Exercise 
Goal Setting 
Goals 
Relaxation 
Session 5 
Exercise 
Art Work 
Being Believed 
Relaxation 
Session 6 
Exercise 
Coping/Fear avoidance 
Sleep 
Relaxation 
Session 7 
Exercise 
Medication 
Goal Review 
Relaxation 
Session 8 
Exercise 
Thoughts and Feelings 
Relaxation 
Session 9 
Exercise 
Stress 
Expert Patient 
Goal Review 
Relaxation 
Session 10 
Exercise 
Memory 
Assertiveness 
Relaxation 
Session 11 
Exercise 
Change 
Setback Planning 
Relaxation 
Session 12 
Exercise Circuit 
Revisit Goals 
What Next? 
Questions & Answers 
Relaxation 
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3.3.3 Questionnaires of Psychological and Health-related Variables 
3.3.3.1    Short form 36-item general health questionnaire (SF36) 
The SF36 questionnaire is a 36-item self-report questionnaire that measures health 
related functions in eight domains: general health, physical functioning, role 
limitations due to physical health, role limitations due to emotional problems, social 
functioning, bodily pain, vitality, and mental health (Ware & Sherbourne 1992). The 
score on each item ranges from 0 to 100, with higher scores representing better 
health and well-being (Hays et al. 1993). 
A number of studies support reliability and validity of the SF-36 in both general 
(Brazier et al. 1992; McHorney et al. 1993) and patient (Garratt et al. 1993; 
McHorney et al. 1994) populations (discussed in detail in McDowell 2006, pp.649-
665). Garratt and colleagues (1993) report good consistency between the items; 
correlation coefficients within the eight domains all exceed the accepted level of 0.4 
(Kline 1986); internal consistency measured by Cronbach’s α (Cronbach 1951) for 
all scales exceeds the accepted level of 0.7 (Nunnally & Bernstein 1994). The SF-36 
has also been shown to be sensitive to changes in patient health over a course of 
treatment (Kopjar 1996; Hemmingway et al. 1997). 
3.3.3.2    Hospital anxiety and depression scale (HADS) 
The HADS consists of 14 self-scored items designed to assess levels of anxiety and 
depression. Each item is related to either symptoms of anxiety or depression and has 
four responses which are scored from 0 to 3 according to symptom severity (e.g. I 
feel tense and wound up: most of the time (3); a lot of the time (2); from time to time 
(1); not at all (0)). The HADS consists of two independent scales: anxiety (HADS-A) 
and depression (HADS-D), each with seven items, leading to a score between 0 and 
21. A score of 0 to 7 is considered normal; 8 to 10 suggests the presence of the mood 
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disorder; a score 11 or higher indicates a valid case of anxiety or depression 
(Zigmond & Snaith 1983; Snaith 2003).  
The HADS has been validated against psychiatric interviews (Zigmond & Snaith 
1983) and against other scales for the measurement of anxiety and depression 
(Aylard 1987) in patient groups. A review of 747 studies using the HADS concluded 
that it was a suitable measure for assessing anxiety and depression in both patient 
and healthy populations (Bjelland et al. 2002). Internal consistency of both subscales 
has been verified in a study of a large mixed sample of 64,648 persons, which 
reported a Cronbach’s α of 0.80 for HADS-A and 0.76 for HADS-D (Mykletun et al. 
2001).  
3.3.3.3    Pain coping strategies questionnaire (PCSQ) 
The PCSQ is a self-administered, 44-item questionnaire designed to elicit which 
cognitive and behavioural coping strategies are put into use when an individual 
experiences pain (Rosenstiel & Keefe 1983). 42 of the items are rated by the 
responder on the same 7-point Likert-type scale ranging from 0 (never do) to 6 
(always do that) in response to statements designed to assess six different coping 
strategies (diverting attention, reinterpreting pain, catastrophising, ignoring 
sensations, praying or hoping, coping self-statements, increased activities). The final 
two items: ‘control over pain’ and ‘ability to decrease pain’ are also scored on a 7-
point scale. Scores from subscales are combined to generate three coping factors: 
cognitive coping/suppression (reinterpreting + ignoring + coping); helplessness 
(catastrophising - increased activities - control - ability); and diverting attention/ 
praying (diverting attention + praying), with higher scores indicating greater use of 
the coping strategy. 
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The PCSQ was developed in conjunction with samples of chronic LBP patients 
(Rosenstiel & Keefe 1983), however it has since been shown to be a valid tool for 
use in a variety of chronic pain conditions including rheumatoid arthritis, diabetic 
neuropathy, cancer, chronic headache, and neuralgia (Keefe et al. 1989; Lawson et 
al. 1990; Geisser et al. 1994; Snow-Turek et al. 1996). Rosenstiel and Keefe (1983) 
reported that the subscales all have satisfactory internal consistency, with Cronbach’s 
α scores all above 0.7. 
The 6-item catastrophising scale within the PCSQ was used to assess pain 
catastrophising in participants. The score was the total of all 6 items, with higher 
scores indicating a higher degree of catastrophising. This subscale has been reported 
to be the most useful measure of catastrophising, when compared to other 
psychometric tools in a sample of LBP patients (Main & Waddell 1991). 
3.3.3.4    Frenchay activities index (FAI) 
The FAI is a 15-item self-report questionnaire that provides a measure of everyday 
activities of normal living (Holbrook & Skilbeck 1983). The total score reflects 
overall lifestyle activity, with higher scores conferring greater activity. The scale was 
originally developed for use in stroke patients, and has been found to be suitable for 
use in that population; with acceptable internal reliability (Cronbach’s α > .7) 
(Schuling et al. 1993). The FAI has also been assessed for reliability and validity in a 
large sample drawn from the general population (Turnbull et al. 2000); this study 
reported that the scale has high test-retest reliability, and good construct validity, 
particularly in middle aged and elderly people. The FAI contains items relating to 
very basic activities (such as housework) and is sensitive to changes in patient groups 
whose basic daily activities are compromised as a result of illness. 
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3.3.4 Participants 
360 patients attended one of the 40 programmes between October 1997 and May 
2010. Patients were included in the analysis if they had completed questionnaires at 
baseline, and either outcome, or follow-up time points, in order to maximise the data 
available for paired comparisons. Patients who had completed questionnaires at only 
one time point were excluded. 
3.3.5 Data Processing and Analysis 
Questionnaires were scored according to their prescribed marking schemes. Raw 
scores were recorded using Excel 2007 (Microsoft, Redmond, WA) and further 
analysis was performed with SPSS 20 (Statistics Package for the Social Sciences, 
IBM, Chicago, IL). The data were analysed as two separate datasets, the first dataset 
containing data from pairs of baseline and outcome questionnaires 
(baseline/outcome), and the second dataset containing data from pairs of baseline and 
follow-up questionnaires (baseline/follow-up). Paired comparisons were computed 
using Student’s related samples t-test. Effect sizes were calculated using Cohen’s d 
(Cohen 1969, 1992). Correlations between changes in scores from baseline to 
outcome and baseline to follow-up were calculated using the Pearson product-
moment r correlation. Cases with missing data points were excluded from the 
analyses in a pair-wise fashion. 
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3.4 RESULTS 
195 patients completed or part-completed questionnaires at baseline and at least one 
other time point (mean age = 46.2 ±10.21, age range = 22-68), 123 (63%) females 
and 72 (37%) males. 132 completed questionnaires at the baseline and outcome time 
points; 123 at baseline and follow-up; (60 at all three time points). Overall means and 
standard deviations are shown for each subscale in Table 3.2. 
 
Table 3.2 Descriptive statistics of scores on all scales at the three time points. 
Questionnaire (Subscale) 
Baseline 
Mean (n) ±SD 
Outcome 
Mean (n) ±SD 
Follow-up 
Mean (n) ±SD 
SF36 (General health) 33.6 (195) ±15.2 35.8 (141) ±16.3 34.7 (128) ±16.6 
SF36 (Physical functioning) 23.2 (195) ±20.1 25.6 (141) ±20 25.8 (128) ±21.8 
SF36 (Role limitations due 
to physical health) 
13.9 (195) ±16.9 17.6 (141) ±19.5 14.4 (128) ±20.0 
SF36 (Role limitations due 
to emotional problems) 
30.3 (195) ±40.6 34.0 (141) ±40.7 37.5 (128) ±42.7 
SF36 (Social functioning) 37.6 (195) ±23.3 42.0 (141) ±22.1 41.7 (128) ±23.4 
SF36 (Bodily pain) 23.7 (195) ±16.9 24.6 (141) ±15.6 24.9 (128) ±14.9 
SF36 (Vitality) 24.5 (195) ±17.3 27.1 (141) ±17 27.6 (128) ±16.8 
SF36 (Mental health) 47.9 (195) ±18.7 53.7 (141) ±19.4 52.9 (128) ±18.1 
HADS (Anxiety) 11.7 (164) ±4.3 10.6 (108) ±4 10.4 (96) ±3.9 
HADS (Depression) 10.4 (164) ±3.7 9.8 (108) ±3.6 9.6 (97) ±4.1 
FAI 23.9 (172) ±9.1 22.8 (116) ±8.9 26.3 (99) ±9.2 
PCSQ (Catastrophising) 17.0 (164) ±8.6 14.8 (107) ±7.9 15.1 (95) ±8 
PCSQ (Cognitive coping 
/suppression) 
33.7 (164) ±17.6 36.1 (107) ±18 36.3 (95) ±18.8 
PCSQ (Helplessness) -1.5 (164) ±11.8 -6.7 (107) ±11.7 -4.1 (95) ±12.5 
PCSQ (Diverting 
attention/praying) 
23.9 (164) ±13.2 24.5 (107) ±12.6 24.9 (95) ±13.5 
SD = Standard Deviation; SF36 = Short form 36 item general health survey; PCSQ = Pain coping 
strategies questionnaire; HADS = Hospital Anxiety and Depression Scale; FAI = Frenchay Activities 
Index.  
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3.4.1 Differences between Baseline and Outcome Scores 
Between baseline and outcome, paired t-tests revealed a significant difference in 
scores of: the general health, social functioning, and mental health subscales of the 
SF36; the anxiety subscale of the HADS; and in the catastrophising subscale, and 
cognitive coping/suppression and helplessness factors of the PCSQ (Table 3.3). 
 
 
Table 3.3 Baseline and outcome questionnaire scores from patients in the Centre A PMP, 
significance values shown for paired t-tests. 
Questionnaire (Subscale) 
Baseline 
Mean ±SD 
Outcome 
Mean ±SD 
Paired t-test outcome Effect size 
(Cohen’s d) 
SF36 (General health) 32.7 ±15.1 35.1 ±16.3 t = -2.7, df(131), p = .008* -0.24 s 
SF36 (Physical functioning) 25.0 ±21.2 26.2 ±20.3 t = -0.8, df(131), p = .447 -0.07 
SF36 (Role limitations due 
to physical health) 
14.7 ±15.6 17.7 ±20.1 t = -1.7, df(131), p = .101 0.14 
SF36 (Role limitations due 
to emotional problems) 
28.5 ±40.0 34.8 ±41.2 t = -1.7, df(131), p = .093 0.15 
SF36 (Social functioning) 37.7 ±22.5 42.0 ±22.3 t = -2.5, df(131), p = .014* -0.22 s 
SF36 (Bodily pain) 23.5 ±16.0 24.6 ±15.8 t = -0.7, df(131), p = .470 0.06 
SF36 (Vitality) 24.7 ±16.6 26.9 ±17.0 t = -1.4, df(131), p = .172 -0.12 
SF36 (Mental health) 48.3 ±18.9 54.0 ±19.7 t = -3.6, df(131), p < .001* -0.31 s 
HADS (Anxiety) 12.0 ±4.5 10.7  ±4.1 t = 4.2, df(103), p < .001* 0.41 s 
HADS (Depression) 10.4 ±3.6 9.8 ±3.7 t = 1.8, df(103), p = .077 0.17 
FAI 23.3 ±8.4 22.7 ±9.1 t = 0.8, df(99), p = .416 0.08 
PCSQ (Catastrophising) 16.8 ±8.0 14.9 ±8.0 t = 2.5, df(102), p = .015* 0.24 s 
PCSQ (Cognitive coping 
/suppression) 
32.8 ±17.0 36.1 ±18.2 t = -2.5, df(102), p = .016* -0.24 s 
PCSQ (Helplessness) -1.7 ±11.0 -6.4 ±11.8 t = 4.9, df(102), p < .001* 0.48 s 
PCSQ (Diverting 
attention/praying) 
23.1 ±12.4 24.7 ±12.4 t = -1.8, df(102), p = .072 -0.18 
SD = Standard Deviation; SF36 = Short form 36 item general health survey; PCSQ = Pain coping 
strategies questionnaire; HADS = Hospital Anxiety and Depression Scale; FAI = Frenchay Activities 
Index; * = significant difference between scores (α = .05); s = small effect size (d = 0.2–0.5).  
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3.4.2 Differences between Baseline and Follow-up Scores 
Between baseline and follow-up, paired t-tests revealed a significant difference in 
scores of: physical functioning and mental health subscales of the SF36; anxiety and 
depression subscales of the HADS; daily activity measured by the FAI; and the 
helplessness factor of the PCSQ (Table 3.4). 
 
Table 3.4 Baseline and follow-up questionnaire scores from patients in the Centre A PMP, 
significance values shown for paired t-tests. 
Questionnaire (Subscale) 
Baseline 
Mean ±SD 
Follow-up 
Mean ±SD 
Paired t-test outcome 
Effect size 
(Cohen’s d) 
SF36 (General health) 34.5 ±16.0 34.5 ±16.8 t = 0.04, df(122), p = .970 0.003 
SF36 (Physical functioning) 22.4 ±19.9 26.1 ±22.3 t = -2.1, df(122), p = .043* -0.18 
SF36 (Role limitations due 
to physical health) 
14.7 ±19.0 14.4 ±20.3 t = 1.2, df(122), p = .903 -0.01 
SF36 (Role limitations due 
to emotional problems) 
33.6 ±41.3 36.9 ±42.4 t = -0.8, df(122), p = .416 0.07 
SF36 (Social functioning) 37.2 ±23.9 40.9 ±23.3 t = -1.7, df(122), p = .085 -0.16 
SF36 (Bodily pain) 24.6 ±17.0 25.1 ±15.0 t = -0.4, df(122), p = .689 0.04 
SF36 (Vitality) 25.9 ±17.9 27.1 ±16.6 t = -0.7, df(122), p = .467 -0.07 
SF36 (Mental health) 48.8 ±18.6 52.7 ±18.4 t = -2.5, df(122), p = .013* -0.23 s 
HADS (Anxiety) 11.4 ±4.2 10.3  ±3.9 t = 3.1, df(91), p = .003* 0.32 s 
HADS (Depression) 10.4 ±3.6 9.6 ±4.1 t = 2.8, df(91), p = .006* 0.29 s 
FAI 24.7 ±9.2 26.4 ±9.4 t = -2.8, df(91), p = .007* -0.29 s 
PCSQ (Catastrophising) 16.7 ±8.9 15.2 ±8.1 t = 1.9, df(89), p = .058 0.20 
PCSQ (Cognitive coping 
/suppression) 
32.8 ±17.0 36.5 ±19.2 t = -1.6, df(89), p = .104 -0.17 
PCSQ (Helplessness) -2.0 ±12.4 -4.1 ±12.6 t = 2.1, df(89), p = .038* 0.22 s 
PCSQ (Diverting 
attention/praying) 
25.2 ±13.8 24.9 ±13.1 t = 0.3, df(89), p = .781 0.03 
SD = Standard Deviation; SF36 = Short form 36 item general health survey; PCSQ = Pain coping 
strategies questionnaire; HADS = Hospital Anxiety and Depression Scale; FAI = Frenchay Activities 
Index; * = significant difference between scores (α = .05); s = small effect size (d = 0.2–0.5).  
 
 
 
85 
3.4.3 Correlations between Changes in Scores from Baseline to Outcome and 
Baseline to Follow-up 
From baseline to outcome, the increase in scores on the cognitive coping and 
suppression factor of the PCSQ was correlated with improvements in physical 
functioning, role limitations due to physical health, and a decrease in depression 
(Table 3.5). The decreases in scores on the catastrophising and helplessness factors 
were correlated with improvement in scores of: general health, role limitations due to 
physical health, role limitations due to emotional problems, bodily pain, mental 
health, anxiety, and depression. The increase in scores on the diverting 
attention/praying factor was positively correlated with change in FAI scores. 
From baseline to follow-up, the change in helplessness scores correlated with mental 
health and depression. Also, the increase in scores on the diverting attention/praying 
factor was positively correlated with change in FAI scores. 
Table 3.5 Correlations (Pearson’s r) between the changes in factor scores on the PCSQ, and 
subscales on the SF36, HADS, and FAI, from baseline to outcome, and baseline to follow-up 
PCSQ factor: Catastrophising 
Cognitive coping 
/suppression 
Helplessness 
Diverting 
attention/praying 
Baseline/Outcome (N)     
(SF36) General Health (99) -.21** - -.20* - 
Physical Functioning (99) - .26* - - 
Role limitations due to 
Physical health (99) 
-.31** - -.29** - 
Role limitations due to 
Emotional problems (99) 
- .42** -.35** - 
Social Functioning (99) - - - - 
Bodily Pain (99) -.33** - -.25* - 
Vitality (99) - - -.21* - 
Mental Health (99) -.37** - -.33** - 
(HADS) Anxiety (103) .37** - .41** - 
(HADS) Depression (103) .36** -.22* .45** - 
FAI (91) - - - .22* 
Baseline/Follow-up (N)     
(SF36) Mental Health (90) - - -.28** - 
(HADS) Depression (90) - - .24* - 
FAI (84) - - - .25* 
SF36=Short form 36 item general health survey; PCSQ=Pain coping strategies questionnaire; HADS= 
Hospital Anxiety and Depression Scale; FAI = Frenchay Activities Index; * = p < .05, ** = p < .01. 
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3.5 DISCUSSION 
 
In this study of 195 patients attending a CBT-based PMP, there were small but 
significant improvements in several measures of psychophysical health and pain 
coping strategies between baseline/outcome and baseline/follow-up. Scores on 
domains of mental health, anxiety, and helplessness improved significantly between 
both baseline/outcome and baseline/follow-up. However, significant improvements 
in general health, social functioning, catastrophising, and cognitive 
coping/suppression that occurred between baseline/outcome were not observed 
between baseline/follow-up. Conversely, there were significant improvements in 
measures of physical function, daily activity, and depression between 
baseline/follow-up that were not observed between baseline/outcome. 
Looking at improvements made from baseline to outcome, the immediate benefit of 
attending the PMP was to change patients’ use of coping strategies and improve their 
perceived general physical and mental health. Use of the maladaptive coping 
strategies of catastrophising and helplessness (which are closely related) significantly 
decreased, while use of the positive coping strategy – cognitive coping/suppression – 
increased significantly. These results agree with the Cochrane review of CBT for 
pain management (A. Williams et al. 2012), which found the treatment was effective 
in improving measures of mood and catastrophising. Catastrophising has consistently 
been associated with increased pain and psychophysical dysfunction in patient 
groups (Sullivan et al. 2001; Turner et al. 2002). This study has revealed that change 
in catastrophising scores are negatively correlated with change on psychophysical 
health domains including bodily pain, anxiety, and depression. Whether the change 
in catastrophising represents the cause or the effect of psychophysical improvement 
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in patients is unclear due to the correlational nature of the data used. Taken together, 
these findings confirm that the CBT components of the PMP, such as goal setting, 
coping with pain, fear avoidance, coping with stress, and relaxation, are effective in 
bringing about positive mental health changes in patients pre- to post-treatment. 
Alongside CBT, the PMP also contained a substantial physical component: every 
session began with 15-20 minutes of physiotherapy. At outcome, physical domain 
scores had not improved compared to baseline; however at follow-up, scores on the 
physical functioning scale of the SF36 and on the FAI significantly improved 
compared to baseline. This data suggests that physical improvement may not be an 
immediate benefit of attending a PMP, with the benefit emerging over a longer 
period of time. Patients’ also reported better mental health, less anxiety and 
depression, and reduced helplessness at follow-up compared to baseline. Mental 
health improvements were also observed between baseline and outcome, suggesting 
that the mental health benefits are maintained after the treatment program has ended. 
Perceived reduction in disability and increased daily activity may contribute to long-
term maintenance of mental health improvements: a recent overview of Cochrane 
reviews (Geneen et al. 2017) reported that exercise and physical activity was linked 
to positive effects on mental health and quality of life in chronic pain patients. 
3.5.1 Limitations 
There were some methodological limitations to the study. Firstly, given the 
longitudinal nature of the available data, collected at three time-points, an ideal 
method of analysis would have been repeated-measures ANOVA. To make the best 
use of the available data, to maximise group size and statistical power, the present 
study instead used paired t-tests to compare patient scores between baseline/outcome 
and baseline/follow-up, meaning that change in scores between outcome/follow-up 
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was not directly measured. To put into context the lack of data available to perform a 
repeated-measures ANOVA: of the 195 patients studied, only 60 (partially) filled in 
questionnaires at all three time-points (25 fully completed all questionnaires at all 
time-points). This meant that there were a large number of absent data points that 
could not be corrected without making significant assumptions. The retrospective 
design of the study makes missing data an inevitable and unavoidable problem. A 
second limitation to the study is that data regarding the patients’ diagnosed pain 
condition was not collected. It is possible that if patients had been grouped according 
to disease or disorder there may have been differential effects of the treatment upon 
collected measures. Such information would be of benefit to clinical decision making 
regarding treatment options. However, some have argued that disease phenotype is 
not helpful in predicting how a patient will respond to psychological interventions, 
and a more relevant approach to classification is on the basis of psychological factors 
(Turk 1990, 2005; Vlaeyen & Morley 2005). Such classification could reveal patient 
groups that respond better to treatment, however the criteria for classification are not 
yet clear (Kindermanns et al. 2011; Morley et al. 2013). 
3.5.2 Directions for Future Study 
One aspect of psychology to explore in future study is the patients’ beliefs regarding 
locus of control, and how this changes from pre- to post-treatment (Rotter 1966). 
Patients who believe outcomes to be controlled by chance are more likely to use 
maladaptive coping strategies (Crisson & Keefe 1998); those who belief pain is 
controlled by external factors tend to score more highly on measures of disability 
(Turner et al. 2002) and respond worse to treatment (Tota-Foucette et al.  1993); and 
patients who have a more internal locus of control report their pain as less intense 
and frequent (Toomey et al. 1991) and respond better to treatment (Lame et al. 
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2008). Given this evidence that locus of control is a contributing factor to 
psychophysical health and treatment efficacy in patients, its measurement should be 
included in future investigations of PMP efficacy. 
Another direction for future study concerns the method used to measure the effect of 
treatment. It is important to note that despite the treatment having some significant 
effects upon questionnaire measures between the time-points, these effects were 
generally small (i.e. less than half of one standard deviation). Effect sizes reported by 
previous studies of CBT for pain management (reviewed in A. Williams et al. 2012) 
were also of similar magnitude. For a treatment that has been in widespread use for 
over 25 years, it is unclear why the effect on patients’ perceived health status is not 
greater. It is possible that patients who have been living with chronic pain, which 
often presents without overt physical evidence and is not responsive to treatment, 
may develop a pattern of behaviour which seeks validation of their condition from 
healthcare staff. The patients’ may be reluctant to report significant health 
improvements in case it results in withdrawal of treatment; therefore, even following 
several weeks of treatment in a PMP, only small effects are observed on these 
subjectively reported measures of health. This subjectivity is a drawback to using 
self-report questionnaires, which are the de facto gold-standard for measuring the 
efficacy of psychological treatment. 
The next chapter explores the possibility of measuring the effect of a PMP using a 
more objective method, in the form of EEG, as suggested by literature reviewed in 
Sections 2.7–2.9. 
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CHAPTER 4 
 
EEG MEASURES OF PAIN PROCESSING IN PATIENTS 
BEFORE AND AFTER ATTENDING A COGNITIVE-
BEHAVIOURAL THERAPY (CBT) PAIN MANAGEMENT 
PROGRAMME 
4.1 ABSTRACT 
 
Background: The Centre A pain management programme (PMP) has previously been 
shown to bring about significant improvements in questionnaire measures of 
psychophysical health and pain coping strategies in a large sample (Chapter 3). 
Studies reviewed in Sections 2.7-2.9 suggest that neurophysiological differences 
exist between patient and healthy groups, and also that cortical electrical activity can 
change following treatment. In the present study, patients from the Centre A PMP 
underwent periods of EEG recording during experimentally induced pain, both 
before and after treatment, to investigate the effect of treatment upon the cortical 
response to pain. 
Methods: Two studies were carried out. In study A, EEG recording of the cortical 
response to brief, painful contact heat stimulation was conducted in a sample of 12 
patients, both before and after attending a CBT-based PMP. Low-frequency, high-
frequency, and conditioned pain modulation conditions were used. Evoked response 
potentials (ERPs) were extracted from EEG data for comparison. In study B, 
continuous EEG recording was carried out at rest and following medium duration 
(90s) tonic painful stimulation using the cold pressor test. Recording sessions were 
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carried out with 12 patients, both before and after attending a CBT-based PMP; and 
also with 14 healthy control participants over a 12 week period. Participants also 
filled in questionnaires to measure psychophysical health and pain coping strategies, 
as per the earlier study (Chapter 3), including a measure of locus of control. 
Results: Study A: Group mean ERPs were not significantly affected either by the 
different stimulation conditions, or by the treatment programme. There were a few 
significant effects at an individual level, however these did not show any consistent 
pattern across the sample. Study B: In the patient group, paired t-tests revealed the 
effect of cold pressor pain pre-PMP to be significant reductions in θ- and α- power 
(p<.05). There were no significant effects of cold pressor pain post-PMP. There were 
no significant effects of cold pressor pain in the healthy control group. Behavioural 
data from the patient group showed a significant improvement in general health, 
anxiety, depression, catastrophising and helplessness scores from pre- to post-PMP 
(p<.05), there was no effect upon the measure of locus of control. Questionnaire 
scores did not change significantly in the control group.  
Conclusion: The effect of cold pressor pain upon θ- and α-activity is modulated 
following a CBT-based PMP. This may be due to a change in cognitive appraisal of 
painful signals brought about by taking part in the PMP, supported by the reduction 
in catastrophising and feelings of helplessness post-PMP. Patients also learned 
relaxation techniques for dealing with periods of increased pain, which they may 
have employed during cold pressor pain, and which may have contributed to the 
observed stability of θ- and α-power measured post-PMP. Results imply the 
possibility of an objective measure of the outcome of psychological therapy for 
chronic pain. Data should be collected from a waiting-list control group in order to 
confirm findings. 
92 
4.2 BACKGROUND 
 
Previous studies, reviewed in Sections 2.7–2.9, demonstrated that neurophysiological 
differences in pain processing (measured using EEG) exist between chronic pain 
patient and healthy groups, and also that measurable changes can occur from pre- to 
post-treatment. This chapter describes two studies carried out to investigate the effect 
of a CBT-based PMP on EEG measures of pain processing. Participants underwent 
EEG test sessions before and after they had attended a CBT-based PMP which has 
proven efficacy in improving psychophysical health and pain coping strategies from 
baseline to outcome (see Chapter 3). The first study (Study A) investigated the effect 
of the treatment upon ERPs in response to brief painful stimulation. The second 
study (Study B) investigated the effect of treatment upon EEG power spectral density 
(PSD) over a period of continuous EEG recording, both at rest and following 
continuous painful stimulation. 
4.2.1 Choice of Stimuli 
4.2.1.1    Brief (phasic) painful stimulation 
Early studies used a CO2 laser to rapidly heat a small area of skin at around 
10,000°C/sec (Carmon et al. 1976), and this method continues to be used by some 
researchers; however the device must be carefully controlled by a skilled operator to 
avoid the danger of damage to the skin. A method which is far safer and easier to 
control is contact heat stimulation (Contact Heat Evoked Potential Stimulator; 
CHEPS: Medoc, Ramat Yishai, Israel). The CHEPS equipment delivers contact heat 
stimulation using a thermode (a heating thermo-foil covered with a 25μm layer of 
thermo-conductive plastic) which is placed into contact with the skin and heated 
using electrical current. The thermode is programmed to heat rapidly (70°C/sec) to a 
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pre-set temperature and is then cooled immediately (at 40°C/sec) by heat exchange 
with a coolant pumped into the thermode. This process ensures a controlled stimulus 
is delivered for an extremely brief duration (100 ms) at sufficient intensity to induce 
an evoked response. As the whole process is computer controlled, the system will 
deliver identical repeated stimuli to every participant. Further safety measures 
incorporated into the CHEPS are a maximum thermode temperature of 55°C, 
computer controlled safety checks carried out before each block of trials, and an 
emergency stop button which is easy to identify and activate. The CHEPS equipment 
has been used numerous times in both healthy (e.g. A.C.N. Chen et al. 2001; LePera 
et al. 2002; Greffrath et al. 2007; Warbrick et al. 2009) and patient (Atherton et al. 
2007; Chi et al. 2008; Truini et al. 2007; Staud et al. 2008) samples, no problems 
have ever been reported. 
To ensure that the intensity of stimulation is sufficient to generate a feeling of pain in 
the participant, it is common to either use a range of stimulus intensities during the 
experiment, each of which are rated using a verbal or numerical scale; or to carry out 
a pre-test in which participants are exposed to the stimulus at varying intensities, so 
that a painful level may be agreed upon before collecting ERP data. 
4.2.1.2    Continuous (tonic) painful stimulation 
Experimentally induced pain of moderate intensity and medium duration can be set 
up using a number of methods. Three choices are available: chemical, muscle 
fatigue, and temperature. Chemically induced pain using capsaicin is difficult to 
control, often resulting in prolonged skin irritation and distress. Muscle fatigue 
induced by performing muscle work (such as squeezing a tennis ball) whilst 
restricting blood flow using a tourniquet, results in a moderate to high intensity pain 
due to ischaemia. As the participant controls of the intensity of the stimulation, it is 
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difficult to ensure similar levels of stimulation across participant groups. A more 
reliable method of inducing tonic pain at a consistent level in all participants is by 
immersion of the hand into cold water (~4°C) for a set time period. This method is 
known as the cold pressor test (CPT; Hilgard 1975). A water bath is prepared and 
maintained at constant temperature by the addition of ice. After the participant has 
immersed their hand in the water for a few minutes, they experience a medium 
intensity pain which continues for 5-10 minutes. The CPT carries no risk of lasting 
damage, a little reddening of the skin is to be expected but this returns to normal 
within 5-10 minutes of withdrawing the hand from the water. The effects of the CPT 
have been thoroughly investigated (Walsh et al. 1989) and this method has been used 
as an experimental pain stimulus in numerous studies (A.C.N. Chen et al. 1989; Russ 
et al. 1999; Mitchell et al. 2004; Arendt-Nielsen et al. 2008). 
4.2.2 General Aspects 
The studies were approved by the National Research Ethics Service Committee West 
Midlands-Solihull (granted: 15/12/2011, ref: 11/WM/0407) and the Research and 
Development committees at Russells Hall Hospital, Dudley (granted: 14/02/2012, 
ref: ID1004), and was sponsored by Birmingham City University (granted: 
24/10/2011). The study protocol, participant information sheets, and informed 
consent forms were all approved by the above NHS research ethics committees. 
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4.3 STUDY A: THE EFFECT OF PMP TREATMENT UPON CONTACT 
HEAT EVOKED POTENTIAL MEASURES 
 
A.1 BACKGROUND 
 
Previous studies have shown that sensitisation to repetitive heat stimuli, as measured 
by verbal self-report of pain intensity, occurs in healthy subjects at stimulation 
frequencies greater than 0.33 Hz (Price et al. 1977; Herrero et al. 2000; Kleinbohl et 
al. 2006; Meeus & Nijs 2007). Studies have also shown that sensitisation occurs at 
lower frequencies in chronic pain patients suffering from fibromyalgia (Staud et al. 
2001), osteoarthritis (Arendt-Nielsen et al. 2010), whiplash (Curatolo et al. 2001), 
migraine (Weissman-Fogel et al. 2003), temporomandibular disorder (Sarlani et al. 
2004), and chronic fatigue syndrome (Meeus & Nijs 2007). The present study 
explored sensitisation using CHEPs as a measure of pain intensity instead of a verbal 
rating. A number of studies have demonstrated a significant positive correlation 
between the amplitude of pain ERPs and the subjective perception of pain intensity 
using contact heat stimuli (A.C.N. Chen et al. 2001; A.C.N. Chen et al. 2002; LePera 
et al. 2002; Granovsky et al. 2005, 2006, 2008; Greffrath et al. 2007; Roberts et al. 
2008). The effect of conditioned pain modulation (CPM) has previously been shown 
to attenuate ERP amplitudes in both healthy (A.C.N. Chen et al. 1985; Reinert et al. 
2000) and patient groups (Quante et al. 2008). How multidisciplinary pain treatment 
affects ERP amplitudes has not previously been studied. 
This study was designed to investigate CHEP amplitudes in chronic pain patients, 
under three conditions measured before and after PMP treatment. The first condition 
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measured ERPs during low-frequency painful stimulation, where stimuli were 
presented every 6-8 seconds. The relatively long period between stimuli was chosen 
to mitigate any effects of habituation and sensitisation upon ERPs, and this condition 
provided a reference ERP amplitude for comparison with the next two conditions. In 
second condition, stimuli were presented at a high-frequency, every 4-6 seconds, in 
order to reveal any increase in ERP amplitudes as a result of sensitisation, which is 
enhanced in chronic pain patients (Brown & Jones 2009; de Tommaso et al. 2010), 
and which may also be related to pain catastrophising (Granot et al. 2006; George et 
al. 2007). The third condition used a conditioned pain modulation paradigm 
(Yarnitsky et al. 2010) where tonic pain was induced using the CPT, and contact heat 
stimuli were then presented at a low-frequency. This condition was used to 
investigate the presence or absence of DNICs (see Section 2.7.2.5). 
A.1.1    Aim 
The aim of this study was to assess CHEPs in patients pre- and post-treatment in the 
CBT-based PMP at Centre A. 
A.1.2    Objectives 
The objectives of this study were to measure CHEPs under conditions of low- and 
high-frequency stimulation and under a conditioned pain modulation paradigm, and 
to investigate how the differences between measures changed from pre- to post-
treatment. Questionnaire data was collected to verify the efficacy of the treatment in 
the patients studied. 
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A.2 METHODS 
A.2.1    Study Design 
The study used a prospective cohort design to assess the impact of a CBT-based 
PMP treatment upon CHEPs and questionnaire measures collected from patients at 
two time points (baseline and outcome).  
A.2.1.1    Power calculation 
Optimum group size was calculated using the software application G*Power 3.1.2 
(Faul et al. 2007) and with advice from Peter Nightingale, a statistician at University 
Hospitals Birmingham NHS Foundation Trust. In order to detect a large effect size 
(d) of 0.8 (Cohen 1988) from a two-tailed paired test, with a type-I error probability 
of 0.05, the required group size was calculated to be 19‒24. 
A.2.2    Stimulation Equipment 
Contact heat stimulation was delivered using the Contact Heat Evoked Potential 
Stimulator (CHEPS; Medoc, Ramat Yishai, Israel).  Heat pain tolerance thresholds 
were assessed using a peltier-based thermode with a 30x30 mm thermo-sensory 
stimulator (PATHWAY model ATS). Contact heat stimulation for the generation of 
ERPs was delivered by a circular thermode with an area of 572.5mm2, and a heating 
thermo-foil (Minco Products Inc., Minneapolis, MN) covered with a 25μm layer of 
thermo-conductive plastic (Kapton®, thermal conductivity at 23°C of 0.1–0.35 
W/m/K). Two thermocouples are embedded 10 µm within this conductive coating, 
which contacts the skin directly, thus providing an estimate of the skin temperature at 
the thermode surface (Granovsky et al. 2008). The maximum thermode heating rate 
was 70°C/s (~200ms to reach 51°C from 32°C baseline) and the maximum cooling 
rate was 40°C/s.  
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Tonic cold pain was induced using the standard cold pressor test (CPT) procedure 
(Hines & Brown 1932; Wolf & Hardy 1941; Walsh et al. 1989). A water bath was 
prepared and maintained at 4°C (± 1°C) by the addition of ice crystals.  
A.2.3    EEG Equipment Setup 
EEG data was recorded using a 10 channel system (VAmp, BrainProducts, Munich, 
Germany). The EEG cap consisted of 9 Ag/AgCl scalp electrodes distributed 
according to the 10–20 system (AFz (ground), Fz, FCz (reference), Cz, Pz, C3, C4, 
T7, T8) with one additional electrode attached below the left eye (on the lower 
orbital portion of the orbicularis oculi muscle) for detection of eyeblink artefacts. 
Data was sampled at 2 kHz, using FCz as a reference. Impedance at all recording 
electrodes was less than 10 kΩ. The amplified EEG signals were transmitted to a 
recording computer running Brain Vision Recorder software version 1.10 
(BrainProducts, Munich, Germany), where it was down sampled to 500 Hz and saved 
to disk. The EEG recording software received stimulus timing information from the 
CHEPS equipment via a cable which was connected to the EEG amplifier.  
A.2.4 Participants 
12 participants (10 female, 2 male, mean age = 52, range = 39–64) were recruited 
consecutively from the population of chronic pain patients who had been enrolled 
into the PMP at Centre A. Test sessions took place at Centre A and were carried out 
in two-week periods before and after patients attended the 11-week CBT-based PMP 
(described in Chapter 3). All data was collected by the author. For the duration of the 
test session, participants sat in a quiet, dimly lit room. Participants were fitted with 
EEG recording equipment and given time to become familiar with the contact heat 
and cold water bath stimuli prior to testing. This ensured that participants were as 
relaxed as possible once recording began and also that participants were used to the 
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stimuli, thus minimising any brain activity related to the novelty of the stimuli, which 
has been shown to affect ERPs in previous studies (Granovsky et al. 2005; Iannetti et 
al. 2008; Legrain et al. 2012). 
A.2.5 Calibration of Contact Heat Testing Temperature 
In order to determine the testing temperature, heat pain tolerance thresholds were 
measured with the thermo-sensory stimulator applied to the right volar forearm and 
held firmly in place by the investigator. This step also allowed the participants to 
become familiar with the equipment and contact heat sensations. Pain tolerance 
thresholds were assessed using the ‘Limits’ programme provided with PATHWAY 
software version 4.0.11.0 (Medoc, Ramat Yishai, Israel). The thermo-sensory 
stimulator temperature was increased from 32°C at a rate of 1°C/sec to a maximum 
of 52°C. This heating rate was chosen to minimise any artificially high readings 
caused by reaction time (i.e. as the temperature continues to rise during the reaction 
time between subjective tolerance and button press, which has previously been found 
to be an issue with rates > 2°C/sec; Yarnitsky & Ochoa 1990).   Pain tolerance 
threshold was defined as the point at which the subject could no longer tolerate the 
pain. Participants were asked to press a button indicating when this point had been 
reached. Participants were shown the following scale as a reference: 0, no pain; 1, 
slight intense; 2, mild intense; 3, moderate intense; 4, slight pain (pain threshold); 5, 
mild pain; 6, moderate pain; 7, moderate–strong pain; 8, strong pain; 9, severe pain; 
10, unbearable pain (Niddam et al. 2001). The thermo-sensory stimulator was 
programmed to return to baseline at a rate of 5°C/sec once the button had been 
pressed. The procedure was repeated three times in order to generate a mean value. 
The thermode was moved after each stimulus to one of three adjacent, non-
overlapping locations on the right volar forearm. 
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The temperature set point for the phasic heat stimulation trials was then calibrated. 
This was the temperature which consistently elicited a rating from the participant of 
7 out of 10 on the NRS. This rating was selected based on previous studies which 
used a range of temperatures and collected ratings for each level, finding that an 
average rating of between 5.8 and 6.5 on an 11-point NRS was required to 
consistently elicit CHEPs (A.C.N. Chen et al. 2001; LePera et al. 2002; Granovsky et 
al. 2005; I.A. Chen et al. 2006). Using the ‘Pulses’ programme provided with the 
PATHWAY software, 5 consecutive stimuli (inter-stimulus interval (ISI) 4-6s) were 
delivered at the tolerance threshold temperature and the participant was asked to 
verbally rate the pain intensity immediately after each stimulus was felt (thermode 
moved after each stimulus). If the rating was consistently below 7, the temperature 
was increased by 1°C for another 5 stimuli. If the rating was above 7, the temperature 
was reduced by 1°C for another 5 stimuli. The process was repeated until the desired 
temperature was reached, or until the maximum temperature of the stimulator (55°C) 
was reached. This set the temperature to be used during both test sessions, therefore 
this part was not repeated during the outcome session. 
A.2.6 CHEPS Stimulation and Recording 
CHEPs were recorded in three blocks of trials, each consisting of 30 consecutive 
stimuli at the test temperature (Figure 4.1). In order to investigate the effect of the 
frequency of stimulation, the first block of trials used a variable ISI of 6-8s (low-
frequency) and the second block used a variable ISI of 4-6s (high-frequency) 
delivered to the right volar forearm. When the thermode temperature passed 37°C a 
signal was sent from the CHEPS machine to the EEG amplifier to indicate the onset 
of each stimulus. In order to reduce the peripheral habituation effect caused by 
nociceptor fatigue, the thermode was moved to one of three adjacent, non-
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overlapping locations after every two pulses (Mayhew et al. 2013). There was a 
break of two minutes between blocks. 
A.2.6.1    Conditioned pain modulation: CHEPS and cold pain stimulation 
The CPT described earlier was used to induce a tonic pain stimulus lasting around 10 
minutes. Participants were asked to place their left hand and wrist into the cold water 
bath for a period of 90 seconds. EEG data was not recorded during the CPT 
procedure due to the risk of EEG data contamination from involuntary body 
movements and facial muscle activity caused by exposure to the cold water bath. 
Previous work has shown that the effect of tonic pain upon the EEG continues for 
some minutes after the stimulus has been withdrawn (Reinert et al. 2000; Stevens et 
al. 2000), and that peak discomfort occurs after around 90 seconds (Walsh et al. 
1989). Participants removed their hand from the water and placed it onto a towel, and 
a third block of 30 low-frequency stimulation CHEPs was recorded. 
 
 
Figure 4.1 Diagram of the test procedure. 
 
A.2.7 Data Processing and Analysis 
EEG data were processed and analysed using four software applications: Brain 
Vision Analyzer v2.0 (BrainProducts, Munich, Germany); EEGLAB 8.0 (Delorme & 
Makeig 2004; Swartz Centre for Computational Neurosciences, La Jolla, CA; 
http://www.sccn.ucsd.edu/eeglab) running on Matlab 2007b (MathWorks, Natick, 
MA); Excel 2007 (Microsoft, Redmond, WA); and SPSS 20 (IBM, Chicago, IL). 
Low-frequency 
stimuli (30)
High-frequency 
stimuli (30)
Cold Pressor 
(90 seconds)
Low-frequency 
stimuli (30)
Rest 
 
Rest 
 
(2 mins) (2 mins) 
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A.2.7.1    EEG data pre-processing 
Raw EEG files were divided into three periods of contact heat stimulation, being 
low-frequency stimulation (henceforth: CHEPS-low), high-frequency stimulation 
(henceforth: CHEPS-high), and low-frequency stimulation following tonic cold 
stimulation with the CPT (henceforth: CHEPS-cold). Data were filtered to remove 
non-physiological noise using a band-pass filter between 0.53Hz and 70Hz. CHEPS 
data periods were further divided into peristimulus epochs -1000ms to +2000ms 
around the event marker, therefore retaining EEG data which occurred in the one 
second preceding and the two seconds following the contact heat stimulation. In 
order to eliminate voltage offset in each epoch caused by the fluctuating signal, 
baseline correction was applied by subtracting the mean prestimulus voltage (-500 to 
-5 ms) from the entire epoch. Epochs were visually inspected, and those 
contaminated with obvious eyeblinks were discarded. Eyeblinks were defined as any 
activity which exceeded +/- 100µV occurring in the -500 to +1000ms time window. 
A.2.7.2    Analysis of evoked response potentials 
For each block of trials the remaining epochs were combined to produce an averaged 
waveform for each electrode. The electrode channel (either Cz or Pz) which 
displayed the most obvious ERPs was selected for further analysis of the waveform. 
N2 and P2 single trial peak latencies and amplitudes were extracted from epochs 
using the automated method (Mayhew et al. 2006). A basis-set is constructed from 
the subject average ERP waveform, then regressors are formed that represent the N 
and the P peak of interest and then this basis set is regressed against each single-trial 
in the data. The regression coefficients between the data and the basis-set are used to 
reconstruct a fit for each trial and then the amplitudes and latencies are measured 
from this. The single-trial amplitude and latency data were then visually inspected 
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for errors in the automated extraction method: any N2 and P2 amplitude results that 
were expressed as negative numbers were discarded as they did not represent the 
ERP of interest. The main effects of frequency of stimulation (CHEPS-low vs. 
CHEPS-high) at the two time points; and stimulation in the presence of cold pain 
(CHEPS-low vs. CHEPS-cold) at the two time points on N2-P2 peak-to-peak 
amplitude were calculated using the Wilcoxon test for paired samples (as Shapiro-
Wilk tests indicated that some data could not be assumed to come from a normally 
distributed population; Wilcoxon 1945; Shapiro & Wilk 1965). Comparisons were 
also performed on a per participant basis using a Mann-Whitney U test (Mann & 
Whitney 1947). 
A.2.8 Questionnaire Data Collection and Analysis 
In the period one week prior to the EEG test session, a pack was sent to participants 
containing five questionnaires: Short Form 36-item general health questionnaire (SF-
36); Hospital Anxiety and Depression Scale (HADS); Pain Coping Strategies 
Questionnaire (PCSQ); Frenchay Activities Index (FAI); Multidimensional Health 
Locus of Control Scale Form C (MHLC-C), together with instructions that they 
should bring the completed questionnaires with them to the subsequent test session. 
Questionnaire scores were collated and analysed in a pair-wise fashion as per the 
previous audit (as described in Section 3.3.5). 
 
A.3 RESULTS 
A.3.1    CHEPs Data 
In each block of 30 trials, an average of 2.1 trials per block were discarded due to 
contamination by eyeblinks. Of the remaining 27.9 trials, 7.2 trials did not contain an 
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identifiable N2-P2 ERP complex. Each block of 30 trials therefore generated an 
average of 20.7 data points. 
A.3.1.1    Effect of frequency 
At baseline, the Wilcoxon test indicated that as a group, there was no significant 
difference in N2-P2 amplitudes between low- and high-frequency stimulation (Figure 
4.2, blue line). When analysed individually, two participants had significantly 
smaller N2-P2 amplitudes at high-frequency compared to low at baseline. These 
were participant 7 (Low, 4.51 vs. High, 1.96; U = 47, p < .001) and participant 14 
(Low, 7.43 vs. High, 4.01; U = 79, p = .022). 
At outcome, the Wilcoxon test indicated that as a group, there was no significant 
difference in N2-P2 amplitudes between low- and high-frequency stimulation (Figure 
4.2, red line). When analysed individually, the N2-P2 amplitude of participant 8 was 
larger at high-frequency compared to low at outcome (Low, 15.29 vs. High, 19.18; U 
= 300, p = .044) and the N2-P2 amplitude of participant 11 was smaller at high-
frequency compared to low at outcome (Low, 10.82 vs. High, 5.62; U = 272, p = 
.049). 
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Main effect of stimulation frequency on ERP amplitude at baseline and outcome. 
 
Figure 4.2 Group mean N2-P2 peak-to-peak amplitude of low- and high-frequency contact 
heat stimulation at baseline (blue line) and outcome (red line). 
 
 
A.3.1.2    Effect of conditioned pain modulation 
At baseline, the Wilcoxon test indicated that as a group, there was no significant 
difference in N2-P2 amplitudes between stimulation alone or following immersion in 
the CPT (Figure 4.3, blue line). When analysed individually the N2-P2 amplitude of 
participant 8 was larger following CPT compared to stimulation alone (Low, 14.88 
vs. Low + CPT, 20.36; U = 423, p = .005) and the N2-P2 amplitude of participant 7 
was smaller following CPT compared to stimulation alone (Low, 5.21 vs. Low + 
CPT, 2.91; U = 99, p = .005) 
At outcome, the Wilcoxon test indicated that as a group, there was no significant 
difference in N2-P2 amplitudes between stimulation alone or following immersion in 
the CPT (Figure 4.3, red line). When analysed individually the N2-P2 amplitude of 
participant 8 was larger following CPT compared to stimulation alone (Low, 15.29 
vs. Low + CPT, 22.31; U = 284, p = .049) and the N2-P2 amplitudes of participants 2 
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and 5 were smaller following CPT compared to stimulation alone (participant 2: 
Low, 19.43 vs. Low + CPT, 7.74; U = 96, p < .001; participant 5: Low, 13.38 vs. 
Low + CPT, 9.21; U = 140, p = .031) 
 
Main effect of conditioned pain modulation on ERP amplitude at baseline and outcome. 
 
Figure 4.3 Group mean N2-P2 peak-to-peak amplitude of low-frequency contact heat 
stimulation alone and following CPT at baseline (blue line) and outcome (red line). 
 
A.3.2 Questionnaire Data 
Comparisons were performed on participants’ questionnaire subscale scores between 
baseline and outcome using Student’s t-test for related samples. There were 
significant improvements on the SF-36 subscales of general health, social 
functioning, and mental health; all subscales of the PCSQ; and in scores of anxiety 
and depression. Results are summarised in Table 4.1 below. 
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Table 4.1 Baseline and outcome questionnaire scores from patients in the CHEPS study, 
significance values and effect sizes shown for paired sample t-tests. 
Questionnaire (Subscale) 
Baseline (n = 12) 
Mean ±SD 
Outcome (n = 12) 
Mean ±SD 
p d 
SF36 (General health) 24.7 ±13.6 44.0 ±17.0 .001 -1.2 l 
SF36 (Physical functioning) 22.5 ±11 25.1 ±20.7 _ 
 
_ 
 
SF36 (Role limitations due 
to physical health) 
93.8 ±15.5 79.8 ±27.8 _ 
 
_ 
 
SF36 (Role limitations due 
to emotional problems) 
71.1 ±26.4 69.3 ±38.8 _ 
 
_ 
 
SF36 (Social functioning) 30.3 ±19.9 45.6 ±22.1 .038 -0.7 m 
SF36 (Bodily pain) 79.1 ±12.6 67.6 ±22.4 _ 
 
_ 
 
SF36 (Vitality) 23.3 ±15.7 32.7 ±23.1 _ 
 
_ 
 
SF36 (Mental health) 41.4 ±19.4 57.8 ±23.3 .01 -0.9 l 
PCSQ (Catastrophising) 21.1 ±8.4 14.0 ±7.5 .01 0.9 l 
PCSQ (Cognitive coping 
and suppression) 
32.5 ±10.4 46.3 ±18.5 .008 -0.9 l 
PCSQ (Helplessness) 3.8 ±12.8 -12.2 ±11.8 .001 1.4 l 
PCSQ (Diverting 
attention/praying) 
25.4 ±15 33.6 ±14.2 .041 -0.7 m 
HADS (Anxiety) 13.6 ±5.4 10.5 ±4.1 .027 0.8 l 
HADS (Depression) 11.1 ±4.1 8.0 ±3.7 .007 1.0 l 
Frenchay Activities Index 28.8 ±10.8 30.6 ±12.4 _ 
 
_ 
 
MHLC-C (Internal) 16.6 ±7.8 17.7 ±6.8 _ 
 
_ 
 
MHLC-C (Chance) 15.3 ±8.1 15.6 ±7.3 _ 
 
_ 
 
MHLC-C (Doctors) 8.1 ±2.9 8.1 ±3.7 _ 
 
_ 
 
MHLC-C (Others) 7.6 ±2.7 6.6 ±2.8 _ 
 
_ 
 
SD = Standard Deviation; SF36 = Short form 36 item general health survey; PCSQ = Pain coping 
strategies questionnaire; HADS = Hospital Anxiety and Depression Scale, MHLC-C = 
Multidimensional Health Locus of Control questionnaire form C; m = medium effect size (d > 0.5), l = 
large effect size (d > 0.8). 
 
A.4 DISCUSSION 
A.4.1    Contact Heat Evoked Potential Amplitudes 
A.4.1.1    Effect of stimulus frequency 
Group mean N2-P2 peak-to-peak ERP amplitudes were generally unaffected by the 
frequency of stimulation, remaining around 10 μV. N2-P2 amplitudes were actually 
significantly smaller during high- compared to low-frequency in two participants (7, 
14) at baseline, and in one participant (11) at outcome. This decrease in amplitude 
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may have been due to habituation carrying over from one block of trials to the next. 
Central habituation to non-overlapping stimuli has previously been observed after 
20-30 trials (Valeriani et al. 2005; Warbrick et al. 2009). In the present study each 
block consisted of 30 trials separated by a two minute break; as such the observed 
reductions would be consistent with previous accounts of central habituation. 
However, this was not a reliable observation across participants and there may be 
other explanations, such as variations in attention towards stimuli which may change 
as participants become accustomed to the sensations (Lorenz & Garcia-Larrea 2003). 
Looking at the results of all participants, it can be seen that there were almost the 
same number of increases as decreases in amplitude between blocks, suggesting that 
– either there was some habituation between blocks which masked any sensitisation 
that may have occurred in participants, or there was in fact no reliable observable 
effect of stimulus frequency. Most visible differences were non-significant, which is 
likely due to the combination of a large variation in amplitudes across trials and a 
small number of trials that was made smaller by discarding contaminated trials. 
Future work may benefit by controlling for habituation by counterbalancing the order 
of high- and low-frequency blocks and taking longer breaks between blocks to allow 
recovery. Larger numbers of trials would reduce the impact of variance on statistical 
tests, and could be achieved by adding further blocks of trials, however the added 
discomfort caused to participants by adding further stimuli and prolonging the 
session may cause participants to withdraw from the study. 
One participant (8) showed a significant increase in amplitude at high- compared to 
low-frequency at outcome, that was also visually obvious but non-significant at 
baseline; this could be due to sensitisation and would fit with previously observed 
abnormal sensitisation in fibromyalgia patients (Staud et al. 2001). Participant 8 is 
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diagnosed with fibromyalgia; however other members of the group also suffering 
from fibromyalgia (11, 14, 15) did not show similar results. In the present study the 
use of a heterogeneous group of patients meant that any trend would need to be 
universal across conditions in order to be noticed. A homogenous group of patients 
would be the ideal method to control for the effects of condition, however to recruit 
sufficient numbers of similar patients would have either required a lot more time, or 
a larger number of sites feeding into the study. To further counter this point, it could 
be argued that the use of a heterogeneous sample is more representative of the real 
world and therefore may provide more clinically useful information than a study of a 
particular condition. 
A.4.1.2    Effect of conditioned pain modulation 
A conditioned pain modulation (CPM) paradigm was used to investigate diffuse 
noxious inhibitory control (DNIC) in patients and the effect of a PMP on this 
measure. CHEPs recorded alone and during a period of tonic pain (induced by CPT) 
were compared, and one would expect to observe a reduction of ERP amplitudes 
during the CPM trials if there was any DNIC effect. Such a reduction has previously 
been found in a healthy sample, but was absent in a specific patient group (i.e. 
chronic tension type headache; Buchgreitz et al. 2008); however, in osteoarthritis 
patients a reduction in ERP amplitudes has been observed (Quante et al. 2008). The 
effect of a PMP upon these measures has not previously been reported. The results 
do not reveal a consistent pattern of DNIC (or lack of) across participants at either 
baseline or outcome. At both time points the average N2-P2 peak-to-peak amplitude 
was slightly larger in the CPM condition compared to the phasic stimulation alone 
condition. Looking at individual participant data there were similar numbers of 
increases and decreases at both time points; the most parsimonious explanation for 
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this is the test paradigm was not reliably inducing an observable DNIC effect and 
that observations are the result of natural variation in ERPs. In those patients where a 
significant reduction was observed, this is unlikely to be due to habituation from 
previous blocks of stimuli as there was a long break between blocks during which the 
CPT water bath was prepared, the hand immersed, and a period of resting EEG 
recording. A significant increase in amplitudes was observed at both time points in 
participant 8, which may have been due to abnormal central sensitisation 
characteristic of fibromyalgia; however other members of the group also suffering 
from fibromyalgia (11, 14, 15) did not show similar results. 
It is possible that no DNIC was observed because the effects of cold pressor pain on 
DNIC had diminished by the time ERPs were recorded. Patients had already 
withdrawn their hand before commencement of the CHEPS recording, allowing 
some recovery time, although patients did casually report that the hand remained 
painful for some minutes following CPT. This problem could have easily been 
avoided by having the patients immerse their hand into the cold pressor during the 
CHEPs recording, thereby ensuring that maximum tonic pain was being experienced 
at the same time as phasic stimuli were applied. The reason for not pursuing this 
methodology was that in the author’s personal experience of administering dozens of 
CPTs, participants do not remain in a relaxed physical state during the immersion 
period – shivering, clenching of muscles, verbal outbursts, and breath holding often 
occur – all of which affect the quality of EEG data. This may be taken into 
consideration in future work by providing participants with a period of training or 
familiarisation with the CPT during which they can practice remaining as relaxed as 
possible in the interest of good quality EEG recording; however this would require 
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more time, either as a longer test session or even a separate session before EEG 
recording.  
A.4.1.3    CHEPS artefact 
A final observation to note is the presence of an artefact in the CHEPs data. This was 
observed as a large deflection which peaked around 240ms post-stimulus. The 
artefact was observed in most of the participants’ data, and varied in amplitude both 
between and within sessions. Such an artefact is created by an electric field 
disturbance originating in some part of the CHEPS equipment, and has previously 
been noted in a study which compared CHEPs and LEPs, which found the artefact 
was peculiar to CHEPs epochs and absent from LEPs epochs (Iannetti et al. 2006, 
p.240). As the artefact occurs both at the same time in each trial and before the start 
of the ERP of interest, it does not contaminate the ERP and should not be cause for 
concern. If CHEPS stimulation was being applied to a site more proximal to the head 
(e.g. the face compared to the arm), nerve conduction times would be shortened and 
therefore ERPs may overlap with the artefact. The artefact can be eliminated by 
ensuring that all electrodes are connected with an impedance that it as close to zero 
as possible (< 5 kΩ) and this would explain why the artefact is not consistently 
reported in CHEPs studies. In practice it is not always possible to achieve such low 
impedance due to individual variations in scalp and hair characteristics which impact 
on the quality of connection between electrode and scalp, and for the present study 
an impedance of < 10 kΩ was acceptable. 
A.4.2 Questionnaire Scores 
The effect of cognitive-behavioural therapy and multidisciplinary pain management 
upon questionnaire measures of psychophysical health and pain coping strategies 
have been discussed in the preceding Chapters. The PMP used in this study has been 
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shown to bring about small effects in measures of general health, social functioning, 
mental health, anxiety, catastrophising, cognitive coping/suppression, and 
helplessness. The effect of treatment on questionnaire scores collected from the small 
sample of patients in the present study were significant improvements on scores of 
general health, social functioning, mental health, anxiety, depression, 
catastrophising, cognitive coping/suppression, and helplessness. The effect of 
treatment upon questionnaire scores was therefore highly similar to the earlier audit 
carried out with large number of patients.  
Following the previous audit, a measure of locus of control was also administered to 
patients in the present study. Earlier work suggested that patients who believe 
outcomes to be controlled by chance are more likely to use maladaptive coping 
strategies (Crisson & Keefe 1998), however no such relationship was found in the 
present sample (results not shown). From baseline to outcome, there was very little 
change in any of the dimensions measured using the MHLC-C. 
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4.4  STUDY B: THE EFFECT OF PMP TREATMENT UPON POWER 
SPECTRAL DENSITY AT REST AND DURING TONIC PAIN 
 
B.1 BACKGROUND 
 
This study was designed to investigate the effects of PMP treatment upon the EEG 
power spectral density (PSD) of participants, under two conditions measured before 
and after treatment. In the first condition continuous EEG data was recorded from 
participants during a period of rest. In the second condition continuous EEG data was 
recorded during a period of tonic pain that was induced using the CPT. Comparative 
data was also recorded from a control group consisting of healthy participants. 
Previous work (discussed earlier in Section 2.7.3) has shown that the effect of CPT 
upon PSD in healthy subjects is a general increase in δ-, θ-, and β-power 
accompanied by a decrease in α-power (A.C.N. Chen et al. 1989; Backonja et al. 
1991; A.C.N. Chen & Rappelsberger 1994; Ferracuti et al. 1994; Stevens et al. 2000; 
Chang et al. 2002a; Dowman et al. 2008; Shao et al. 2012). Some of these studies 
also reported regional effects on PSD, with α-power decreases observed in either 
frontal, central, temporal, and parietal areas; two studies observed decreased α-power 
in areas contralateral to the stimulated limb (Ferracuti et al. 1994; Dowman et al. 
2008). 
The effect of CPT upon PSD in chronic pain patients is less well studied. Two 
studies have reported no differences in the resting PSD between pain patients and 
healthy controls (Schmidt et al. 2012; Vossen et al. 2014). The effect of CPT upon 
PSD was studied in fibromyalgia patients and healthy controls (Stevens et al. 2000); 
114 
the findings were an increase in δ-, θ-, and β-power compared to rest in both groups, 
in the healthy group there was a decrease in α-power, whereas α-power increased 
slightly in the patient group for a short time after immersion in the cold pressor.  
Brief sessions of non-pharmacological pain treatments (hypnosis, meditation, 
biofeedback, and tDCS) have been shown to affect PSD in chronic pain patients 
(discussed in Section 2.9.3.3; M.P. Jensen et al. 2013a, 2014). One study investigated 
the effect on PSD of an 8-week course of MBSR in pain patients and found no 
difference (Schmidt et al. 2015). To date there has been no study of the effects of a 
PMP upon PSD in chronic pain patients. The present study will investigate the 
effects of a CBT-PMP upon PSD at rest and during induced pain, and upon the 
difference between PSD in the rest and pain conditions. 
B.1.1    Aims 
The aims of this study were to assess PSD at rest and during induced pain, in patients 
pre- and post-treatment in the CBT-based PMP at Centre A, and to compare this with 
data from healthy controls. 
B.1.2    Objectives 
The objectives of this study were: to record continuous EEG at rest and during CPT 
induced pain in a group of patients before and after treatment, and to take the same 
measurements in a group of healthy controls. Questionnaire data was also collected 
to verify the efficacy of the treatment in the patients studied. 
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B.2 METHODS 
B.2.1 Study Design 
The study used a prospective cohort design to assess the impact of a CBT-based 
PMP treatment upon PSD and questionnaire measures collected from patients and 
healthy controls at two time points (baseline and outcome).  
There were 12 participants in the patient group (10 female, 2 male, mean age = 52, 
range = 39–64), recruited consecutively from the population of chronic pain patients 
who had been enrolled into the PMP at Centre A. Test sessions were carried out in 
two-week periods before and after patients attended the Centre A CBT based PMP, 
and took place at Centre A.  
The control group consisted of 14 participants (10 female, 4 male, mean age = 36, 
range = 20–68), recruited consecutively from the population of staff and students at 
Birmingham City University. Volunteers were excluded if they reported having any 
history of chronic pain, long term use of analgesics or history of psychological 
treatment. Test sessions took place under laboratory conditions at Birmingham City 
University, Edgbaston.  All data was collected by the author. For the duration of the 
test sessions, participants sat in a quiet, dimly lit room. Participants were fitted with 
EEG recording equipment and given time to become familiar with the cold water 
bath stimuli prior to testing. 
B.2.2 Test Procedure 
EEG data was recorded with the same equipment setup as used in Study A (see 
Section A.2.3 above). There were two periods of EEG recording, before and after 
exposure to the CPT (Figure 4.4). 
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B.2.2.1    Continuous EEG recording at rest 
EEG data was recorded for 180 seconds with the subject sitting still and relaxed and 
eyes open. The first 90 seconds of the recording period were discarded as 
participants often moved around to get comfortable during this time. 
B.2.2.2    Continuous EEG recording during cold pressor induced pain 
The CPT described earlier was used to induce a tonic pain stimulus lasting around 10 
minutes. Participants were asked to place their left hand and wrist into the cold water 
bath for a period of 90 seconds. EEG data was not recorded during the CPT 
procedure due to the risk of EEG data contamination from involuntary body 
movements and facial muscle activity caused by exposure to the cold water bath. 
Previous work has shown that the effect of tonic pain upon the EEG continues for 
some minutes after the stimulus has been withdrawn (Reinert et al. 2000; Stevens et 
al. 2000), and that peak discomfort occurs after around 90 seconds (Walsh et al. 
1989). Participants then removed their hand from the water and placed it onto a 
towel. Continuous EEG data was then recorded for 90 seconds whilst participants sat 
still with eyes open. 
 
Figure 4.4 Diagram of the test procedure. 
 
B.2.3    Data Processing and Analysis 
The last 90 seconds of the initial rest period (henceforth: rest-rest) and the 90 second 
period following stimulation with the CPT (henceforth: cold-rest) were filtered to 
EEG recording              
(180 seconds)
Cold Pressor            
(90 seconds)
EEG recording                
(90 seconds)
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remove non-physiological noise using a band-pass filter between 0.53Hz and 150Hz, 
with a notch filter applied at 50Hz to remove noise caused by mains electricity (i.e. 
alternating current which oscillates at 50Hz). Data were converted from the time 
domain to the frequency domain using the Fast Fourier Transformation (FFT) 
function in Brain Vision Analyser 2.0. For EEG data the FFT takes a signal which 
describes fluctuations in voltage over time and converts it into an output which 
describes the power at each frequency in the entire time period. The FFT was set to 
run with a 0.2Hz resolution, use a Hanning window of 10% length, apply variance 
correction, and output in units of power (µV2). The power contained within the four 
commonly used frequency bands was calculated at each electrode, the bands defined 
as: Delta (δ) 0.6‒4.0Hz; Theta (θ) 4.2‒7.4Hz; Alpha (α) 7.6Hz‒12.4Hz; Beta (β) 
12.6‒30.0Hz. In order to control for global power fluctuations between sessions, the 
absolute spectral power in each band was converted to the relative spectral power in 
each band at each electrode and expressed as a percentage. The power from the left 
hemisphere electrodes (C3, T7) were combined, as were the right hemisphere 
electrodes (C4, T8), to examine the power fluctuations in each hemisphere region. 
The main effect of treatment/time upon the relative spectral power in each band (over 
each hemisphere in the rest-rest period within each group) was calculated using a 
Wilcoxon Signed-Rank test for related samples (as the Shapiro-Wilk test indicated 
that some data could not be assumed to come from a normally distributed 
population). The main effect of the CPT upon the relative spectral power within each 
frequency band (over each hemisphere at the two time points within each group) was 
calculated using Wilcoxon Signed-Rank tests. Between-group differences in the 
effect of the CPT on relative spectral power within each frequency band (over each 
hemisphere in each rest period) were calculated using Mann-Whitney U tests.   
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B.3 RESULTS 
 
B.3.1    EEG power – analysis of the effect of CPT 
B.3.1.1    Within-group differences 
Relative EEG spectral power in each of the four bands, in left and right hemisphere 
regions, was compared within each group between the rest-rest and cold-rest 
recording periods. Results are illustrated for the patient group in Figure 4.5 and for 
the healthy control group in Figure 4.6. 
In the patient group, at baseline, there were significant decreases in relative spectral 
power following the CPT in the theta (θ) band in both the left (Z = -2.93, p = .003) 
and right (Z = -2.40, p = .016) hemispheres. There were also significant decreases in 
relative spectral power following the CPT in the alpha (α) band in both the left (Z = -
2.58, p = .009) and right (Z = -2.05, p = .041) hemispheres. There were no significant 
differences in the delta or beta bands. 
At outcome, there were no significant differences in any of the four power bands. 
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Effect of CPT upon relative spectral power in the PMP patient group 
 
Figure 4.5 Effect of cold pressor on relative spectral power in each of the four bands in the 
left and right hemisphere electrodes (PMP patients group). At baseline (blue lines) there 
were significant within-session decreases in theta and alpha power in both hemispheres after 
immersion in the cold pressor, * = significant at p < .05 level, ** = significant at p < .01 
level. There were no between-session significant differences. 
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In the healthy control group, at baseline and at outcome, there were no significant 
differences in relative spectral power following CPT, in any of the four power bands. 
 
Effect of CPT upon relative spectral power in the healthy control group 
 
Figure 4.6 Effect of cold pressor on relative spectral power in each of the four bands in the 
left and right hemisphere electrodes (healthy control group). There were no significant 
differences in power, either within- or between-sessions. 
 
B.3.1.2    Between-group differences 
The change in relative spectral power from rest-rest to cold-rest in each of the four 
bands in each hemisphere was compared between-groups at baseline and outcome 
time-points. Results are illustrated in Figure 4.7. At baseline, there were significant 
differences between the groups in the alpha band over the left hemisphere (Patient 
median = -2.86, Control median = 1.99, Z = 2.71, p = .005) and the theta band over 
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the right hemisphere (Patient median = -2.59, Control median = -0.84, Z = 2.15, p = 
.031). At outcome, no significant differences were observed between the groups. 
 
Baseline: effect of CPT on spectral power in left and right hemisphere electrodes 
 
 
Outcome: effect of CPT on spectral power in left and right hemisphere electrodes 
 
Figure 4.7 Effect of cold pressor test (CPT) on spectral power in patient and control groups 
at baseline (upper) and outcome (lower). At baseline, there were significant differences 
between groups in the effect of CPT on alpha power in the left hemisphere and theta power 
in the right hemisphere, * = significant at p < .05 level, ** = significant at p < .01 level. 
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B.4 DISCUSSION 
 
PSD was calculated for periods of continuous EEG recorded during periods of rest, 
both before and after the induction of tonic pain by the CPT. Previous work has 
either investigated the effect of tonic pain upon PSD, or the effect of a treatment 
upon PSD; the present study was designed to measure both of these effects. In 
addition, because the effect of tonic pain upon PSD was measured both before and 
after treatment it was possible to also investigate the effect of treatment upon this 
variable. As any pre- to post-treatment differences could have been unrelated to the 
treatment, both groups were measured in the same fashion to provide comparative 
data. The use of a control group also meant that between-group comparisons could 
be made, however these should be viewed with caution as individual differences 
between-groups such as effects of medication upon PSD were not controlled for. 
 
B.4.1 Within-group differences 
B.4.1.1    Patient treatment group 
At baseline, there were significant decreases in θ-power and α-power following 
exposure to the cold pressor in the patient group. Following the treatment 
programme, there were no significant changes in relative power spectral density. 
Post-treatment θ-power stability could represent patients maintaining a more relaxed 
state in the presence of pain (Sherlin 2009). Previous studies have also linked θ-
power increase during pain with efforts to control pain in experienced meditators 
(Larbig et al. 1982; Larbig 1994), and with reduced pain perception in a patient 
sample (Russ et al. 1999). Lack of decrease in the present PT sample is not the same 
123 
as an increase, but it does show a change in the expected direction if the PMP 
treatment ‒ which included relaxation, and other exercises in pain control ‒ did affect 
top-down pain control in patients. The lack of a decrease in α-power at follow-up 
compared to baseline may be related to effects of treatment; however it has 
previously been suggested that α-frequency changes indicate selectivity of salient 
features of stimulation. A decrease in α-power in preparation for a motor response to 
the painful stimulus is accompanied by an increase in β-power (B. Bromm & Lorenz 
1998). The absence of a significant α-power decrease at follow-up may represent a 
reduction in stimulus salience for the patients, having already experienced the cold 
pressor in the baseline session. There were consistent, but not significant, increases 
in β-power following stimulation which likely represent high-frequency afferent 
nociceptive activity processing by the cortex. 
B.4.1.2    Healthy control group 
Studies reviewed in Section 2.7.3 and Table 2.8 investigated the effect of tonic pain 
upon PSD in healthy subjects, finding an inconsistent pattern of results: δ-power was 
seen to increase or not change; θ-power was observed to increase, decrease, or not 
change depending on the study; α-power tended to decrease, rarely was there no 
change; β-power often increased or there was no change. In the present study the 
PSD of the healthy control group was not significantly affected by tonic pain from 
the CPT, at both baseline and follow-up test sessions (Figure 4.6). It could be argued 
that this result agrees with previous studies, as between those studies using the CPT 
in Table 2.8, no change was observed in each of the different power bands at least 
once (A.C.N. Chen et al. 1989; Backonja et al. 1991; A.C.N. Chen & Rappelsberger 
1994; Ferracuti et al. 1994; Dowman et al. 2008; Shao et al. 2012). However, the 
124 
most common finding of a decrease in α-power accompanied by an increase in β-
power was not observed in the healthy control group.  
 
B.4.2 Between-group differences 
Before discussing between-group differences in PSD it should be noted that 
participants were recruited conveniently and consecutively into the study, therefore 
groups were not intentionally matched in terms of age, gender, pain condition, or 
medication use. All groups contained a majority of female participants and were also 
closely matched in age; however these similarities reflect the characteristics of the 
populations in general and were not planned in advance. 
At baseline, there were significant differences between groups in the effect of cold 
pressor pain upon PSD. The changes in left hemisphere α-power and right 
hemisphere θ-power were significantly different between the two groups at baseline. 
There were no significant differences between the groups at follow-up (Figure 4.7). 
The absence of difference between groups at follow-up could represent an effect of 
the treatment, acting to normalise the cortical response to cold pressor pain in the 
patients. Previously, only one study had compared the effect of CPT on PSD in 
healthy and pain patient (fibromyalgia) groups (Stevens et al. 2000), finding that the 
effect on EEG spectra was largely similar in both groups.  
In the present study, there was a slight decrease in α-power following CPT in both 
groups at both time points, with the exception that α-power increased in left 
hemisphere electrodes in the healthy group at baseline. The reduction in α-power 
likely represents an event related desynchronisation (ERD) in response to 
somatosensory stimulation that is not specific to pain (Pfurtscheller & Aranibar 
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1977; B. Bromm & Lorenz 1998; see also Section 2.7.3.3 of this work). The increase 
in α-power observed may be related in a similar fashion, representing an event 
related synchronisation (ERS) that also occurs in response to a stimulus, and may be 
observed in the same frequency band at a different location to the ERD, or in the 
same location in a different band (Pfurtscheller 1992; Pfurtscheller & Lopes da Silva 
1999). Indeed, in the present samples, there were also slight increases in β-power 
following stimulation that may be explained by ERS. 
The significant difference in right hemisphere θ-power observed at baseline may 
represent efforts to block out, or dissociate from feelings of pain, with previous work 
suggesting there is a link (Larbig et al. 1982; Bernstein & Putnam 1986; Russ et al. 
1999). A tentative explanation would be that pain patients tended to focus more on 
the pain at baseline (pre-treatment) than the healthy group, hence the difference in θ-
power. At follow-up (post-treatment) the θ-power change was similar between 
groups, with even a slight increase in in the patient group over the healthy group – 
this may represent a positive effect of the treatment. Patients may have employed 
relaxation techniques learned during treatment in order to block out the feeling of 
pain. 
 
B.4.3 Limitations and suggestions for further study 
A limitation to the study was the absence of a patient control group drawn from the 
same population. Without comparison to such a group it is possible that the observed 
differences between baseline and follow-up in the patient treatment group could have 
been due to the effects of familiarity with and repetition of the cold pressor. Whilst 
efforts were made to familiarise participants with the stimulus before recording, this 
is a possibility that cannot be ruled out without a patient control group 
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A second limitation concerns the heterogeneity of the patient group studied. It has 
been discussed earlier (Sections 2.8-2.9) that the effects of painful stimulation and 
pain treatments can differ across different diagnostic groups. The present study used 
a convenience sample in which patients were recruited consecutively into the study, 
regardless of diagnosis, in order to gather the maximum data in the time available. 
Using a mix of patients has the disadvantage that for any effect to be observed, it 
must be robust across all patients, or be a large effect in enough patients to generate a 
significant statistical test overall. In homogenous patient groups it is possible to 
detect smaller effects as the confounding variable of different conditions is removed. 
The advantage to a heterogeneous group is that it more accurately represents the real 
world. The PMP under investigation is intended to be effective across a wide range 
of chronic pain conditions and therefore it would be expected to produce effects that 
are shared by a mix of patients. 
The observed effect of treatment upon changes in θ-power following CPT in the 
present study points to the possibility that psychologically based pain treatment can 
affect the way in which the brain processes, or reacts to painful stimulation. Previous 
literature has linked θ-power to efforts to block out, or dissociate from feelings of 
pain (Larbig et al. 1982; Bernstein & Putnam 1986; Russ et al. 1999). The CBT-
based PMP programme did not explicitly train patients in techniques to help them 
dissociate from feelings of pain. There were guided relaxation sessions throughout 
the course that may have led patients to learn that they can mentally influence their 
pain experience. Future work might benefit from the study of a PMP that teaches 
patients explicitly a technique for dissociation from pain. A treatment such as the 
ACT-based PMP (Sections 2.5.8–2.5.9) in which the technique of mindfulness is 
taught to and practised by the patients, would be ideal for such an investigation. 
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B.4.4 Conclusion 
The effect of cold pressor pain upon θ- and α-activity is modulated following a CBT-
based PMP. This may be due to a change in cognitive appraisal of painful signals 
brought about by taking part in the PMP, supported by the reduction in 
catastrophising and feelings of helplessness post-PMP. Patients also learned 
relaxation techniques for dealing with periods of increased pain, which they may 
have employed during cold pressor pain, and which may have contributed to the 
observed stability of θ- and α-power measured post-PMP. Results imply the 
possibility of an objective measure of the outcome of psychological therapy for 
chronic pain. Future work should include data collected from waiting-list control and 
different treatment (ACT-based PMP) groups in order to confirm and extend 
findings. 
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CHAPTER 5 
PSYCHOSOCIAL HEALTH AND ATTITUDES TO PAIN IN 
PATIENTS ATTENDING AN ACCEPTANCE AND 
COMMITMENT THERAPY (ACT) PAIN MANAGEMENT 
PROGRAMME 
5.1 ABSTRACT 
Background: The use of ACT as a treatment approach for chronic pain problems has 
grown steadily over the past 15 years. During this time evidence has accumulated 
that supports the use of ACT as a good alternative to CBT, with similar effects on a 
range of treatment outcomes (Veehof et al. 2011). In contrast to CBT, thoughts, 
feelings and behaviours are not seen as the problem which must be addressed; rather 
the patients’ response to these factors is the target for change. This study aimed to 
investigate changes in psychosocial health and attitudes to pain in a cohort of patients 
throughout a course of ACT for pain management. 
Methods: Between June 2012 and August 2015, 258 patients attended the PMP at the 
West Midlands NHS regional hospital (Centre B). Before (baseline) and after 
(outcome) treatment patients were asked to complete the Hospital Anxiety and 
Depression Scale (HADS), the Pain Catastrophising Scale (PCS), the Psychological 
Inflexibility to Pain Survey (PIPS), the Chronic Pain Acceptance Questionnaire 
(CPAQ), the Acceptance of Illness Scale (AIS), and the Fear Avoidance Beliefs 
Questionnaire (FABQ). In order to be included in the analysis patients were required 
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to have at least part-completed questionnaires at both time points (n = 131, mean age 
= 52.9 ±11.98, age range = 27-82). 
Results: There were significant improvements (p < .01) in scores on all scales 
between baseline and outcome, with the exception of the FABQ ‘work’ subscale. 
Conclusion: The pain management programme has been instrumental in bringing 
about significant improvements in psychosocial health and attitudes to pain in 
patients. 
 
5.2 BACKGROUND 
 
The West Midlands NHS regional hospital (henceforth: Centre B) PMP is 
conceptually based upon acceptance and commitment therapy (ACT) for the 
treatment of chronic pain (discussed earlier in Section 2.5.8). The programme is 
delivered by the Centre B multidisciplinary pain clinic team, consisting of 
psychologist, specialist nurse, physiotherapist and occupational therapist. The 
psychologist is trained in ACT and experienced in applying its principles to the 
management of chronic pain.  
Upon being enrolled into the programme, patients are asked by the clinical staff to 
fill in several questionnaires: the Hospital Anxiety and Depression Scale (HADS), 
the Pain Catastrophising Scale (PCS), the Psychological Inflexibility to Pain Survey 
(PIPS), the Chronic Pain Acceptance Questionnaire (CPAQ), the Acceptance of 
Illness Scale (AIS), and the Fear Avoidance Beliefs Questionnaire (FABQ). Patients 
are also asked to fill in the same questionnaires at the end of the programme. 
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Since the inception of the ACT-based PMP in Centre B in June 2012, until the time 
that this study was conducted (August 2015), the programme has been run 27 times, 
and 258 patients have attended. 
5.2.1 Evidence for Efficacy of ACT for Chronic Pain 
A systematic review and meta-analysis of 19 acceptance based interventions for 
chronic pain by Veehof and colleagues (2011) found medium effect sizes for pain 
intensity, depression, anxiety, physical wellbeing, and quality of life. A later 
systematic review of ten RCTs concluded ACT was effective in increasing physical 
functioning, and decreasing anxiety, depression, and distress, compared to inactive 
treatments (Hann & McCracken 2014). 
5.2.2 Programme structure (and comparison to CBT-based programme) 
The programme follows a timetable (Table 5.1) which is similar in many respects to 
the previously studied CBT-based PMP at Centre A. Both programmes include 
regular exercise; goal setting exercises and homework tasks; educational 
presentations on the physiology of pain, pain medications, pacing of activity, sleep 
hygiene, the interaction between thoughts, feelings and behaviours; discussion with 
an expert patient; and weekly relaxation exercises. There are differences between the 
two programmes which reflect the differing approaches of CBT and ACT. One of the 
main tenets of CBT is identifying maladaptive or irrational thoughts and challenging 
their veracity, with the goal of changing the way in which such thoughts are 
interpreted and thus lessening their impact on mental wellbeing. In contrast, ACT 
teaches clients to accept negative thoughts as part of normal life and to deal with 
them through a process of non-judgemental awareness, where they do not get ‘caught 
up’ in negative thoughts and emotions, thereby lessening their impact on mental 
wellbeing. The programmes also differed in the type of relaxation techniques that 
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were taught. The CBT approach contained deep breathing and guided visualisation 
sessions designed to encourage a relaxed body and mind. The ACT programme 
included periods of guided mindfulness meditation which were intended to not only 
relax the body, but also as an exercise to practice the skill of non-judgemental 
awareness. 
 
Table 5.1 Timetable of Centre BPain Management Programme. 
Session 1 
Introduction to the programme 
Ice-breaker discussion 
Pain physiology 
Introduction to exercise (diary) 
Mindfulness/Relaxation 
Session 2 
Exercise 
What is ACT? What is mindfulness? 
Pacing 
Goal setting 
Mindfulness/Relaxation 
Session 3 
Exercise 
Acceptance and Control 
Values 
Mindfulness/Relaxation 
Session 4 
Exercise 
Occupational therapy – functional session 
Expert patient 
Mindfulness/Relaxation 
Session 5 
Exercise 
Committed action 
Thoughts, feeling and behaviours 
Mindfulness/Relaxation 
Session 6 
Exercise 
How to talk about pain 
The spine 
Healthy living 
Mindfulness/Relaxation 
Session 7 
Exercise 
Sleep 
Pain theories and TENS theory 
Acupuncture 
Mindfulness/Relaxation 
Session 8 
Exercise 
Medication 
Relapse prevention and flare-ups 
Neighbourhood support service 
Mindfulness/Relaxation 
 
Psychophysical outcomes have been shown to be similar in both ACT- and CBT-
based treatments for chronic pain. A systematic review and meta-analysis (mentioned 
above, Veehof et al. 2011) reported that the effects of ACT on pain intensity (d = 
0.37) and depression (d = 0.32) were comparable to those of CBT (reported to be 
132 
0.21 & 0.38, respectively, by Williams et al. 2012). One RCT has directly compared 
CBT and ACT treatment for chronic pain (Wetherell et al. 2011). Outcomes from the 
two types of treatment were equivalent: there were no significant differences in 
improvement on any outcome variables. Participants found the CBT rationale more 
credible and had higher expectations for improvement, and ACT participants 
reported significantly higher levels of satisfaction than CBT participants. The study 
also investigated possible mediators for improvement on measures of pain 
interference: in both CBT and ACT conditions, perceived pain control was 
significantly negatively correlated with pain interference, whereas pain acceptance 
was not. This finding was contrary to the findings of other studies which placed 
importance on acceptance over control-oriented strategies (Wetherell et al. 2011). A 
more recent study has investigated the mediating role of acceptance in 
multidisciplinary CBT for chronic pain (Åkerblom et al. 2015). Despite not targeting 
acceptance in their CBT approach, pain-related acceptance was reported as the 
strongest mediator of change in measures of pain interference, pain intensity, and 
depression. These results suggest that the therapeutic mechanism underlying CBT 
and ACT might share common ground in the psychological flexibility model, which 
emphasises pain-acceptance and control over the effects of pain (McCracken & 
Vowles 2014; McCracken & Morley 2014). 
5.2.3 Aims 
The primary aim of this study was to assess the efficacy of the ACT-based PMP at 
Centre B. The secondary aim was to compare these findings where possible to the 
results of the earlier audit of a CBT-based PMP. 
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5.2.4 Objectives 
The objectives of this study were to gather the entire available patient generated 
questionnaire data together into a single dataset, and to analyse this dataset to reveal 
overall changes in psychosocial health and attitudes to pain from baseline to 
outcome. 
 
5.3 METHODS 
5.3.1 Study Design 
The study used a longitudinal retrospective design to assess the impact of an ACT-
based PMP treatment upon questionnaire measures collected from patients at two 
time points (baseline and outcome). In order to be included in the analysis patients 
were required to have completed questionnaires at both time points.  
5.3.1.1    Power Calculation 
To determine the required sample size, an a priori power calculation was carried out 
using G*Power 3.1.9 software (Faul et al. 2007), in a similar manner to that 
described in the earlier study of the Centre A PMP (Section 3.3.1.1). Population 
effect size was estimated at 0.32 using the results of the meta-analysis by Veehof and 
colleagues 2011. Probability of type 1 error (α) was set at 0.05 and power was set at 
0.8, as is the convention suggested by Cohen (1969, 1992) that is typically used in 
behavioural sciences research (Sullivan & Feinn 2012). 
The calculation using the above parameters reported that a sample size of 79 
participants would be required for power to be above the 0.8 level. 
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5.3.2 Pain Management Programme Design 
Centre B ran two programmes in parallel per three month period. The programme 
consisted of eight sessions of approximately 150 minutes each given over a period of 
eight consecutive weeks to groups of 8-10 patients. 
5.3.3 Questionnaires of Psychosocial Health and Attitudes to Pain 
5.3.3.1    Hospital Anxiety and Depression Scale (HADS) 
The HADS consists of 14 self-scored items designed to assess levels of anxiety and 
depression. Each item is related to either symptoms of anxiety or depression and has 
four responses which are scored from 0 to 3 according to symptom severity (e.g. I 
feel tense and wound up: most of the time (3); a lot of the time (2); from time to time 
(1); not at all (0)). The HADS consists of two independent scales: anxiety (HADS-A) 
and depression (HADS-D), each with seven items, leading to a score between 0 and 
21. A score of 0 to 7 is considered normal, 11 or higher indicates probable presence 
of the mood disorder, and 8 to 10 being suggestive of the presence of the mood 
disorder (Zigmond & Snaith 1983; Snaith 2003).  
The HADS has been validated against psychiatric interviews (Zigmond & Snaith 
1983) and against other scales for the measurement of anxiety and depression 
(Aylard 1987) in patient groups. A review of 747 studies using the HADS concluded 
that it was a suitable measure for assessing anxiety and depression in both patient 
and healthy populations (Bjelland et al. 2002). Internal consistency of both subscales 
has been verified in a study of a large mixed sample of 64,648 persons, which 
reported a Cronbach’s α of 0.80 for HADS-A and 0.76 for HADS-D (Mykletun et al. 
2001).  
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5.3.3.2    The Pain Catastrophising Scale (PCS) 
The PCS is a self-administered, 13-item questionnaire designed to assess specific 
elements of catastrophising – helplessness, rumination, magnification. Participants 
are asked to reflect on past painful experiences and indicate the extent to which they 
experienced the 13 thoughts or feelings when experiencing pain (Sullivan et al. 
1995). There are five levels of response ranging from 0 (not at all) to 4 (all the time).  
The PCS uses five items taken from the catastrophising subscale of the PCSQ (Pain 
Coping Strategies Questionnaire, Rosentiel & Keefe 1983), plus eight statements 
derived from examples of catastrophising ideation by Sullivan and colleagues (1995). 
The scores from the 13 items load onto three factors (helplessness, rumination, 
magnification). This three factor structure has been confirmed in samples of chronic 
pain patients (Osman et al. 1997), pain-free adults (Osman et al. 2000), and has also 
been shown to be consistent across sexes and across patient and non-patient groups 
(D’Eon et al. 2004; Quartana et al. 2009). The PCS has good internal consistency 
with Cronbach’s α overall = 0.87, rumination = 0.87, magnification = 0.66, and 
helplessness = 0.78 (Sullivan et al. 1995). 
5.3.3.3    The Psychological Inflexibility in Pain Scale (PIPS) 
The PIPS is a 16-item questionnaire developed to assess processes underlying the 
efficacy of acceptance and exposure based treatments for pain (Wicksell et al. 2007). 
Items are scored according to a two-factor model (avoidance of pain, cognitive 
fusion). The avoidance subscale measures the self-reported tendency to engage in 
certain behaviours that function to avoid pain and related distress (e.g. ‘‘I avoid 
scheduling activities because of my pain”), while the fusion subscale assesses the 
frequency of thoughts that, if they are acted on, are likely to lead to avoidance 
behaviours (e.g. ‘‘I need to understand what is wrong in order to move on”). Items 
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are rated on a 7-point Likert- type scale from ‘‘never true” (1) to ‘‘always true” (7), 
with higher scores indicating greater psychological inflexibility (Wicksell et al. 
2010a). 
The PIPS has been shown to be sensitive to change following psychological 
treatment for chronic pain based upon exposure and acceptance (Wicksell et al. 
2008). The two factor structure (avoidance, fusion) has been confirmed in samples of 
patients suffering from chronic back pain (Barke et al. 2015) and fibromyalgia 
(Rodero et al. 2013). 
5.3.3.4    The Chronic Pain Acceptance Questionnaire (CPAQ) 
The CPAQ is a 20-item questionnaire designed to measure pain-related acceptance 
(McCracken et al. 2004). Scores load onto two subscales (activity engagement, pain 
willingness). Activity engagement measures the extent to which pain restricts 
behaviour, and pain willingness measures the degree of effort put into controlling 
pain. Respondents are asked to rate the truth of each statement (e.g. “I am getting on 
with the business of living no matter what my level of pain is”) on a 7-point scale 
from 0 (never true) to 6 (always true). The subscale and total scores from the CPAQ 
have been validated against measures of avoidance, emotional distress, and patient 
functioning in cross-sectional analyses, and also show good internal consistency 
(Cronbach’s α = 0.78–0.82; McCracken et al. 2004). 
5.3.3.5    The Acceptance of Illness Scale (AIS) 
The AIS is an 8-item scale designed to assess acceptance of an illness and the 
presence of negative emotions associated with the illness (Felton et al. 2001). 
Respondents indicate the extent to which they agree with the eight statements (e.g. “I 
have problems adapting to limitations imposed by my illness”) on a 5-point scale 
from 1 (strongly agree) to 5 (strongly disagree). A higher score indicates more 
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acceptance of the illness. The scale has been shown to have good internal 
consistency with a Cronbach’s α of 0.85 (Juczyński 2001). 
5.3.3.6    The Fear Avoidance Beliefs Questionnaire (FABQ) 
The FABQ is a 16-item scale designed to assess the level of fear avoidance beliefs 
(Waddell et al. 1993). Patients are required to rate their agreement with each of the 
16 statements on a 7-point scale (0 = completely disagree to 6 = completely agree). 
There are two subscales: the work subscale consisting a seven items (e.g. ‘My pain 
was caused by my work or by an accident at work’) and a four-item physical activity 
subscale (e.g. ‘Physical activity makes my pain worse’). The FABQ has been shown 
to be a valid measure of fear-avoidance beliefs in samples of chronic pain patients 
(Crombez et al. 1999; Kovacs et al. 2006). Both subscales have good internal 
consistency (Cronbach’s α = 0.75-0.82; Swinkels-Meewisse et al. 2003). 
5.3.4 Participants 
258 patients attended one of the 27 programmes between June 2012 and April 2015. 
In order to maximise the data available for paired comparisons, patients were 
included if they had part-completed questionnaires. Patients were excluded if they 
had not filled in questionnaires at both time points. 
5.3.5 Data Processing and Analysis 
Questionnaires were scored according to their prescribed marking schemes. Raw 
scores were recorded using Excel 2007 and further analysis was performed with 
SPSS 20. Paired comparisons between questionnaire scores at baseline and outcome 
were computed using Student’s related samples t-test. Effect sizes were calculated 
using Cohen’s d. Cases with missing data points were excluded from the analyses in 
a pair-wise fashion.  
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5.4 RESULTS 
131 patients completed or part-completed questionnaires at baseline and outcome 
(mean age = 52.9 ±11.98, age range = 27-82), 114 (87%) females and 17 (13%) 
males. 
5.4.1 Differences between Baseline and Outcome Scores 
Between baseline and outcome, paired t-tests revealed a significant difference in 
scores of: the anxiety and depression subscales of the HADS; the rumination, 
magnification, and helplessness subscales of the PCS; the cognitive fusion and 
avoidance subscales of the PIPS; the engagement and pain willingness subscales of 
the CPAQ; the AIS; and the activity subscale of the FABQ (Table 5.2). 
 
Table 5.2 Baseline and outcome questionnaire scores from patients in the Centre B PMP, 
significance values shown for paired t-tests. 
Questionnaire (Subscale) Baseline 
Mean ±SD 
Outcome 
Mean ±SD 
Paired t-test outcome 
Effect size 
Cohen’s d 
HADS (Anxiety) 12.6 ±4.9 10.7 ±4.9 t = 6.0, df(129), p < .001* 0.53 m 
HADS (Depression) 11.1 ±4.4 8.7 ±4.4 t = 8.0, df(130), p < .001* 0.70 m 
PCS (Rumination) 10.6 ±4.3 8.4 ±4.7 t = 5.2, df(97), p < .001* 0.53 m 
PCS (Magnification) 6.3 ±2.9 5.1 ±3.2 t = 4.1, df(97), p < .001* 0.41 s 
PCS (Helplessness) 14.2 ±5.7 11.2 ±6.2 t = 5.3, df(97), p < .001* 0.53 m 
PIPS (Cognitive fusion) 23.6 ±4.1 21.0 ±5.6 t = 5.7, df(104), p < .001* 0.55 m 
PIPS (Avoidance) 40.0 ±11.5 32.0 ±11.6 t = 8.0, df(103), p < .001* 0.79 m 
CPAQ (Engagement) 33.4 ±11.9 40.1 ±12.5 t = -5.2, df(102), p < .001* -0.52 m 
CPAQ (Pain willingness) 16.5 ±8.6 20.2  ±9.2 t = -4.5, df(101), p < .001* -0.44 s 
AIS (Total) 19.6 ±9.0 23.5 ±6.0 t = -4.7, df(116), p < .001* -0.43 s 
FABQ (Activity) 17.1 ±4.8 12.4 ±6.1 t = 4.0, df(16), p = .001* 0.98 l 
FABQ (Work) 23.1 ±13.6 20.9 ±10.9 t = 0.8, df(12), p = .421 0.23 s 
SD = Standard Deviation; HADS = Hospital Anxiety and Depression Scale; PCS = Pain 
Catastrophising Scale; PIPS = Psychological Inflexibility to Pain Survey; CPAQ = Chronic Pain 
Acceptance Questionnaire; AIS = Acceptance of Illness Scale; FABQ = Fear Avoidance Beliefs 
Questionnaire; * = significant difference between scores (α = .05), s = small effect size (d = 0.2–0.5); m 
= medium effect size (d = 0.2–0.8); l = large effect size (d > 0.8). 
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5.4.2 Correlations between Changes in Scores from Baseline to Outcome 
From baseline to outcome, the increase in scores on the anxiety and depression 
subscales of the HADS were correlated with several other measures (Table 5.3). 
 
Table 5.3 Correlations (Pearson’s r) between changes in subscale scores on the HADS, and 
subscale scores on the PCS, PIPS, CPAQ, AIS, and FABQ, from baseline to outcome. 
Scale Subscale (N) Anxiety Depression  
 
PCS 
 
Rumination(100) .31** .28**  
Magnification (100) - .28**  
Helplessness (100) .37** .41** 
 
PIPS 
Cognitive fusion (105) .27** .27**  
Avoidance (104) 
 
.34** .38**  
CPAQ 
Engagement (103) - -.31**  
Pain willingness (102) 
 
- -  
AIS 
 
Acceptance (115) 
 
-.31** -.30**  
FABQ 
Fear of activity (15) - -  
Fear of work (11) - -  
** = significant at p < .01 level. HADS = Hospital Anxiety and Depression Scale; PCS = Pain 
Catastrophising Scale; PIPS = Psychological Inflexibility to Pain Survey; CPAQ = Chronic Pain 
Acceptance Questionnaire; AIS = Acceptance of Illness Scale; FABQ = Fear Avoidance Beliefs 
Questionnaire. 
 
5.5 DISCUSSION 
 
In this study of 131 patients attending an ACT-based PMP, there were significant 
improvements in several measures of psychosocial health and attitudes towards pain 
from baseline to follow-up. The majority of questionnaires used focused on the way 
patients’ responded to and dealt with pain, and therefore were well-suited to assess 
the efficacy of the delivery of the programme. The general measure of mental health 
(HADS) also demonstrated a significant improvement in both feelings of anxiety and 
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depression in the patients, with mean scores on both scales falling to < 11 following 
the programme. Correlational analysis demonstrated that reductions in anxiety and 
depression scores correlated with reduced catastrophising and inflexibility to pain 
and increased acceptance of pain. This agrees with earlier studies (McCracken & 
Eccelston 2005; Vowles et al. 2008, 2014), which consistently show that increased 
acceptance is associated with improved emotional, social, and physical functioning, 
as well as decreased use of healthcare and medication, and better work status. 
5.5.1 Limitations and suggestions 
The present study did not include measures of patient general health, physical 
function, daily activity, social function, or pain intensity. Such measures could have 
been included to give a more rounded picture of changes in patient quality of life 
across the duration of the programme, and also to investigate correlations between 
the change in attitudes to pain and more general health outcomes. For example, the 
ACT-based programme contained an exercise/physiotherapy component; however 
there was no record made of patient activity. The inclusion an activity scale such as 
the FAI, or the SF-36 general health status questionnaire is recommended for future 
assessment of this PMP. 
5.5.2 Comparison with audit of CBT-based programme (Chapter 3) 
Direct comparison with the CBT programme audit is difficult because only the 
HADS was a common measure in both groups. Both studies revealed a significant 
improvement in anxiety scores from baseline to outcome, however effect size was 
slightly larger in the ACT sample. Depression scores did not significantly improve at 
outcome in the CBT sample, but there was a significant improvement in the ACT 
group. One explanation for this finding is that ACT teaches acceptance of negative 
thoughts as part of normal life and how to deal with them through a process of non-
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judgemental awareness, thereby lessening their impact on mental wellbeing. At the 
follow-up data collection point in the CBT sample, depression scores were 
significantly improved over baseline, which indicates that this benefit of treatment 
took longer to emerge, and this may be due to differences in treatment approach 
compared to ACT. 
The PCS is comparable to the catastrophising subscale of PCSQ as it uses some of 
the same statements, however the scoring is different – PCS uses 3 subscales. Both 
CBT and ACT audits showed significant improvements in catastrophising scores, 
however the effect size was larger in the ACT group. Acceptance has been suggested 
to have a mediating effect on catastrophising in chronic pain (Vowles et al. 2008) 
and this could explain the larger effect of ACT on catastrophising compared to CBT 
that was observed.  
The CBT audit had a follow-up data collection point, which was not available in the 
ACT audit. A follow-up data collection would ideally be included reveal the longer-
term effects of the ACT treatment, as the earlier CBT audit revealed that some 
treatment benefits did not emerge until the follow-up data collection point. The 
questionnaires used to assess the ACT-based programme mainly focused on mental 
health and pain acceptance, whereas the CBT audit also surveyed changes in general 
health and in daily physical activity. In order to gain a more complete picture of 
patient outcomes such questionnaires should be added to the battery used to assess 
the ACT-PMP patients in future. 
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CHAPTER 6 
EEG MEASURES OF TONIC PAIN PROCESSING IN 
PATIENTS BEFORE AND AFTER ATTENDING AN 
ACCEPTANCE AND COMMITMENT THERAPY (ACT) PAIN 
MANAGEMENT PROGRAMME 
6.1 ABSTRACT 
Background: The ACT-based pain management programme at Centre B has been 
shown to bring about significant improvements in psychosocial health and attitudes 
to pain in a large sample (Chapter 5). Previous work in this thesis (Chapter 4: Study 
B) revealed that CBT-based treatment may affect the cortical electrical response to 
pain. The present study used the identical test paradigm in a sample of patients 
before and after ACT-based treatment. To confirm findings, a waiting-list/treatment 
as usual control group was also tested in a similar manner. 
Methods: Continuous EEG recording was carried out at rest and following medium 
duration (90s) tonic painful stimulation using the cold pressor test. Recording 
sessions were carried out with 4 patients, both before and after attending an ACT-
based PMP; and also with 13 waiting-list/treatment as usual control patients over a 
12 week period. Participants also filled in questionnaires to measure psychophysical 
health and pain coping strategies, as per earlier studies. 
Results: There were no significant effects of cold pressor pain upon EEG spectral 
power in either the patient treatment or patient control group. Questionnaire scores 
did not change significantly between baseline and follow-up sessions in either the 
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patient treatment or patient control group. Comparing the effect of the CPT on 
spectral power between all four groups (including the CBT and healthy control 
groups), spectral power changes were not similar between all patient groups at 
baseline; at follow-up, the effects of CPT on PSD were different from baseline, but 
there was no consistent pattern to suggest treatment effects. 
Conclusion: The earlier finding that θ- and α-power are reduced in a patient group at 
baseline following cold pressor pain was not supported in either of the patient groups 
tested in this study. Group size in the treatment (ACT) group was small (4) meaning 
statistical tests lacked power and small/medium effects of the CPT (if any) could not 
be identified. Patient control group size was equivalent to group sizes used in the 
earlier study, yet the effect of the CPT at the baseline session did not match that of 
the earlier patient group. Results cast doubt on earlier significant findings, and these 
should be ideally be confirmed by repeating the study with larger patient groups. 
 
6.2 BACKGROUND 
 
This study was designed to investigate the effects of PMP treatment upon the EEG 
power spectral density (PSD) of participants, under two conditions, measured before 
and after treatment. The study used an identical protocol to that of the earlier study 
(Chapter 4, Study B) with one major difference: the treatment programme was based 
upon principles of ACT rather than CBT. Participants underwent EEG test sessions 
before and after they had attended an ACT-based PMP, which has proven efficacy in 
improving psychosocial health and attitudes towards pain from baseline to outcome 
(Chapter 5). Comparative data was also recorded from a ‘treatment as usual’ control 
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group consisting of patients who were on the waiting list for the treatment 
programme. 
The earlier study of patients attending a CBT-based PMP revealed that the effect of 
cold pressor pain upon relative PSD at baseline (before treatment) was a significant 
reduction in both θ- and α-power in both left- and right-hemispheres, compared to 
PSD recorded at rest.  Following treatment, these significant changes in relative PSD 
in response to cold pressor pain were no longer observed. Furthermore, in 
comparison to a healthy control group, pre-treatment between-group differences in 
left-hemisphere α-power and right-hemisphere θ-power were not observed post-
treatment. These results suggest the possibility that treatment can effect brain activity 
in response to painful stimulation in patients, bringing it closer to brain activity of 
healthy persons. A waiting list control group was included in the present study to 
provide comparative data, to confirm that the change in brain activity previously 
observed in patients was related to the treatment, and not due to the effect of 
familiarity with the stimuli from the baseline to the outcome test session. 
To investigate the relationship between changes in questionnaire scores and changes 
in EEG data pre-post treatment, a short case series was also performed. Two patients 
were chosen as cases, being those who had the largest and the smallest change in 
EEG PSD pre-post treatment (across both EEG studies). This may reveal a 
correlation between certain self-report measures and brain activity. 
6.2.1 Aims 
The aims of this study were to assess PSD at rest and during induced pain, in patients 
pre- and post-treatment in the ACT-based PMP at Centre B, and to compare this with 
data from a control group of waiting list/treatment as usual patients, as well as with 
data from the previous EEG study (Chapter 4: Study B). A case series was also 
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performed to investigate the relationship between changes in questionnaire scores 
and changes in EEG data. 
 
6.2.2 Objectives 
The objectives of this study were: to record continuous EEG at rest and during CPT 
induced pain in a group of patients before and after treatment, and to take the same 
measurements in a group of patient controls. Questionnaire data was also collected to 
verify the efficacy of the treatment in the patients studied. 
6.2.3 General Aspects 
The study was approved by the National Research Ethics Service Committee West 
Midlands-Solihull (granted: 15/12/2011, ref: 11/WM/0407) and the Research and 
Development committees at Russells Hall Hospital, Dudley (granted: 14/02/2012, 
ref: ID1004) and New Cross Hospital, Wolverhampton (granted: 18/02/2013, ref: 
12CRIT01), and was sponsored by Birmingham City University (granted: 
24/10/2011). The study protocol, participant information sheets, and informed 
consent forms were all approved by the above NHS research ethics committees. 
 
6.3 METHODS 
 
6.3.1 Study Design 
The study used a prospective cohort design to assess the impact of an ACT-based 
PMP treatment upon PSD and questionnaire measures collected from treated patients 
and waiting list controls at two time points (baseline and outcome).  
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There were 4 participants in the patient group (3 female, 1 male, mean age = 49, 
range = 39–56), recruited consecutively from the population of chronic pain patients 
who had been enrolled into the PMP at Centre B. Test sessions were carried out in 
two-week periods before and after patients attended the Centre B PMP, and took 
place at Centre A. 
The control group consisted of 13 participants (12 female, 1 male, mean age = 49, 
range = 33–64), recruited consecutively from the population of chronic pain patients 
who were on the waiting list of the PMP at Centre B. Test sessions were carried out 
10 weeks apart, and took place at Centre A.  All data was collected by the author. For 
the duration of the test sessions, participants sat in a quiet, dimly lit room. 
Participants were fitted with EEG recording equipment and given time to become 
familiar with the cold water bath stimuli prior to testing. 
 
6.3.2 Test Procedure 
EEG data was recorded with the same equipment setup as used in Chapter 4 (see 
Section A.2.3). The test procedure was identical to that used in Chapter 4: Study B 
(see Section B.2.2), consisting of two periods of EEG recording, before and after 
exposure to the CPT (Figure 6.1). 
 
Figure 6.1 Diagram of the test procedure. 
 
EEG recording              
(180 seconds)
Cold Pressor            
(90 seconds)
EEG recording                
(90 seconds)
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6.3.3 Data Processing and Analysis 
Data from recording periods were filtered, converted from the time domain to the 
frequency domain using the Fast Fourier Transformation (FFT), and relative spectral 
power in each of the four bands (δ, θ, α, β) calculated for the left and right 
hemispheres in an identical manner to Chapter 4: Study B (see Section B.2.3). The 
main effect of treatment/time upon the relative spectral power in each band (over 
each hemisphere in the rest-rest period within each group) was calculated using a 
Wilcoxon Signed-Rank test for related samples (as the Shapiro-Wilk test indicated 
that some data could not be assumed to come from a normally distributed 
population). Between-group differences in the relative spectral power within each 
frequency band (over each hemisphere in each rest period) were calculated using a 
Mann-Whitney U test. The main effect of the CPT upon the relative spectral power 
within each frequency band (over each hemisphere at the two time points within each 
group) was calculated using Wilcoxon Signed-Rank tests. 
6.3.4 Questionnaire Data Collection and Analysis 
In the period one week prior to the EEG test session, a pack was sent to participants 
containing five questionnaires: Short Form 36-item general health questionnaire (SF-
36); Hospital Anxiety and Depression Scale (HADS); Pain Coping Strategies 
Questionnaire (PCSQ); Frenchay Activities Index (FAI); Multidimensional Health 
Locus of Control Scale Form C (MHLC-C), together with instructions that they 
should bring the completed questionnaires with them to the subsequent test session. 
Questionnaire scores were collated and analysed in a pair-wise fashion as per the 
previous studies (see Section 3.3.5). 
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6.3.5 Comparison of PSD Data with Data from the Previous Study 
PSD data from the waiting list control group was compared with PSD data obtained 
from the patient treatment and healthy control groups from the earlier study (Chapter 
4: Study B). Between-group differences in the effect of the CPT on relative spectral 
power within each frequency band (over each hemisphere in each rest period) were 
calculated using a Kruskall-Wallis test for k independent samples (k > 2) (Kruskall & 
Wallis 1952). Post-hoc testing was performed using Dunn’s test (Dunn 1964), 
adjusted p-values were used to correct for multiple comparisons. 
 
6.4 RESULTS 
 
6.4.1    EEG power – analysis of the effect of CPT 
6.4.1.1    Within-group differences 
Relative EEG spectral power in each of the four bands, in left and right hemisphere 
regions, was compared within each group between the rest-rest and cold-rest 
recording periods. Results are illustrated for the patient treatment group in Figure 6.2 
and for the waiting list control group in Figure 6.3. 
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In the patient treatment group, at baseline and at outcome, there were no significant 
differences in relative spectral power following CPT, in any of the four power bands. 
Effect of CPT upon relative spectral power in the patient treatment group 
 
Figure 6.2 Effect of cold pressor on relative spectral power in each of the four bands in the 
left and right hemisphere electrodes (patient treatment group). There were no significant 
differences in power, either within- or between-sessions. 
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In the waiting list control group, at baseline and at outcome, there were no significant 
differences in relative spectral power following CPT, in any of the four power bands. 
 
Effect of CPT upon relative spectral power in the waiting list control group 
 
Figure 6.3 Effect of cold pressor on relative spectral power in each of the four bands in the 
left and right hemisphere electrodes (waiting list control group). There were no significant 
differences in power, either within- or between-sessions. 
 
6.4.1.2    Between-group differences 
The change in relative spectral power from rest-rest to cold-rest in each of the four 
bands in each hemisphere was compared between-groups at baseline and outcome 
time-points. There were no significant differences between the two groups. 
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6.4.2 Questionnaire Data 
Comparisons were performed on participants’ questionnaire subscale scores between 
baseline and outcome using Student’s t-test for related samples. There were no 
significant differences in any scores between baseline and follow-up. Results are 
summarised in Table 6.1 below. 
 
Table 6.1 Baseline and outcome questionnaire scores from patients in Centre B PMP and 
waiting-list controls. 
 Treatment group (n =4)  Control group (n = 13) 
Questionnaire (Subscale) 
Baseline 
Mean ±SD 
Outcome 
Mean ±SD 
 Baseline 
Mean ±SD 
Outcome 
Mean ±SD 
SF36 (General health) 32.7 ±0.0 54.0 ±23.7  33.6 ±23.7 37.8 ±27.1 
SF36 (Physical functioning) 25.0 ±0.0 22.5 ±21.0  18.5 ±23.3 23.5 ±28.9 
SF36 (Role limitations due 
to physical health) 
0.0 ±0.0 0.0 ±0.0  8.0 ±20.9 9.6 ±24.0 
SF36 (Role limitations due 
to emotional problems) 
25.0 ±0.0 41.5 ±49.9  22.4 ±36.8 12.8 ±29.0 
SF36 (Social functioning) 37.5 ±0.0 42.8 ±14.4  32.9 ±23.6 39.1 ±25.4 
SF36 (Bodily pain) 25.0 ±0.0 34.0 ±31.3  20.4 ±17.0 18.5 ±17.5 
SF36 (Vitality) 25.0 ±0.0 26.9 ±17.0  21.3 ±20.2 23.2 ±20.0 
SF36 (Mental health) 48.3 ±18.9 71.0 ±10.5  45.9 ±14.8 48.9 ±21.1 
PCSQ (Catastrophising) 16.8 ±5.3 12.0 ±6.6  11.2 ±3.9 11.2 ±5.4 
PCSQ (Cognitive coping 
and suppression) 
32.8 ±14.7 54.0 ±15.4  12.0 ±4.6 10.0 ±4.2 
PCSQ (Helplessness) -1.7 ±13.9 -18.4 ±7.6  22.5 ±12.1 27.2 ±11.2 
PCSQ (Diverting 
attention/praying) 23.1 ±12.4 35.5 ±15.9  18.5 ±10.5 16.6 ±10.0 
HADS (Anxiety) 11.8 ±5.3 7.9 ±3.4  33.9 ±15.7 42.9 ±18.7 
HADS (Depression) 10.0 ±3.8 6.7 ±3.7  3.3 ±14.7 -1.4 ±13.7 
Frenchay Activities Index 30.5 ±11.7 35.0 ±14.2  23.6 ±10.9 21.0 ±9.4 
MHLC-C (Internal) 12.8 ±6.4 14.0 ±4.2  18.5 ±6.6 18.2 ±7.5 
MHLC-C (Chance) 8.5 ±2.9 12.0 ±2.6  12.5 ±6.3 13.8 ±5.0 
MHLC-C (Doctors) 6.3 ±1.9 6.5 ±4.5  7.8 ±1.9 7.6 ±2.0 
MHLC-C (Others) 8.3 ±2.9 6.5 ±2.9  6.9 ±2.4 6.8 ±2.9 
SD = Standard Deviation; SF36 = Short form 36 item general health survey; PCSQ = Pain coping 
strategies questionnaire; HADS = Hospital Anxiety and Depression Scale; FAI = Frenchay Activities 
Index, MHLC-C = Multidimensional Health Locus of Control questionnaire form C. 
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6.4.3 EEG data – comparison with data from previous study (Chapter 4: 
Study B) 
 
Table 6.2 Demographic information for all participant groups. 
 Patient Treatment 
(ACT) 
n = 4 
Patient Treatment 
(CBT) 
n = 12 
Patient Control 
 
n = 13 
Healthy Control 
 
n = 14 
Gender (N) M (1); F (3) M (2); F (10) M (1); F (12) M (4); F (10) 
Age (years) ±SD 49 ±6.4 52 ±8.8 49.2 ±10.4 36 ±14.6 
Pain Condition:     
Fibromyalgia (FM) 2 4 4 - 
Back/neck pain - 2 1 - 
Disc degeneration 1 3 2 - 
Post injury pain 1 1 1 - 
Arthritis (OA/RA) - 2 3 - 
Neuropathic pain - - 2 - 
 
A Kruskall-Wallis test was conducted to compare the change in relative spectral 
power from rest-rest to cold-rest in each of the four bands in each hemisphere 
between-groups at baseline and outcome time-points. The test showed that at 
baseline there was a statistically significant difference in the change in left 
hemisphere α-power (χ2 (3, N = 39) = 8.42, p = .038). Post-hoc comparisons using 
Dunn’s test indicated that the mean change in left hemisphere α-power for the patient 
treatment (CBT) group (M = -3.96, SD = 4.0) was significantly different than the 
healthy control group (M = 2.13, SD = 5.0, z = -2.87, p = .025). At outcome there 
were no statistically significant differences between the three groups. Results are 
illustrated in Figure 6.4. 
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Baseline: effect of CPT on spectral power in left and right hemisphere electrodes 
 
 
Outcome: effect of CPT on spectral power in left and right hemisphere electrodes 
 
Figure 6.4 Effect of cold pressor test (CPT) on spectral power in patient treatment (PT) 
(CBT and ACT groups), patient control (PCtrl) and healthy control (HCtrl) groups at 
baseline (upper) and outcome (lower). At baseline, there was a significant difference 
between the PT (CBT) and HCtrl groups in the effect of CPT on alpha power in the left 
hemisphere, * = significant at p < .05 level. 
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6.5 DISCUSSION 
 
6.5.1 Within-group differences 
6.5.1.1    Patient treatment group 
At both baseline and outcome sessions, there was no significant change in EEG 
spectral density following immersion in the cold pressor. Also questionnaire scores 
revealed no significant differences in psychophysical health and attitudes to pain at a 
group level. The group size was small (4 participants), meaning that statistical 
significance tests of the effects of the CPT on PSD, or of the treatment on 
questionnaire scores were heavily influenced by variance in individual data points. 
For example, there were obvious changes in questionnaire subscale mean scores 
from pre- to post-treatment (Table 6.1), however these were smaller than one 
standard deviation. 
The effect of CPT upon spectral power was similar across sessions: δ- and β-power 
increases were accompanied by decreases in θ- and α-power (Figure 6.2). If there 
was any effect of the treatment upon the response to cold pressor pain, it was too 
small to be identified. Large, consistent effects across all participants were absent, 
and the small group size meant that small/medium effects would not be picked up. 
6.5.1.2    Patient control group 
The patient control group showed that treatment as usual has no significant effect on 
psychosocial parameters measured using self-report questionnaires and this was as 
expected.  
In response to the CPT, α-power decreased in both sessions, θ-power did not change 
in both sessions, whereas δ-power decreased slightly at baseline, but increased 
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slightly at follow-up, also β-power increased at baseline but decreased at follow up. 
None of the changes were significant, but the slight differences between sessions 
may indicate some effect of familiarity with the stimulus. 
6.5.2 Between-group differences (including groups from previous study) 
At baseline, the effect of CPT on PSD in the patient groups was not similar between 
all three groups (Figure 6.4, upper). Alpha-power was significantly reduced by the 
CPT in the CBT patient treatment group, visibly reduced (non-significantly) in the 
patient control group, and barely changed in the ACT patient group. The effect on θ-
power was similar between the two treatment groups; there was a visible decrease in 
both groups, however in the patient control group there was no observable change. 
All patients were drawn from a similar population and were at same stage of 
treatment (baseline/pre-treatment), and would be expected to show similar response 
to CPT. The earlier finding that θ- and α-power are significantly reduced following 
cold pressor pain was not supported by either of the patient groups tested in this 
study.  
There was a consistent increase in left-hemisphere β-power following CPT in all 
patient groups, but in the healthy control group there was a decrease in β-power. 
Beta-power increases could have been the result of muscle activity artefacts, which 
have previously been found to contaminate high-β frequencies (Backonja et al. 
1991).  Indeed, as the left hand had been placed in the cold pressor, it is possible that 
the left side increase in β-power was due to left arm, shoulder, and neck muscle 
movements made by the participants in response to discomfort in the left hand. 
Previous studies have reported inconsistent or absent θ-power changes in response to 
CPT in healthy subjects (Table 2.8). The one study that tested a patient sample 
(Stevens et al. 2000; fibromyalgia) reported an increase in θ-power during tonic pain 
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compared to rest. The present study tested groups of patients with a mix of 
conditions, meaning that the effect of tonic pain on θ-power could not be predicted 
based on earlier work that tested patients with the same condition together. Such 
contrasting findings between three groups drawn from the same population could 
suggest that θ-power changes are not a reliable effect of tonic pain, and if the study 
were repeated with new samples, quite different results may be found. It must be 
noted that group sizes were smaller than planned in this study, meaning that the 
effect of individual data on the group average is relatively greater compared to larger 
sample sizes, and this may have influenced the result. The desired group size of 19 
participants was not attained due to difficulties in recruiting and retaining sufficient 
participants in the time available. Individual differences were controlled for where 
possible by the use of paired comparisons to analyse the group data; each participant 
was only compared to him/herself under different conditions, meaning it was the 
difference between the conditions that was analysed, rather than absolute values. In 
this way, any participants exhibiting abnormal absolute values would not overly 
influence the group average. 
6.5.3 Limitations and suggestions 
These inconsistent findings may be due to methodological inconsistencies between 
the present studies and previous research in this area. In the present studies 
participant EEG was not recorded whilst the hand was immersed in  the cold pressor 
and significant effects on PSD may have subsided by the time that recording was 
started following withdrawal from the CPT. Two earlier studies performed EEG 
recording during and after immersion in the cold pressor:  A.C.N. Chen and 
colleagues (1989) reported that post-CPT readings remained slightly different to rest 
but not to the significant extent seen during immersion in the CPT; also Stevens and 
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colleagues (2000) recorded a post-CPT EEG at one minute after withdrawal, δ-power 
remained elevated compared to rest but other bands displayed no real difference 
compared to rest. These studies therefore make a convincing case for recording 
during immersion in the cold pressor to ensure the observation of maximal change in 
PSD. In the present studies, recording was not conducted during CPT in order to 
minimise EEG contamination from muscle activity caused by participants not being 
relaxed. Whilst the advantage of this method is a period of relatively artefact-free 
recording, it has the disadvantage of not recording the data from the time when the 
effect of tonic pain upon PSD was at its peak. The alternative method, favoured by 
almost all of the earlier CPT studies (Table 2.8), has been to record EEG during 
immersion in the cold pressor and then remove artefact contaminated data in a pre-
processing step before performing FFT. In these earlier studies the finding that tonic 
pain causes a temporary decrease in α-power and increase in β-power is relatively 
consistent. The reason that this outcome was not found across participant groups at 
baseline in the present study is most likely due to the fact that EEG was recorded 
after CPT rather than during CPT, meaning that the effect of tonic pain upon the 
EEG was not at maximum during recording. 
The present study also neglected to remove artefacts from the continuous EEG data, 
on account of the participants being at rest during the recording, which meant that 
movements were minimal. The presence of movement artefacts may have influenced 
the result, however this is unlikely based upon previous studies. Movement artefacts 
may not be a problem when studying < 25Hz activity, as at least two studies have 
shown that muscle activity does not interfere with these frequencies. Dowman and 
colleagues (2008) tried to control for muscle artefacts by recording a control 
condition in which participants made a wincing facial expression. 
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A final limitation is that there was no control for vigilance. The frequency 
composition of resting EEG may fluctuate according to the level of vigilance or 
arousal of the subject at the time of recording, which may also vary across sessions 
and subjects. It is therefore possible that the observed effects of tonic pain upon PSD 
were solely due to increased arousal and vigilance compared to the resting condition. 
Guidelines from the international pharmaco-EEG society suggest that vigilance can 
be controlled by having subjects perform some continuous cognitive task whilst at 
rest, incorporating a fixation point to minimise eye movement artefacts; also sleep 
pattern over the preceding few days, the time since last meal, and type of food 
consumed can affect vigilance levels and should be taken into account (Jobert et al. 
2013). 
6.5.4 Conclusion 
The earlier finding that θ- and α-power are reduced in a patient group at baseline 
following cold pressor pain was not supported in either of the patient groups tested in 
this study. Group size in the patient treatment (ACT) group was small (4) meaning 
statistical tests lacked power and small/medium effects of the CPT (if any) could not 
be identified. Patient control group size was equivalent to group sizes used in the 
earlier study, yet the effect of the CPT at the baseline session did not match that of 
the earlier patient group. EEG recording may yield more consistent results if brain 
activity is sampled during immersion in the cold pressor. Results did not support 
earlier significant findings, and these should be confirmed by repeating the studies 
with the suggested methodological change using a larger group of participants. 
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6.6 CASE SERIES 
 
To investigate the relationship between changes in questionnaire scores and changes 
in EEG data pre-post treatment, a short case series was also performed. Two patients 
were chosen as cases, being those who had the largest and the smallest change in 
EEG PSD pre-post treatment (across both EEG studies). A relationship between the 
change of PSD and in certain questionnaire scores may indicate a psychological basis 
for changes in brain activity. 
6.1 Case study 1: Patient A 
Patient A showed the largest differences in the effect of the CPT upon PSD pre-post 
treatment. More specifically, large fluctuations in δ-, θ-, and β-power following 
exposure to the CPT pre-treatment were far less pronounced post-treatment, whereas 
there was the opposite effect of CPT on α-power (small change pre-treatment, large 
change post-treatment). 
Pre-post treatment questionnaire scores for patient A showed improvement on all 
scales, particularly SF36 (Role limitations due to emotional problems), SF36 (Social 
functioning), daily activity, and catastrophising. 
6.2 Case study 2: Patient B 
Patient B showed the least differences in the effect of the CPT upon PSD pre-post 
treatment. At both pre- and post-treatment test sessions there was little effect of 
exposure to the CPT upon PSD. 
Pre-post treatment questionnaire scores for patient B were a mix of improvements on 
some scales (for example use of the cognitive coping and suppression pain coping 
strategy), and worsening on other scales, particularly SF36 (Physical functioning), 
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SF36 (Social functioning), and catastrophising. Daily activity score remained at the 
same level pre-post treatment. 
6.3 Case series discussion 
Patient A improved on all scales of the self-report measures post-treatment, as well 
as displaying large fluctuations in PSD following CPT at baseline, which reduced at 
follow up (with the exception of an increase in α-power). Conversely, the PSD of 
Patient B was relatively unaffected by exposure to the CPT at baseline and follow-
up; and fewer improvements on questionnaire scores were seen, in fact some scores 
worsened. Given these findings, it is suggested that baseline EEG fluctuation 
following exposure to a tonic pain stimulus might be a possible indicator of future 
PMP treatment efficacy. As this interpretation is based on just two cases, caution 
must be advised, however it does give a useful direction to proceed in future work. 
Also interesting to note is that in Patient A the changes in PSD (increased α-power) 
accompanied improvements in catastrophising, social functioning, and daily activity 
scores; whereas in Patient B there was little change in PSD and scores on the same 
scales actually worsened following treatment. Previous studies have made a link 
between α-power and catastrophising scores, suggesting that the α-activity may be 
related to a suppression of negative feelings (Davison 2004, Klimesch et al. 2007, 
M.P. Jensen et al. 2015).  This is a tentative link, however future work might focus 
on how α-activity is related to catastrophising based on these findings. 
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CHAPTER 7 
CONCLUSIONS 
 
7.1 INTRODUCTION 
Studies reported in this thesis have investigated the effect of two multidisciplinary 
pain management programmes upon psychosocial measures in the form of self-report 
questionnaires, and also upon neurophysiological responses to pain recorded using 
EEG. Experimental Chapters 3 and 5 contained investigations of whole populations 
of patients who had attended either the Centre A CBT-based PMP or the Centre B 
ACT-based PMP since they were started. These studies both revealed significant 
improvements in self-report questionnaire scores from pre- to post-treatment. 
Literature reviewed in Chapter 2 showed that successful treatments for pain 
(surgical, pharmacological, and psychological) are associated with measurable 
changes in brain activity. However, studies had not previously investigated the effect 
of group multidisciplinary pain management upon brain activity related to pain 
processing. Based on these findings, neurophysiological experiments were performed 
in samples of patients from each programme, and also in patient and healthy control 
groups, both to identify brain activity in response to painful stimulation, and to 
examine any pre- to post treatment changes in this brain activity. These were 
reported in Chapters 4 and 6. In the CBT-based PMP patient group, cold pressor pain 
caused a significant reduction in α- and θ-power at baseline, which was no longer 
significant following treatment. Both control groups showed very little intra- and 
inter-sessional difference in spectral density. The ACT-based PMP patient group 
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ultimately lacked sufficient numbers, meaning the results could not be used to make 
meaningful comparisons between the two programmes. However, the effect of cold 
pressor pain upon θ- and α-activity was found to be modulated following a CBT-
based PMP. These findings lend support to the understanding of pain as a 
biopsychosocial phenomenon – a treatment such as the PMP which focuses on the 
‘psycho’ and ‘social’ components of the biopsychosocial model not only brings 
about change in measures of those components, but also in measures of brain activity 
(the ‘bio’ part of biopsychosocial). 
7.2 SUMMARY OF FINDINGS 
The effect of both treatment programmes was a significant, but small, improvement 
in the majority of questionnaire measures, pre- to post-treatment. These findings 
agree with previous studies which have also found that psychologically-based, 
multidisciplinary pain management tends to bring about small but significant 
improvements in patients, and is more effective than treatment as usual (Morley et al. 
1999; Hoffman et al. 2007; Veehof et al. 2011; A. Williams et al. 2012; Hann & 
McCracken 2014). These improvements followed treatment with PMPs that were 
based on cognitive theory (CBT-based PMP) or the psychological-flexibility model 
(ACT-based PMP). The questionnaires used in the two audit studies differed in their 
assessment of the underlying theory of the treatment programme. The CBT-based 
programme audit focused on aspects of the cognitive triad (thoughts, feelings, 
behaviours) such as coping strategies, catastrophising, mental health, and daily 
activity. Conversely the ACT-based PMP audit looked at psychological-flexibility 
and acceptance, as well as mental health. Therefore, each audit lent weight to the 
theory underlying the treatment programme; however the cognitive model, being 
elegant in its simplicity, offers a neat framework for understanding the efficacy of 
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pain treatment by PMP.  Despite this, the inherent problem with using self-report 
questionnaires to assess treatment outcomes is that they are a measure of subjective 
experience and cannot reveal underlying physiological mechanisms that may 
accompany successful treatment. Nonetheless, subjective measures are important in 
understanding the psychosocial changes that occur across treatment, and these 
changes are known to influence the initiation, exacerbation, attenuation, and 
maintenance of pain (Jensen & Turk 2014). 
The EEG studies revealed that the effect of tonic pain upon spectral power was 
different between healthy and patient samples, and that there were measurable 
changes pre- to post-treatment that were not seen in the treatment as usual sample. In 
the treated group of patients, the effect of tonic pain pre-treatment were significant 
decreases in θ- and α-power, accompanied by an observed increase in β-power. Post-
treatment, θ- and α-power were less effected by tonic pain, an increase in β-power 
was still observed. Decreased α-power accompanied by an increase in β-power is a 
characteristic response to salient events (B. Bromm & Lorenz 1998), and has often 
been explained as an event-related desynchronisation (Pfurtscheller & Aranibar 
1977) of resting rhythms (α) with the corresponding synchronisation of faster (β) 
rhythms as the brain reacts to the event (Pfurtscheller 1992; Pfurtscheller & Lopes da 
Silva 1999). Decrease of slow θ- and α-rhythms in the patient treatment group 
indicates an interruption of resting brain activity by the tonic pain stimulus, and the 
increased β-power indicates arousal. Post-treatment, the less severe reduction in θ- 
and α-rhythms means that the pain stimulus did not interrupt resting brain activity to 
the same extent as at pre-treatment, indicating there was an effect of treatment upon 
the cortical response to painful stimulation. This may have been due to a change in 
cognitive appraisal of painful signals brought about by taking part in the PMP, 
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supported by the reduction in catastrophising and feelings of helplessness post-
treatment. Patients also learned relaxation techniques for dealing with periods of 
increased pain, which they may have employed during exposure to cold pressor pain, 
and which may have contributed to the observed stability of θ- and α-power 
measured at outcome. A caveat to this is that observations may have been due to a 
familiarity with the stimulus at the outcome session, however this is unlikely, as the 
control groups tested did not exhibit significant differences between baseline and 
outcome measurements. The case studies hinted at a link between improved 
catastrophising scores and the effect of experimental pain upon EEG spectral density, 
suggesting a possible cortical basis for the effect of psychological treatment. 
PMP treatment has a measurable effect upon brain activity related to pain. This is a 
novel finding that has the potential to influence the way in which treatment for 
chronic pain is assessed and even how it is delivered. Treatments which modulate 
EEG activity could potentially be beneficial to individuals with chronic pain in 
helping them learn to regulate their experience of pain. Evaluations of treatment-
related brain activity changes might also allow for sub-grouping of patients and help 
to develop individualised treatments. The effects of psychological treatments on 
cortical activity could form the basis of a neuropsychological model of pain, which 
may be used to guide future research in understanding the mechanisms of clinical 
psychological treatments and the brain states that may facilitate treatment response. 
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7.3 CLINICAL IMPLICATIONS AND SUGGESTIONS FOR FURTHER 
STUDY 
7.3.1 Programme delivery 
The two PMP audits both showed that patients made significant improvements on 
domains of measurement pre- to post-treatment regardless of specific psychological 
format (CBT or ACT). This finding agrees with the observations made by other 
researchers that different psychological treatments tend to result in similar outcomes 
(Wetherell et al. 2011; A. Williams et al. 2012). However, there was one notable 
difference between the two programmes other than the psychological basis – the 
CBT-based programme had been running for over 15 years, whereas the ACT-based 
programme was just into its third year. The fact that both programmes significantly 
improved measures of psychological health and wellbeing, suggests that outcomes 
are less dependent on the particular contents of the programme and expertise of staff, 
and may be due to a more vague and general group behaviour effect. Patients’ 
chronic pain is a private experience that is difficult to communicate to others, 
especially to the majority of people who only understand pain as an acute sensation. 
Treatment within a group who all suffer from similar problems can have a positive 
impact on the individual. A shared experience, a sense of not having to ‘go it alone’, 
opportunities to discuss their problems with people who have also experienced 
similar, and a feeling of intra-group connectedness can only be achieved in the group 
therapy setting, and these factors may be just as important as the content of the 
programme. 
The provision of pain management programmes tends to be limited to larger cities 
and towns due to the availability of trained staff and specialists required to run the 
treatment. If group treatment can be beneficial even when delivered by less 
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experienced and specialised staff, this would mean that more programmes can be 
rolled out into the community and at a greatly reduced cost. Physically impaired 
patients often find it difficult to attend treatment due to the inconvenience of 
travelling to and from larger centres. Local programmes would make it easier for 
patients to comply with the demands of attending and mean that ultimately many 
more patients would have access to treatment and support for their condition. 
7.3.2 Maintenance of improvements 
The audit of the CBT-based PMP contained data collected at baseline, outcome, and 
at a follow-up session three months after the programme had ended. Improvements in 
mental health were seen at outcome and remained improved at follow-up, compared 
to baseline. There was no change in scores on measures of physical activity at 
outcome, but at follow-up significant improvements had been made. This suggests 
that patients continued to put into practice themselves what they had learned on the 
programme, particularly activity pacing which requires a gradual increase in daily 
activity and could explain why the significant physical activity improvements 
emerged only at follow-up.  Conversely, significant decrease in the use of 
maladaptive coping strategies and increase in adaptive cognitive coping and 
suppression seen at outcome were not observed at follow-up, with scores not 
significantly different from baseline. The cognitive aspect of self-management may 
therefore be difficult to maintain in the absence of weekly treatment sessions.  
Studies which contain several follow-up data collection points over periods of 
months, years, or decades provide valuable insight into the long-term maintenance of 
initial positive benefits. The problem with such studies is that over time many 
patients are lost to follow-up, particularly those who no longer attend regular visits to 
healthcare providers where they can be surveyed. The patients who have maintained 
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positive improvements do not provide long-term data, meaning that later follow-up 
collection of data may only represent those patients who have relapsed to pre-
treatment levels, which emphasises the perceived lack of long-term benefit.  
A possible solution to the problem of long-term maintenance of benefits and to 
diminishing compliance with research is the use of technology. Online pain 
management programmes, software applications, automated email and text based 
communication, multi-user video telecommunication, and other methods of service 
delivery offer exciting opportunities that can address long-term self-management, 
barriers to treatment, social support, and the rising cost of healthcare (Murray et al. 
2005). Further research might examine the effects of these technologically driven 
treatments in order to monitor and refine their positive benefits, as well as identify 
the types of patients who might benefit most from them. 
7.3.3 Neurophysiological testing 
Pre- to post-treatment differences in the effect of tonic pain upon EEG power 
spectral density may be attributed to the effects of the pain management treatment 
programme. It is possible that specific aspects of the treatment were responsible for 
the observed effects on brain activity. If this were the case, it might be possible to 
make treatment programmes more streamlined to achieve the positive outcomes 
while using fewer resources. Future work in this area could therefore study outcomes 
in a group of patients that are tested before and after attending several sessions 
containing isolated components of the multidisciplinary programmes studied – for 
example: physiotherapy, relaxation techniques, pain education, mindfulness, and so 
on. A counterbalanced design would control for order effects, and this may even 
reveal an additive or subtractive effect depending on the order of treatment.  
168 
It is also important to bear in mind that individual patients will respond differently to 
treatment, and it is unlikely that one approach will benefit all patients. Chronic pain 
patients are usually grouped by clinicians’ conception of the pain phenotype, which 
is limited by lack of objective signs and reliance of patient account. If response to 
treatment can be measured objectively using EEG, and indeed is related to pre-
treatment measurements, it may be the case that certain patients respond differently 
to the treatment depending upon baseline physiology. Patients could be identified as 
more likely to be ‘responders’ before adding them to a treatment programme 
waiting-list. Patients who are classed as ‘non-responders’ could be given different 
forms of treatment sooner, rather than pursuing ineffective treatment which 
ultimately leads to a worsening of their overall condition. Such a strategy would 
improve outcomes for patients whilst also being more cost-effective than the current 
approach, where pain management programmes are delivered based on the 
preferences of the clinicians providing the treatment rather than on individual patient 
requirements. Ideally, treatment is flexible and not ‘one-size-fits-all’, and can be 
adapted depending on patient preferences and ongoing changes in both psychological 
and physiological measures. 
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